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ABS1RACT 
Induction of the aryl hydrocarbon hydroxylase (AHH) P450IA1 occurs 
in many organisms following exposure to polycyclic aromatic hydrocarbons 
(P AH). Regulation of induction of P450IA 1 (called P-450E) was examined in the 
estuarine teleost Fundulus heteroclitus. Antibodies were a primary tool in this 
work; their specificity and cross reactivity with other species were investigated by 
immunoblot and catalytic inhibition studies. Scup (Stenotomus chrysops) P-450E 
protein had been previously purified (Klotz et al., 83) and antibodies generated 
against it (Park et al., 86a). Monoclonal antibody (MAb) 1-12-3 reacted only with 
P-450E when tested in immunoblot analysis with five scup P-450 fractions. This 
and six other MAbs recognized purified P-450E, as well as a single comigrating 
band in microsomes from B-naphthoflavone- (BNF) treated scup. Polyclonal 
antibodies (PAb) reacted with P-450E but not with other scup P-450 fractions, and 
reacted strongly with the BNF-induced, comigrating band. PAb also faintly 
recognized other microsomal proteins, which were not changed in intensity by 
xenobiotic treatment. MAb 1-12-3 recognized P-450E induced by 3,4,5,3',4',5'-
hexachlorobiphenyl and Aroclor treatment and the P-450E orthologue in teleost 
species including rainbow and brook trout, winter flounder, and Fundulus. 
P-450E was induced in these fish by BNF and other xenobiotics. P-450E protein 
content in all fish analyzed correlated with ethoxyresorufin 0-deethylase (EROD) 
activity. EROD was strongly inhibited by MAb 1-12-3 in scup and trout. PAb 
inhibited AHH and EROD more than 90%, inhibited ethoxycoumarin 0-deethylase 
by about 60%, and did not inhibit aminopyrine N-demethylase, confirming the 
identity of P-450E as the major inducible EROD and AHH catalyst in these fish. 
Several MAbs and the PAb recognized purified rat P450IA1 and a BNF-induced, 
comigrating band in microsomes. MAb 1-12-3 and the PAb also recognized a 
second band, which comigrates with P450IA2, in microsomes from BNF-treated 
rats. These results establish the identity of P-450E in scup and other fish and the 
immunochemical relationship of P-450E with rat P450IA 1. 
The mode of PAH-type induction was investigated by examining hepatic 
P-450E content, catalytic activity, and mRNA levels in Fund(.!.lus after exposure to 
a single dose of BNF. In a 20 day experiment, EROD was elevated in BNF-
treated animals from Day 4 through Day 20. Increases in immunodetectable 
P-450E showed the same trend, with low control values and at least a 19-fold 
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increase in the BNF-treated fish. Teleost RNA was used in in vitro translation 
reactions in the presence of [3H]-leucine. Precipitation of Fundulus liver RNA 
translation products with anti-P-450E PAb gave no detectable signal from control 
fish, while the BNF-treated animals showed incorporation of [3H]-leucine in a 
single 56,000 Mr band. In a 48 hour experiment, EROD and P-450E levels were 
again coordinately increased in response to BNF treatment, and immunoprecip-
itation of translation products showed increased signal at all times 6 hours or more 
post-treatment. eDNA pfPt450-3', which encodes trout P450IA1 (Heilmann et 
al., 88), yielded unique bands on Southern blots with scup, trout and Fundulus 
DNA. A Northern blot of RNA from BNF-treated Fundulus showed increases in 
a single band with time when probed with the trout eDNA. P-450E mRNA 
increases preceded P-450E protein and EROD increases by about 25 hr, support-
ing the hypothesis that transcriptional activation is involved in induction of P-450E 
in fish. In another BNF study, Fundulus P-450E mRNA levels declined rapidly, 
returning to control levels by 5 days, while protein and activity levels remained 
elevated for at least 13 days. Thus, P-450E expression also appears to be under 
other forms of regulatory control. 
Microsomal protein, P-450E protein, and P-450E heme half-lives (ti/2) 
were examined in Fundulus during elevated P-450E expression. Decay in 
incorporated radiolabel ([3H]-leucine and [14C]-ALA) was followed over time. 
The immunoprecipitation method used for RNA translation products was modified 
for precipitation of P-450E protein from microsomes. A preliminary experiment 
indicated that Fundulus microsomes contained no free labeled amino acid at 2 or 
23 hr after injection, and that specific radioactivity was higher at 2 than at 23 hr. 
In a longer experiment, [14C] counts were not detectable in total microsomes, but 
peak [3H] incorporation into microsomal protein was observed at 1.5 hr after 
injection, followed by a rapid decrease and stabilization at 30 hr. A calculation of 
the "rapid" and "slow" phases indicated that microsomal proteins had a "fast" t112 
of 9.3 hr and a "slow" t112 of 190 hr. Both [14C] and [3H] were detectable in 
PAb-precipitated P-450E. Leucine incorporation peaked at 1.5 hr, with a second 
peak at 190 hr. Using only the early time points, P-450E protein was calculated to 
have a t112 of 32 hr. This was consistent with the 43 hr calculated from the time 
for P-450E to reach half the induced steady state. [14C] incorporation peaked at 8 
hr, indicating a lag between leucine and ALA incorporation into the holoenzyme. 
The subsequent decline in [14C] was relatively slow, leading to a calculated heme 
t112 of 104 hr. Further studies of heme and apoprotein turnover will be needed to 
frrmly establish the roles of these players in the regulation of P-450E expression. 
This study addressed, on a molecular level, how xenobiotics in the 
marine environment elicit a biochemical response - induction of P-450E - in marine 
teleosts. 
Thesis Supervisor: John J. Stegeman, Senior Scientist, WHOI 
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INTRODUCI10N 
Biological oceanography concerns the interactions of marine organisms 
with the biological, chemical and physical aspects of their environment. A 
significant class of interactions is that of the organism with organic chemicals in 
the aquatic milieu . These interactions include chemical challenges by 
anthropogenic pollutants and other foreign or xenobiotic compounds. When these 
compounds are hydrophobic, they tend to partition into biological membranes and 
thus accumulate in tissue. Biotransformation to more polar metabolites is the 
initial step toward their eventual elimination (or activation, see below). Thus, 
biotransformation of xenobiotic compounds may affect the survival and 
reproductive capacity of the individual and population health and distribution. 
To understand how an organism responds to chemical exposure, one 
must not only examine the behavioral (e.g., avoidance), morphological (e.g., 
weight loss or tumorogenesis) and biochemical (e.g., change in biomolecules) 
manifestations of its response, but also explore the underlying mechanisms 
initiating and directing such responses. Accumulation of chemicals within an 
individual and throughout the food web is frequently related to the 
physicochemical properties (e.g., Kow) of the chemicals and simple partitioning 
between a "black box" animal and the water (MacKay, 82; Chiou, 85). It is more 
realistic and more interesting from a physiological viewpoint to consider the 
metabolism of such compounds in the organism's attempts to remove them from 
its body. In animals studied thus far, the enzymes most efficient at xenobiotic 
transformations are not constitutive to the organism but are induced in the presence 
of lipophilic compounds similar or identical to those xenobiotics that these 
enzymes metabolize. The factors regulating such biotransformation- the cellular 
mechanisms of induction of cytochromes P-450 - will be addressed in this thesis. 
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Study of the regulation of the P-450 systems in marine teleosts may serve as a 
"casebook" of sensitive organismal response to changing conditions in the oceans. 
P-450s are related enzymes comprizing a gene superfamily (Nebert et al., 
87) that can metabolize xenobiotics such as polynuclear aromatic hydrocarbons 
(PAH), as well as endogenous compounds such as fatty acids and steroids (e.g., 
estradiol and testosterone), in mammals, teleosts, and other species (Stegeman, 
81). Initially, a xenobiotic is hydroxylated (Phase I), conferring a polar "handle" 
to the hydrophobic substrate. Hydroxylated intermediates may be enzymatically 
conjugated (e.g., with glucuronides, Phase II enzymes), to form more highly 
polar compounds that are then easily eliminated. This is an inactivation or 
detoxication pathway, a biochemical adaptation in the face of chemical challenge. 
However, xenobiotics may be activated to deleterious metabolites by certain 
P-450s and subsequent enzymes. For example, the ubiquitous procarcinogen 
benzo[a]pyrene (BP) may be biotransformed to a highly reactive dihydrodiol 
epoxide that reacts rapidly with cellular macromolecules, including vital enzymes 
and nucleic acids (Weinstein et al., 78). This alkylation of proteins or DNA/RNA 
may lead to cellular dysfunction or mutation. Therefore, P-450s can be involved 
in toxification as well as detoxication. Many factors determine which pathway(s) 
will be followed, including reaction kinetics, the presence of isozymes (specific 
enzymes of the P-450 gene superfamily) responsible for the initial hydroxy lations, 
and the presence and activity of conjugating enzymes. 
Research in the laboratories of Drs. J.J. Stegeman (WHOI) and C. 
Walsh (MIT) has led to the isolation and characterization of the major aryl 
hydrocarbon hydroxylating (AHH) enzyme, termed cytochrome P-450E, from the 
marine teleost Stenotomus chrysops (scup). P-450E is the major PAH-inducible 
form of P-450 and is the major aryl hydrocarbon hydroxylase (AHH) and 
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ethoxyresorufin 0-deethylase (EROD) catalyst in this species (Klotz et al., 83 and 
86). This thesis examines the regulation of induction of xenobiotic-metabolizing 
P-450s in marine teleosts, focusing specifically on the Fundulus heteroclitus 
orthologue of scup P-450E. Specific questions addressed in this project include 
an elucidation of the time course of induction of EROD activity in teleosts, 
comparison of this activity with levels of the P-450E protein, and examination of 
the mechanism of P-450E induction at a molecular level. In particular, P-450E 
mRNA levels are examined to test the hypothesis that transcriptional enhancement 
underlies the induction of P-450E protein and activity levels. Possible 
involvement of heme and protein turnover rates in P-450E regulation are also 
examined. Answers to these questions should provide a clearer understanding of 
the responses of marine organisms to their environment, as well as interesting 
parallels to the more thoroughly studied "higher" organisms. 
REVIEW OF TIIE MAMMALIAN LI1ERA TURE 
To obtain an understanding of marine P-450s and how they work - from 
mechanisms of enzyme activity to molecular regulation- we must first peruse the 
mammalian literature, because selected mammals (rats, mice, rabbits and humans) 
have historically been the main focus of study. In this overview, based on the 
primary literature and Cytochrome P-450: Structure, Mechanism and 
Biochemistry (Ortiz de Montellano, 86), I will concentrate on mice and rats, since 
the pioneering work on P-450s and their regulation has been carried out with these 
animals. 
General P-450s 
In eukaryotes, the P-450s are a family of membrane-bound heme-
containing proteins exhibiting a characteristic absorption maximum near 450 nm 
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when in the carbon monoxide-bound, reduced form (Omura and Sato, 64). They 
are the terminal oxidases in reactions in which electron equivalents are passed from 
reduced nicotinamide adenine dinucleotide (phosphate) (NAD(P)H) via the 
flavoprotein NAD(P)H reductase and the cytochrome to molecular oxygen, 
activating it and facilitating insertion of one oxygen atom into the substrate 
(Guengerich and MacDonald, 84; White and Coon, 80). Thus, P-450s are called 
monooxygenases or mixed function oxidases (MFO). Additional interactions of 
P-450s with the fatty acid desaturase cytochrome bs and its reductase occur, but 
their significance in vivo is not clear (Schenkman et al., 76; Morgan and Coon, 
84; DeMarco and McCoy, 85). A simplified scheme of electron flow in the 
monooxygenase system is shown below. 
RH,02 
NADPH -7 NADPH-cyt P-450 reductase~ P-450 ( 
(membrane bound) (mb bound) 
02. stearyl CoA 
NADH ----4 NADH-cyt bs reductase ----4) bs ( 
(membrane bound) (mb bound) 
H20, oleyl CoA 
P-450s can catalyze the oxidation, reduction and hydrolysis (including 
C-, N- and S-oxidation, dehalogenation, epoxidation, desulfurization, 
dealkylation, and deamination) of a variety of substrates, including steroids, fatty 
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acids and lipophilic xenob iotics. Multiple isozymes (Lu and West, 80) with broad 
and overlapping substrate specificities are responsible for the surprising range of 
reactions possible. Steroid biosynthesis occurs mainly in the mitochondria and 
endoplasmic reticulum (ER) of adrenal cortical and gonadal tissue; steroid 
catabolism occurs mainly in the liver, but also takes place in target organs and the 
kidney. The oxidative metabolism of xenobiotics, the focus of this discussion, is 
carried out predominantly by P-450s located in the smooth endoplasmic reticulum 
(SER) of hepatic tissue. In general, "constitutive" forms involved in the 
metabolism of endogenous substrates exhibit greater substrate specificity than 
those involved in xenobiotic metabolism. For example, the side chain cleavage 
enzyme (P-450scc or P450XIIA 1) is specific for cholesterol only, ·.~hile PAH-
inducible P450IA I can react with a variety of xenobiotics. 
Inducible Mammalian P-450s 
In early studies of P-450 systems, monooxygenase activity was found to 
increase in response to chemical treatment. P-450 specific content (nmol P-450 
per mg protein , measured spectrally) also increased, and it was postulated that 
induction of specific isozymes was responsible for increased enzymatic activity 
(Conney, 67). Recent molecular studies have confirmed these theories and shoWn 
that in mammals increased protein levels are due to increased rates of synthesis 
(e.g., Gonzalez et al., 84). Thus, P-450s fit into the pattern of most inducible 
proteins: production is increased when the cell is faced with an inducing agent. 
Many compounds are now known to mediate induction of P-450-related 
activity in mammals (Cooney, 67; Nebert et al., 8 1). The major ones include 
barbituates and other related drugs (e.g., phenobarbital (PB)), PAHs (e.g., 3-
methylcholanthrene (MC)), and pregnenolone 16-alpha carbonitrile (PCN). This 
discussion will focus on the PAH-type inducers, the most widely studied type in 
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aquatic systems, while mentioning key findings pertaining to the other classes of 
inducers. 
In early studies (Kato et al., 66; review by Conney, 67) enzyme 
activities, total spectral P-450 and metabolite quantities were measured in 
subcellular fractions equivalent to the ER (microsomes) after animals were 
exposed to chemicals. Protein synthesis was found to be necessary for the 
induction of enzyme activity: inducers did not alter the enzyme's substrate affinity 
(V max was altered, but Km was not); protein synthesis inhibitors actinomycin D 
and puromycin blocked induction; amino acid incorporation was stimulated; and 
RNA levels appeared to increase. The focus was on PB- and MC-type 
compounds, and the existence of multiple isozymes was suggested by differences 
in substrate preferences, metabolite profiles, and spectral changes seen with the 
two inducer types. PB treatment resulted in general stimulation, with gross 
morphological changes (e.g., SER proliferation), increases in microsomal protein 
yield and stimulation of several different MFO activities. MC provided more 
limited stimulation, with fewer MFO activities induced and only minor if any 
morphological changes. More recently, the differential regulation of P-450 
activities has been shown to have a molecular basis: separate, discrete mRNAs 
encode for MC-inducible, PH-inducible, and constitutive P-450 proteins (e.g., 
Fagan et al., 83). 
Many isozymes and their corresponding cDNAs have now been 
identified. Constitutive P-450s - those generally present in untreated animals, as 
opposed to those only present after chemical exposure - have been receiving 
increasing attention due to the development of more powerful techniques for 
identifying and isolating them. Recent reviews (Schenkman et al., 87; Waxman, 
88) include such constitutive isozymes. Table 1-1 lists some of the major 
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constitutive and inducible isozymes characterized in rat hepatic microsomes and 
outlines where applicable their major known inducers and catalytic activities. After 
years of confusion, a committee of experts (Nebert et al., 87) suggested a unified 
P-450 nomenclature based on nucleotide sequences. These designations are 
slowly being implemented in the P-450 field, and I have included some of the 
more familiar common names in Table 1-1 . 
Although rat liver microsomes have been the major source of starting 
material for P-450 purification, some other mammalian species have also been 
intensively studied. Counterparts to the major rat PAR-inducible forms have been 
identified and purified in mice and rabbits. Homologous proteins (or genes) are 
defined as those descended with divergence from a common ancestral gene. Fitch 
(71) has suggested that homologous proteins should be subdivided into two 
categories as follows. The first category contains homologous proteins that result 
from gene duplication, such that both copies descended "side by side" during the 
history of the organism. These proteins are paralogous proteins (e.g., alpha and 
beta subunits of hemoglobin). Rat P-450c and P-450d have been proposed to be 
such products of gene duplication (Adesnik and Atchison, 86). The second 
category of homologous proteins results from speciation, such that the history of 
the gene reflects the history of the species. These proteins are labeled orthologous 
proteins (e.g., alpha hemoglobin in mouse and man). Mouse PI450 and rat 
P-450c (and scup P-450E!) would thus be considered orthologous proteins; this 
terminology is utilized throughout this thesis. Table 1-2 lists the P450IA 
orthologues in three mammalian species, and will serve as a reference in the 
ensuing discussions. 
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TABLE 1-1: Some Rat Hepatic P-450s and their Characteristic Properties 
Designation a 
P-450a (IIA1) 
(UT-F, 3) 
P-450b (lffi 1) 
(PB-B, PB-4) 
P-450c (IA1) 
(BNF-B) 
P-450d (IA2) 
(ISF-G) 
P-450e (lffi2) 
(PB-D, PB-5) 
P-450f (IIC7) 
P-450g (--) 
(RLM 3) 
P-450h (IIC11) 
A. max, Mr. 
nm xlOOO 
452 48 
450 52 
447 56 
447 52 
450.5 52.5 
447.5 51 
447.5 50 
451 51 
(UT-A, 2c, RLM 5) 
P-450i (--) 
(UT-I, 2d, RLM 4) 
P-450j (IIE1) 
(RLM6) 
449 50.5 
451/2 51.5 
Inducers/ Major Catalytic Activitiesb 
PB, MC (minor)// T 7-alpha OH 
PB (minor)// T 166-0H 
MC, BNF (major), PCB// Ailll, EROD 
isosafrole (major), MC// E2 2-0H 
PB (minor)// low activity (- P-450b) 
untreated// T 16-alpha OH 
male-specific, strain dep.// T 66-0H 
male-spec.// T 2-, 16-alpha OH, E2 2-0H 
female-specific// steroid disulfate 156-0H 
EtOH, isoniazid// nitrosamine deM 
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P-450 k (ITC6) 450 47 .5 PB, (hormone indep.)// warfarin 7-0H 
(PB-C, PB-1, RLM5a) 
P-450p (IllAl) 450 51 PCN, PB//T 6B-OH, E2 2-0H 
(PB-2a, PCN-E) 
aAlphabethicallisting is according to the convention of Levin and co-workers 
(Ryan et al., 79, 82, 84, and 85), followed by the gene designation, if known 
(Nebert et al., 87). Other common names are given in the next line. 
hKnown inducing chemicals or sex differences are listed here, followed by the 
major known enzymatic activities of the purified P-450 in reconstituted systems. 
Absolute values range considerably from laboratory to laboratory so no values are 
given. Abbreviations not defined in the text are given in the List of Abbreviations. 
Data summarized from the following reports, and references therein: 
Stegeman and Kloepper-Sams, 87; Waxman, 88; Schenkman et al., 87. 
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TABLE 1-2: P-450IAa Orthologues 
P-450IA1 P-450IA2 
Species 
rat P-450c P-450d 
mouse Pt450 
rabbit P-450 6 P-450 4 
a See Nebert et al. (87) for details of P-450 isozyme nomenclature. 
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Re~lation of P450JA 1 
The best characterized mechanism of P-450 induction has been elucidated 
in the P450IA gene subfamily. Initially, it was found that two mouse strains 
showed differential responses to application of7,12-dimethylbenzanthracene to the 
skin. Genetic crosses of "nonresponsive" D2 animals and "responsive" B6 
animals indicated an autosomal dominant response; the locus was called In 
(phenotype inflammation, Taylor, 71). Induction of AHH activity following MC 
treatment paralleled the In phenotype ( B6 mice were induced, D2 mice were not); 
this was termed the Ah or aryl hydrocarbon responsive locus (Nebert and Jensen, 
79). TCDD (2,3,7,8-tetrachlorodibenzo-p-dioxin) was found to be 30,000 fold 
more potent as an inducer of Alll-I activity than MC in B6 mice, and elicited a 
weak response in D2 mice (Poland and Glover, 74). Because it could be 
synthesized with high [3H] specific activity, TCDD became very useful as both an 
inducer and a binding tracer in later studies. 
Poland and co-workers postulated the presence of a TCDD-binding 
protein, which could serve as a receptor, based on correlations of exposure to 
TCDD-analogs with the AHH response (Poland and Glover, 73) and the "toxic 
potential" of different mouse strains. This "TCDD" or "Ah" receptor was found in 
murine hepatic cytosol (Poland et al., 76). It binds specifically and reversibly to 
many polyaromatics, but not to phenobarbital or steroids such as PCN, 
dexamethasone or 17-0H-corticosterone. No physiological (endogenous) ligands 
have been found for the Ah receptor, leaving open questions on the evolution of 
response to environmental conditions. Specific binding is not the only 
characteristic of a classical cytosolic receptor: it must also be transported to the 
nucleus. Nuclear translocation of the receptor-TCDD complex (Greenlee and 
Poland, 79) was demonstrated to be temperature and time dependent (Okey et al., 
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80). Appearance of the complex in the nucleus corresponds well with AHH 
induction in responsive cell cultures (Hepa-1 and H-4-II-E). Nuclear localization 
of the receptor alone is not sufficient for induction. HTC cells have receptor/cell 
numbers between those ofHepa-1 and H-4-II-E and exhibit nuclear translocation, 
but no induction is detectable. Mirroring the controversy over the subcellular 
localization of the estradiol receptor, there have been conflicting reports on the 
distribution of "free" (unbound) Ah receptors (references 46 and 47 in Arnold et 
al., 88). However, there is a consensus that the bound form has an increased 
affinity for DNA and can be found in the nuclear fraction. 
There have been numerous technical difficulties in purifying the A h 
receptor, but many of its physical properties have been established. It is a 
cytosolic protein with (under certain conditions) a Mr of around 100 kD, it 
sediments at 4 to 5S in high ionic strength sucrose density gradients, and at 9S in 
lower salt sucrose density gradients, has a Stokes radius of 60 A, adsorbs to 
hydroxylapatite, interacts with polyanions such as DNA-cellulose and heparin-
Sepharose (Gasiewicz and Neal, 82), and has a high affinity for planar 
polyaromatic hydrocarbons. It has no affinity for steroid hormones. Its 
hydrophobic character (Poellinger and Gullberg, 85) may be a dominant factor in 
determining its ligand binding properties (Bandiera et al., 83). By using 
molybdate as a stabilizing agent (Denison et al., 86; Manchester et al. , 87), a "low 
affinity" Ah receptor has now been found in D2 animals originally thought to lack 
the receptor (Okey et al., 88). 
Like several steroid hormone receptors, the Ah receptor appears to form an 
"inactive" complex (Perdew, 88; Denis et al. , 88) with two molecules of hsp 90, a 
highly conserved heat shock protein (Lindquist, 86). The hsp 90 may serve to cap 
the ligand binding site in the absence of the ligand, retaining the receptor in the low 
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DNA-affinity state (Baulieu, 87). Denison et al. (88) have suggested that, given 
the high affinity of the TCDD/receptor complex for the third dioxin responsive 
element upstream of the coding region of the PI450 structural gene, DNA affinity 
techniques might be successfully exploited for (the imminent) purification of the 
native Ah receptor. With the use of a specifically designed photoaffinity label, 
Perdew and Poland recently isolated the Ah receptor from B6 mice (88). A 
20,000 fold purification was achieved, but unfortunately denaturing conditions 
were necessary in the latter stages of purification. 
The concentration of "cytosolic" Ah receptor may not be the dominant 
factor in determining maximal activity. Treatment with PB can double the 
concentration of unbound cytosolic Ah receptors in responsive mice and rats 
without increasing the affinity for TCDD or doubling the induction of AHH 
activity (Okey and Vella, 84). In a comparative study of mammalian species, 
Denison and Wilkinson (85) were able to identify a TCDD-binding moiety in all 
animals tested, but saw no relationship between concentration of the receptor and 
AHH inducibility. Thus, this system may be similar to steroid hormone receptor 
systems where only a fraction of the total receptor population must be bound to 
give a maximal response. In a number of mammalian species, Gasiewicz and 
Rucci (84) found Ah receptors with similar biochemical properties which 
translocate to the nucleus subsequent to TCDD treatment. The receptors have the 
same order of binding preference to a number of P AHs and dibenzo-p-dioxin 
congeners. The animals vary in their sensitivity to TCDD, however, indicating 
that other factors also contribute to these responses. 
Attempts to generate monoclonal antibodies (MAb) against the Ah receptor 
have led to the production of antibodies against the 90 kD heat shock protein 
(Perdew, 88). hsp 90 was apparently a major contaminant or a dominant antigen 
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in the partially purified Ah receptor fraction. The MAbs generated by Perdew can 
co-precipitate the Ah receptor and the heat shock protein, and may be useful in 
novel purification schemes. The future availability of monoclonal antibodies 
specific to the Ah receptor should more greatly facilitate studies of this protein and 
its role in the regulatory pathway of P450IA1. 
Another protein, called the carcinogen- or PAH-binding protein or "4S" 
protein, binds PAHs such as benzo[a]pyrene- but not TCDD - in mouse liver 
cytosols and has a higher concentration in these tissues than does the Ah receptor. 
It has characteristics consistent with a receptor moiety, including high affinity and 
saturable binding (Collins and Marietta, 84). Various PAHs bind to the protein, 
which sediments at 4S in sucrose density gradients, while TCDD and steroids like 
cortisol, estradiol, and PCN do not. The protein has been purified from mouse 
and rat cytosols, and has a Mr of about 40 kD in rats (Arnold et al., 87) and 29 kD 
in mice (Collins and Marietta, 86). A similar binding moiety has been located in 
the cytosolic fractions of various vertebrates, including scup and chick (Barton and 
Marietta, 88; see also Chapter 4 Discussion). Houser et al. (87) found that the 4S 
protein specifically binds one or more upstream regions of the rat P-450c gene, 
and observed chloramphenicol acetyl transferase (CAT) activity in cells transfected 
with these regions and treated with MC. This research group also recently 
described the distribution of the 4S protein before and after MC treatment; 
immunohistochemical analysis suggested that the protein is predominantly found 
in the cytoplasm of untreated rats and translocates to the nucleus after treatment 
(Arnold et al., 88). However, there is as yet no consensus as to the physiological 
function of this protein or its role, if any, in the expression of P450IA 1. 
The regulatory domains 5' of the coding region of mouse Pt450 have been 
examined in detail. The use of variant cell lines and molecular biological 
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techniques have provided insights into the interactions between ligands, receptors 
and gene transcription. Whitlock and co-workers have identified at least three cis-
acting dioxin-responsive elements (DRE) in the 5' region of the mouse P450IA 1 
gene (e.g., Jones et al., 85; Denison et al., 88). All three can increase 
transcription of a heterologous (CAT assay) promoter-run system in an 
orientation- and distance- independent fashion (e.g, Jones et al., 86; Durrin and 
Whitlock, 87), and are thus considered enhancer sequences (Lewin, 87). The 
transcriptional control of the gene also includes a promoter and a putative repressor 
binding site (Whitlock, 86 and 87; Nebert and Gonzalez, 87). Watson and 
Hankinson (88) recently transfected genomic DNA from dominant Allli-deficient 
mutant cells into "wild type" Hepa-1 cells and obtained AHH-negative 
transfectants. They hope to use this method to lead to the cloning, identification 
and characterization of a trans-acting negative regulator of Pt450 induction. 
Following activation of transcription rates, Pt450 mRNAs begin to 
accumulate in the cytosol. The time course and magnitude of induction of these 
specific mRNAs can be determined with molecular techniques. By hybridizing 
poly(A)-RNA with a mouse Pt450 eDNA clone, Tukey et al. (82) quantitated 
Pt450 mRNA following TCDD treatment. They found a strong correlation 
between accumulation of the mRNA and amounts of receptor-ligand complex 
appearing in the nucleus of D2, B6 and D2/B6 heterozygotic mice. mRNA 
accumulation may have been due to its stabilization, however, rather than to 
increases in transcriptional activity. Therefore, rates of transcription were 
measured directly in isolated mouse nuclei by nuclear run-off analysis. A 20-fold 
increase in Pt450 mRNA synthesis rates was observed in TCDD-treated cultured 
cells within 30 minutes; this level was maintained for at least 18 hours (Israel and 
Whitlock, 84). In another study, transcription rates were examined in MC-treated 
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mice. D2 mice showed no activation by MC. Transcription rates increased within 
3 hours after MC treatment in B6 mice, reaching maximal rates at 12 hours 
(Gonzalez et al., 84). A 3 to 6 hour lag was observed between transcriptional 
enhancement and increases in mRNA levels. 
Comparison of PI450 gene expression with that of the paralogous mouse 
protein, P3450, has provided further insights into P-450 regulatory mechanisms. 
P3450 (P-450d or P450IA2) mRNA induction exhibited a longer lag time than did 
PI450, although transcription rate increases were temporally similar. Thus, 
transcription of these two inducible genes may be coordinately controlled, while 
post-transcriptional processing may differ. Fagan et al. (86) found that in the first 
48 hours after treatment of rats with MC, P-450c mRNA levels increased more 
rapidly than did levels of P-450d mRNA. Both mRNAs achieved peak levels at 
24 hours and P-450c mRNA then declined less rapidly than did P-450d. These 
researchers did not distinguish between transcription and other forms of mRN A 
regulation. 
Although initial studies seemed to indicate that transcriptional enhancement 
could totally account for the observed increases in mRNA levels, recent reports 
reveal a more complicated story. When induction studies are conducted in mouse 
or rat hepatocyte cultures, the relationship between P-450 transcriptional 
enhancement and prevalence of P-450 mRNA species is not clear-cut. The role of 
post-transcriptional control, originally thought unimportant, has gained greater 
prominance. Pasco et al. (88) found that rat P-450d mRN A can accumulate in 
primary hepatocyte cultures following TCDD treatment, with no changes evident 
in P-450d transcription rates. A similar study of rat hepatocyte cultures presented 
evidence for post-transcriptional control in MC-induction of both P-450c and 
P-450d, although transcriptional control could account for P-450c mRN A 
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increases in vivo (Silver and Krauter, 88). Kimura and coworkers found 
inconsistencies between mouse Pt450 and P3450 transcriptional rates and mRNA 
levels in a number of extrahepatic tissues (Kimura et al., 86). In most of these 
studies, transcription rates are determined by measuring "nuclear runoff' rates in 
isolated nuclei. Little is known about the stabilities of the P-450 mRNA species 
prior to exposure to inducers, so comparisons between different P-450s (e.g., 
P-450c and P-450d) and different tissues ( liver and extrahepatic tissues) generally 
indicate trends only (e.g., Kimura et al., 86 conclude that TCDD "stabilizes" 
P-450d mRNA, because the accumulation of the mRNA is greater for P-450d than 
for P-450c, despite similar fold transcription increases). Further comparative 
studies, both in vivo and in vitro, may clarify this picture. 
In summary, regulation of the expression of P450IA 1 involves a soluble 
receptor that forms a complex with specific ligands and interacts with some 
portion(s) of the ~equence 5' to the PI450 coding region. This interaction leads to 
transcriptional enhancement of the gene, resulting in accumulation of the gene 
product and increases in the corrresponding enzyme activities. Other trans- and 
cis- acting factors are likely to be involved, and the schematic will probably 
become more complex as new details are learned. 
Re~ulation of Other P-450s 
Other forms of regulation have been investigated in P-450 systems. In one 
of the few studies on post-translational modifications of P-450 systems, Pyerin et 
al. (87) found that alkaline phosphatase can decrease the activity of cytochrome 
P-450 reductase, leading to reductions in measured MFO activities in rat and rabbit 
microsornes, and that certain isolated isozymes (including rabbit form 2 and rat PB 
3b [P-450e] and PB 3a [P-450b]) could be phosphorylated in vitro by the catalytic 
subunit of cAMP-dependent protein kinase. Rabbit form 2, the most closely 
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examined, was specifically phosphorylated at serine 128, resulting in deactivation 
of the P-450 and conversion to P-420. A calcium-dependent kinase showed a 
different pattern of isozyme specificity, but its mechanism of action was not 
investigated. MFO inhibitors decreased tumorigenicity, but only when 
administered a short while after carcinogenic hydrocarbons were administered 
(citation in Pyerin et al., 87). Thus, these authors speculate that if similar rapid 
P-450 inactivations occur in vivo, they could be important in the early stages of 
tumorigenicity. Such (or similar) methods of rapid, short-term regulation could be 
essential in regulating normal P-450 functions as well. 
Several steroidogenic P-450s are regulated developmentally (Waxman, 88) 
and/or by peptide hormones, such as adrenocorticotropin (ACTH) via the second 
messenger cAMP (John et al., 85). Some P-450s involved in endogenous 
metabolism are integral proteins of the adrenal cortical inner mitochondrial 
membrane. P-450 sse and P-450 liB precursors are synthesized in the cytosol 
and their transport into the mitochondria is dependent on a membrane potential. 
Despite preliminary evidence to the contrary, their maturation appears to follow the 
same steps as the processing of other mitochondrial precursor proteins (Matocha 
and Waterman, 1985). 
It has been shown that transcriptional activation underlies the induction of 
PB-specific P-450 activities (e.g., Fagan et al., 83). Despite intensive efforts, no 
receptor analogous to the Ah receptor has been found for the genes of the P450IIB 
subfamily. The synthesis and/or incorporation of heme may play a crucial role in 
regulating P-450b catalytic activities. Heme synthesis inhibitors, such as cobalt 
chloride and 3-amino-1,2,4-triazole, inhibit P-450b protein synthesis at the level 
of P-450b transcription. The normal PH-stimulated increase in transcription rates 
is inhibited by these chemicals and P-450b mRN A does not accumulate 
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(Ravishankar and Padmanaban, 85a and 85b; Dwarki et al., 87). Although most 
studies have focused on the effects of heme and heme pathway disruptors on 
P-450b, there is some evidence that they also affect P-450c. A recent article 
examined the effects of such che~icals on the regulation of P-450 (c+d) (Bhat and 
Padmanaban, 88), and the authors concluded that heme can act as a positive 
regulator of gene transcription. As observed with P-450b, addition of hemin 
overcomes the block on mRN A induction. 
Heme may be generally involved in the regulation of P-450 expression at 
several levels. P-450s are the dominant heme-containing proteins of the ER, 
containing up to 70% of the total liver heme in induced animals (Muller-Eberhard 
and Vincent, 85). In mammals, heme appears to act as a feedback inhibitor. 
While not directly inhibiting the activity of delta-aminolevulinic acid synthase 
(ALAS), heme inhibits the transcription, translation, and translocation of ALAS 
(the rate-limiting enzyme in the hepatic heme biosynthetic pathway). As is 
expected for enzymes at the regulatory points in biosynthetic pathways, ALAS 
protein has a short half-life (e.g., 35 minutes in the rat and 120 minutes in the 
chick embryo, compared to several days for the "average" mitochondrial protein; 
references in May et al., 86). ALAS mRNA also has a rapid turnover, with a half-
life of about 5 hours. Heme also induces heme oxygenase, the rate limiting 
enzyme in the degradation of heme. 
There also may be more direct interactions between the P-450 and heme 
regulatory systems. It has been proposed that P-450 induction is contingent upon 
increases in ALAS activity. Poland and Glover (73) found identical 
structure/activity relationships for both ALAS and AHH induction for a series of 
15 dioxin congeners. However, AHH induction was more sensitive to lower 
doses and exhibited a different dose response curve. Cycloheximide repressed 
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ALAS induction totally, while only partially suppressing AHH induction, 
indicating that AHH induction is NOT dependent upon ALAS induction and 
subsequent heme synthesis. In addition, MC induced AHH, but had little effect 
on ALAS. May et al. (86) have recently postulated another hypothesis: that the 
xenobiotics that induce ALAS do so only indirectly, through induction of P-450 
synthesis. According to this model, induction of P-450 apoprotein depletes the 
cellular heme pool, which is usually sufficient to repress heme synthesis. When 
heme is incorporated into the new P-450s, its "free" levels fall below a critical 
point and ALAS is derepressed. Interestingly, allylisopropyl acetamide (AlA) and 
3,5-diethoxy carbonyl-1 ,4-dihydro-2,4,6-trimethyl pyridine (DDC) do not induce 
ALAS in steroidogenic tissues, where xenobiotics do not induce P-450s. If May 
and co-workers are correct, this is simply due to the fact that because of lack of 
apoprotein synthesis, no extra heme is needed. The actual in vivo mechanism is 
probably more complex than May et al. (86) postulate. Although all xenobiotic 
ALAS inducers may also induce P-450(s), not all xenobiotic P-450 inducers also 
induce ALAS (e.g., as mentioned above, MC is a potent inducer of Pt450, but not 
of ALAS). In addition, Hamilton et al. (88) found that 2-propyl-2-isopropyl-
acetamide induced ALAS mRNA prior to induction of P-450 mRNA in cultured 
chick embryo hepatocytes, and treatment of chick embryos with glutethimide 
induced ALAS and P-450 mRNAs sirpultaneously. Therefore, at least in this 
system, induction of P-450 apoprotein is not necessary for induction of ALAS by 
xenobiotics. 
There are also conflicting reports on the ability of heme to exchange 
between different microsomal P-450s (e.g., Sadano and Omura, 83). Treatment 
with cycloheximide inhibited protein synthesis (and thus inhibition of amino acid 
labels into PB and MC P-450s), while incorporation of labeled ALA into P-450 
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heme continued. Thus, heme incorporation is not always coupled to P-450 
synthesis. In a further study, pre-labeled heme was incorporated into newly 
induced P-450s. Other studies showed a strong correlation between heme and 
apoprotein synthesis, with no evidence of excess of either (e.g., Meier et al., 84). 
P-450 apoproteins may be degraded more rapidly than the holoenzyme. Thus, 
heme availability (concentration in the intracellular free heme pool) or switching of 
heme moieties between P-450 species may affect P-450 turnover. Parkinson et al. 
(83a) found that the apoprotein moiety has a shorter half-life than the heme moiety, 
supporting the argument that heme can be recycled. (Others have observed the 
opposite trend, see Chapter 5.) 
Mechanism-based inactivation of P-450s often leads toN-alkylation of 
the P-450 heme cofactor and its subsequent loss. A recent review (Marks et al., 
88) placed porphyrinogenic chemicals into three groups. Members of the ftrst 
group (e.g., DDC) inhibit ferrochelatase by the accumulation of protoporphyrins, 
presumably due to interaction of DDC with P-450 and alkylation of the P-450 
heme moiety. Members of the second group (e.g., AlA) interact with P-450, 
resulting in alkylation of heme nitrogen and formation of an AlA-porphyrin adduct 
(with no ferrochelatase inhibitory capacity). The decline in the free heme pool may 
result from a "cascade:" apoprotein combines with fresh heme, which is attacked 
by AlA and destroyed, P-450 is reconstituted with new heme, which is again 
destroyed, etc., until the heme pool is diminished and ALAS is turned on. The 
fmal group, represented by the PHAHs (polyhalogenated aromatic hydrocarbons), 
is involved in inhibition of uroporphyrinogen decarboxylase. 
It is obvious from the foregoing discussion that interactions between 
heme and P-450 apoproteins, as well as heme and P-450 inducers and inhibitors 
and other regulators, can be very complex. Despite intensive investigation, the 
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picture is far from clear in mammalian or avian systems. These questions have 
been hardly considered in teleost species; some background on general protein 
turnover and heme metabolism, including what little is known about these 
relationships in fish P-450 systems, is described in Chapter 5. 
Molecular Evolution of P-450s 
As more information becomes available about various P-450 primary 
sequences, whether obtained directly from amino acid sequencing of purified 
proteins or derived from eDNA nucleotide sequences, attempts to identify 
conserved domains and assign them functions continue. Use of primary sequence 
information to model tertiary structure has proven difficult. For example, 
hypotheses estimating the number of P-450 segments that span eukaryotic 
membranes have ranged from 1 to 12 segments (e.g. , Nelson and Strobel, 88). 
Theories of the origin and evolution of P-450s continue to be refined. In the most 
thorough evolutionary comparison of P-450s published thus far, Nelson and 
Strobel (87) generated similar phylogenetic trees from two forms of analysis of 34 
sequences. The results indicated that the major divisions of P-450 genes occurred 
as follows: the eukaryotic and prokaryotic forms separated about 1,400 Mybp 
(million years before the present) , endogenous and drug-metabolizing P-450s 
separated about 900 Mybp, and the PB and MC families split about 800 Mybp. 
These and other authors feel that gene duplication has played an important role in 
the divergence of P-450 genes (Nelson and Strobel, 87; Adesnik and Atchison, 
86). In general, these analyses have utilized P-450 sequences from mammals and 
one or two other species (e.g., a few bacterial and one avian sequence). Thus, 
firm conclusions as to the origin and relationships between the different forms of 
P-450s will only be reached after other nonmammalian - and nonvertebrate -
P-450s are added to the database. 
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Although P-450cam (P450CIA1), the soluble camphor-metabolizing 
isozyme from Pseudomonas putida, has been studied in great detail and is the only 
P-450 to date which has been successfully crystallized (Poulos et al., 1985), 
analysis of other prokaryotic or lower eukaryotic P-450s has lagged behind. 
Recently, P-450s from yeast (Sanglard et al., 87; Aoyama et al., 87), from 
bacteria, and from a few lower vertebrates (chick: Hobbs et al., 86; trout: 
Heilmann et al., 88) have been described or should appear shortly in the literature 
(housefly: Nebert and coworkers (Louisiana meeting)). Molecular manipulations, 
such as cleavage of the hydrophobic amino-terminal end of the coding region prior 
to over-expression in bacterial or yeast hosts, may lead to crystallization of a 
truncated eukaryotic protein, but questions concerning the actual structure of the 
enzyme and its interactions with the membrane and membrane-bound components 
of the MFO system will still remain. As the comparative biochemistry of P-450s 
branches out further into "non-traditional" species, we should gain further insights 
into the possible origins and evolutionary relationships of these widely distributed 
proteins. 
REVIEW OF THE TELEOST LITERA TORE 
P-450s in Ag,uatic Animals 
Many freshwater and marine organisms have been analyzed for the 
involvement of MFO systems in xenobiotic biotransformations. Activities in 
invertebrates are generally very low (Stegeman, 81 and 85; Stegeman and 
Kloepper-Sams, 87), and most studies have focused on aquatic vertebrates, 
particularly teleosts. The majority of MFO activity in fish is localized in the 
hepatic tissue, with lesser amounts in the heart, kidney, adrenals and gonads 
(Stegeman, 81; Stegeman et al., 82; Williams et al., 84; Pesonen and 
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Andersson, 87). As in mammals, the hepatic MFO systems of fish are oxygen-
and NADPH- dependent and are localized in the ER fraction. They consist of a 
flavoprotein, NADPH-cytochrome P-450 reductase, and a membrane-bound heme 
protein, cytochrome P-450. Cytochrome bs has an obligate role in the function of 
some fish isozymes, stimulating some activities but having no detectable effect on 
others (Klotz et al. 83 and 86). 
Teleost P-450s are inducible. Catalytic activities associated with P-450s 
can be stimulated in many species by exposure to MC-type compounds, including 
BP, BNF, MC and "MC-type" PCB congeners (Statham, et al., 78; Spies et al., 
82; Stegeman, 81; Gooch et al., submitted, and references therein). A [35-S]-
methionine labeling study showed that there is increased synthesis of microsomal 
proteins in trout exposed to 150 mglkg BNF, indicating that increases in enzyme 
activity may be due to true induction rather than to activation of existing proteins 
(Vodicnik et al., 84). However, P-450 proteins were not specifically identified in 
that study. Results of a representative induction study (Andersson et al., 85) in 
juvenile rainbow trout are shown below. 
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Treatment 
control 
BNF 
EROD Activity 
nmollmin/m~ 
0.022 ± 0.01oa 
3.78 ± 1.74 
control 0.018 ± 0.011 
Fold Increase 
Oyer Control Values 
172 
Clophen A50h;..._ __ ~o~.8:.l.l.8_...,±~0~.4:...L7 ______ ....::4~9 ____ _ 
aFor each group, N = 5. All values represent the mean± sd. 
hClophen A50 is a commercial PCB mixture, similar to the American Aroclor 
mixtures. 
Vodicnik et al. (84) saw induction of a similar magnitude in rainbow trout, with 
150 mg/kg BNF eliciting a 15-fold increase in ethoxycoumarin 0-deethylase 
(ECOD) activity and a 93-fold increase in EROD activity in comparison to controls 
after 48 hours. 
In teleosts treated with MC-type inducers, a 20-fold induction of 
beno[a]pyrene metabolism (BP is the Allli substrate, so the catalyst is also called 
benzo[a]pyrene hydroxylase [BPOH]) can occur. Forlin (80) measured a 27-fold 
induction of BPOH activity after MC treatment and a 23-fold induction after 
Clophen A50 treatment of juvenile rainbow trout. Interestingly, reductions in 
BPOH activity followed PCN and PB treatment in these animals. In a comparative 
study, Stegeman et al. (81) achieved approximately 20-fold induction of BPOH 
activity in croaker (Micropogon undulatus) and rainbow trout treated with BP and 
MC, respectively. Scup, on the other hand, exhibited much less induction. The 
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scup used in this experiment, however, had much higher BPOH control values 
(0.250 nmol/min/mg) than did the croaker and trout (0.026 and 0.011 
nmol/min/mg, respectively). It has been suggested that many scup are 
environmentally induced such that "control" values obtained from untreated feral 
fish represent previous induction (Stegeman and Binder, 79). Healthy scup 
maintained for several months to two years on "clean" Nantucket Sound water 
have much lower microsomal EROD activity levels than do freshly-caught fish 
(B.R. Woodin, P.J. Kloepper-Sams, and J.J. Stegeman, unpublished 
observations), substantiating this view. 
In general, fish seem to be more sensitive to MC-type inducers than 
mamm.als, induction being stronger and more persistent. Vodicnik and co-
workers (84) saw maximal ECOD and EROD activities 48 hours after BNF 
treatment, with maintenance of this level at 72 hours. In Andersson et al.'s study 
mentioned above (85), EROD activities peaked 3 (BNF) and 7 (Clophen 50) days 
after treatment of rainbow trout held at 10 to 12 °C, with conjugating enzymes 
achieving maximal induction even later. Season or temperature can influence the 
timing of induction in these poikilotherms. James and Bend (80) treated 
sheepshead with 10 mg/kg MC during the summer (water temp. 26°) and winter 
(water temp. 14°). Maximal BPOH activity was reached 3 days after treatment in 
the summer, with a return to control values by 14 days. It took 8 days to achieve 
maximal BPOH activity following the winter treatment, with levels still elevated 
after 28 days. The extent, but not the magnitude, of induction was similar in the 
two experiments. All marine fish tested by James and Bend (80) exhibited no 
response in epoxide hydrolase (EH), glutathione (GSH) transferase, or reductase 
activities, although Stegeman (81) found some reductase induction. 
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Several studies have linked PAR-related MFO activity in fish with 
possible consequences such as tumorogenesis or the formation of toxic 
metabolites. In rainbow trout, a constitutive P-450, LM2, activates aflatoxin B 1 
(Williams and Buhler, 83). Hepatic microsomes from untreated trout can catalyse 
the metabolism of BP to intermediates that bind DNA at rates 3 to 4 times greated 
than those of untreated rat microsomes (Ahokas et al., 79). The predominant BP 
adduct appears to be the ultimate carcinogen (Nishimoto and Varanasi, 85). In 
studies of BP activated in fish cell cultures, Smolarek et al. (87) found that the 
major BP-DNA adduct formed resulted from the reaction of (+)-anti-BP-7,8-diol-
9,10 epoxide with deoxyguanisine. The authors conclude that while BP can be 
metabolized to the ultimate carcinogen by these cells, the level of binding of the 
metabolite to DNA is lower(< 5 pmol BP/mg DNA in BF-2 cells) than found in 
comparable studies with rodent embryo cells(> 30 pmol BP/mg DNA). Fish cells 
also showed more efficient conjugation of the BP 7,8 diol, making less material 
available for formation of the ultimate carcinogen. 
An important distinction between the teleost and mammalian systems is 
the apparent lack of response in fish to phenobarbital. Although a few reports 
have indicated that fish respond to PB-type compounds (Pohl et al., 74; Bums, 
76; Verdina et al., 1987), the data are inconclusive and more thorough studies 
have found no evidence of a strong or consistent response (Bend et al., 73; 
Schwen and Mannering, 82; Melancon et al. , 85; Forlin, 80; Vodicnik et al., 84; 
Elskus and Stegeman, in press). Phenobarbital does enter the animal and can be 
metabolized, so the lack of response is not due to "nonexposure." Because little is 
known about the mechanism of PB induction in mammals, even after extensive 
study, it is difficult to determine the cause of a lack of inducibility in fish. Lower 
vertebrates may not have the structural genes for PB-inducible P-450s, or the 
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expression of these proteins may be blocked at some stage. Alternatively, the 
structural genes may be constitutively expressed: untreated fish can catalyze 
activities known to be PB-inducible in mammals, such as benzphetamine 
N-demethylation. These activities may be due in part to MC-type isozymes, which 
are already partially induced in feral fish. 
The effects of other known mammalian P-450 inducers have not been 
widely investigated in teleosts, although a few studies have appeared. Decreases 
in trout Allli and p-nitroanisole 0-demethylase activities occurred after treatment 
with the synthetic steroid PCN, although spectral P-450 content remained 
unchanged (Forlin, 80). Possibly some other isozyme(s), which catalyzes the 
metabolism of substrates different form those examined by Forlin, was induced by 
PCN treatment. Stegeman and co-workers obtained inconclusive results in scup 
treated with isosafrole, the most potent inducer of mammalian P450IA2 
(unpublished observations). Goks¢yr (86) suggested that while phenanthrene 
induces the 58 kD BNF-inducible P-450 protein (the P-450E orthologue) in cod 
(Gadus morhua), PCN induces a unique 59 kD hemoprotein. 
Molecular Aspects and Re2lJlation of Teleost MFQs 
The molecular aspects of P-450 induction in aquatic species have not 
been addressed until recently. Most studies characterize enzyme activities and 
attempt to correlate the level and type of activity induced with environmental 
conditions or chemical exposure in the laboratory. Protein purification and 
reconstitution under defined conditions, antibody production and utilization, and 
molecular cloning techniques~ increasingly being employed in order to more 
rigorously answer questions of xenobiotic induction and its regulation in aquatic 
animals. 
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Isolation of teleost P-450 isozymes has been achieved by few research 
groups. Buhler and co-workers have isolated 4 or 5 liver microsomal P-450s 
from rainbow trout (Williams and Buhler, 82 and 84), and Stegeman's group has 
isolated 5 fractions from scup (Klotz et al., 83). Goks~~Syr (85) has partially 
purified 4 cod P-450 forms. The activities of these purified P-450s have been 
examined with only a restricted suite of substrates, but trends of Allli and steroid 
metabolism are becoming clear. Some characteristics of purified teleost P-450s are 
shown in Table 1-3. 
Chromatography of solubilized, ammonium sulfate-fractionated, scup 
hepatic microsomes on an anion exchange column resulted in the separation of 
several P-450 isozymes (Table 1-3), the fifth major peak eluting being P-450E 
(Klotz et al., 83). This 54.3 leD heme-containing protein has an absorption 
maximum at 447 nm and is the major aryl hydrocarbon hydroxylase in scup liver 
microsomes. P-450E is inducible by the MC-type compound BNF, and Allli and 
EROD activities have been reconstituted using this enzyme (Klotz, et al., 83). 
Reconstituted P-450E, in the presence of purified epoxide hydrolase, forms 
benzo[a]pyrene metabolites that are nearly 40% trans-7 ,8-dihydrodiol, the 
precursor of the ultimate carcinogen, ( + )7 ,8-dihydrodiol-9, 10-epoxide (Stegeman 
and James, 85). 
In a comparative study of Allli induction and Ah receptors in selected 
nonmammalian species, only chicks exhibited both Allli induction and a specific 
TCDD-binding peak (Denison et al., 85). Quail had no detectable Ah receptor, 
despite induction of AHH activity similar to that of the chick. Rainbow trout 
showed minimal inductive response, and no indication of an Ah receptor. 
Additional studies with trout and scup cytosols also provided no indication of an 
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TABLE 1-3: Teleost Hepatic P-450s: Physical Properties and Catalytic Activities 
Isozyme A. max, Mr 
. 
Major Characteristics 
om x1()()() 
~a 
P-450A 447.5 52.7 testosterone 6B-OH, ECOD 
P-450B 449.5 45.9 tentative 15-alpha-OH 
P-450C 450 49-51 
P-4500 451 50 
P-450Ed 447 54.3 EROD and AHH, ECOD 
Rainbow troutb 
LM1 449 50 
LM2 449.5 54 lauric acid OH, aflatoxin activator 
LM3 447.5 56.5 
LM4a 447 58 AHH,EROD 
LM4b 447 58 AHH,EROD 
CQ.dC 
P-450a 447.5 55 noEROD 
P-450b 447.5 54 noEROD 
P-450c 448 58 EROD 
P-450d 448 56 EROD 
a(Klotz et al., 83 and 86) 
b(Williams and Buhler, 83 and 84) 
C(Goks~yr, 85). The only enzyme activity examined was EROD. 
dOrthologues of P-450E are P-450c (rat), Pt450 (mouse), LM4 (trout), P-450c 
(cod). 
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Ah receptor (Hamilton, etc, unpublished results). A recent report from Nebert's 
laboratory, however, indicates that a TCDD-binding peak is present in untreated 
rainbow trout liver cytosols (Heilmann et al., 88). This peak, as measured by 
sucrose density gradient centrifugation of cytosol preincubated with radiolabeled 
TCDD (Okey et al., 79), is saturable and can be displaced by the presence of 100-
fold excess of MC or TCDD. The authors estimate the concentration of the moiety 
to be 7.5 fmol/mg cytosolic protein, similar to that they previously measured in 
some strains of Ah-responsive mice (reference cited in Heilmann et al., 88). 
Further details of the biochemical and physical properties of this moiety should 
provide insight into its possible role in the regulation of non mammalian P450IA 1 
expression. 
In an extension of their earlier studies on the mouse PAR-binding 
protein, Marietta and coworkers sought a PAR-binding protein in other species. 
They found binding activity in all species tested: rat, chicken, guinea pig, scup, 
and rabbit (Barton and Marlena, 88). The scup equilibrium binding constant (l<d = 
10.9 ± 2.3 nM) was similar to that of the rat (Kd = 8.9 ± 1.6 nM), higher than 
mouse, but lower than that of chicken or guinea pig. The concentration of binding 
sites in scup <Bmax = 8.6 ± 0.8 pmol/mg protein) was similar to that in the mouse 
(Bmax = 6.3 ± 0.3 pmol/mg protein). The PAR-binding site could not be 
competed for by the TCDD analog 2,3,7,8-tetrachlorodibenzofuran (TCDBF) in 
any of the cytosols, conflnning that this protein is a moiety distinct from the Ah 
receptor. Scup exhibited a particularly high level of non-specific binding, which 
the authors speculate may indicate the presence of other, low affinity binding sites. 
As mentioned previously, the function of the PAR-binding protein is not known. 
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Environmental Monitorin~ 
Because aquatic organisms have been found to be sensitive to exposure 
to environmental pollutants such as BP, petroleum-derived hydrocarbons, and 
polychlorinated biphenyls, suggestions have been made for the use of these 
organisms, especially fish, in environmental monitoring studies (Parlin, 80; 
Payne, 84; Neff, 85). Various analyses, including MFO activities, have been 
suggested as possible monitoring tools. Some studies have attempted to link 
P-450 induction with reproductive effects (Spies et al., 88a and 88b). P-450 
induction is dependent on a sometimes bewildering variety of factors including 
temperature, diet, route of uptake, time and concentration of exposure, presence of 
other chemicals (possible synergists or suppressors of induction), sex, age, 
developmental stage, etc. While I do not directly address questions of 
environmental monitoring in this thesis, the methods developed and described in 
the following chapters such as immunoblotting and mRNA quantitation can be 
applied to environmental situations (e.g., Stegeman et al., 86, 87 and 88; Raasch 
et al., submitted) The application of these techniques will enhance our 
understanding of P-450E induction in individuals exposed to different 
environmental conditions. 
GENERAL AIMS OF RESEARCH AND SPECIFIC QUESTIONS 
In order to accurately assess the impact of environmental chemicals on 
the monooxygenase system, which may deactivate these compounds or activate 
them to deleterious reactive intermediates, it is necessary to understand the role 
induction plays in the regulation of this enzyme system. The wealth of 
background information on the enzyme itself and the availability of antibody 
probes for identification and measurement of P-450E protein and mRNA levels led 
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me to examine the mechanism of regulation of the xenobiotic-metabolizing 
isozyme P-450E. Originally, I planned to examine P-450E in scup, but various 
logistic problems resulted in a change of focus to its homologue, which shall also 
be called P-450E throughout this thesis, in another teleost, the marsh minnow or 
mummichog Fundulus heteroclitus. Fundulus was selected because of the 
availability of individuals from non-migratory populations found in relatively 
"clean" habitats throughout most of the year, and the ease of maintaining and 
treating large numbers of fish. We also have a good deal of background on the 
physiology of these well-studied animals (American Zoologist, 86) and on the 
basics of the MFO system in Fundulus (Stegeman, 79; Binder and Stegeman, 80; 
Binder and Stegeman, 84; Binder et al., 85). The specific questions which I 
addressed in attempting to understand the regulation of P-450E in Fundulus 
included the following: 
1) What is the temporal pattern of induction of microsomal P-450E-related activity 
in Fundulus heteroclitus after exposure to the MC-type inducer BNF? 
2) Does this increase in activity correspond to increases in the P-450E protein 
levels? 
3) What are the mechanisms of this induction? 
a) Is P-450E-specific mRNA increased? 
b) If so, what is the temporal relationship between protein, 
activity and mRNA increases? 
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4) What are the turnover rates of protein and heme following exposure to BNF in 
Fundulus heteroclitus? 
Prior to addressing these questions, I examined the feasibility of utilizing 
anti-scup P-450E antibodies as probes in the study of regulation, and characterized 
them in more depth. The main questions concerning the antibodies were: 
1) What is the specificity of the monoclonal and polyclonal antibodies generated 
against scup P-450E? 
2) What is the cross-reactivity of the monoclonal and polyclonal antibodies with 
the species generally studied in the lab, as analyzed by 
- immunochemical detection 
- catalytic inhibition 
Chapter 2 describes the published results of investigations of the latter 
questions, setting the stage for the use of the antibodies in Chapters 3, 4, and 5, 
which discuss results of the induction studies. Chapter 3 emphasizes the induction 
of P-450E protein and EROD activity following BNF treatment, and Chapter 4 
examines the relationships between protein and mRNA levels following BNF 
treatment. Chapter 5 explores some questions concerning turnover of protein and 
heme in fish (total, microsomal and P-450E) following treatment with BNF. 
Chapter 6 briefly summarizes the findings reported in Chapters 2 through 5, and 
provides some speculations on possible future research directions. 
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PREAMBLE 
In order to further our studies on the presence and regulation of P-450E 
protein in teleost species, we collaborated with Drs Harry V. Gelboin and Sang S. 
Park of the National Cancer Institute, NIH, in the production of monoclonal 
antibodies (MAbs) against the purified isozyme. Dr. Gelboin has been interested 
in developing a suite of MAbs for use in purification and characterization of P-450 
isozymes from various species (Cheng et al., 84; Park et al., 86b; Waxman et al., 
87). In this case, BALB/c female mice were immunized with P-450E purified by 
Alan Klotz (Klotz et al., 83) and their spleen cells fused with SP2/0Ag14 
myeloma cells. The production and preliminary characterization of the MAbs is 
described in Park et al. (86a). 
Nine hybridomas produced MAbs that strongly recognized P-450E in 
radioimmunoassays (RIA). Four of these nine hybridomas produced antibodies 
which produced precipitin reactions with scup P-450E in double immunodiffusion 
(Ouchterlony) analysis. None of the anti-scup P-450E antibodies could immuno-
precipitate any of the purified mammalian P-450 forms tested (rat PB-B [P-450b], 
rat MC-B and BNF-B [the latter both P-450c, but from two different laboratories]; 
rabbit form 2 [PB-inducible, orthologue to rat P-450b]; and rabbit form 4 [MC-
inducible, orthologue to rat P-450d]). Ouchterlony immunodiffusion analysis is 
dependent on lattice formation, which may not occur with some (most) 
monoclonal antibodies. Thus, the MAbs were also examined for cross-reactivity 
with mammalian P-450s with solid-phase RIA. (The mammalian P-450s were 
bound to a plate and the MAb to be tested was added. Radiolabeled rat anti-mouse 
Ig kappa (light chain) antibodies were added and the amount of radioactivity was 
measured.) In this analysis, one of the anti-scup antibodies, MAb 1-12-3, 
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recognized purified rat MC-B and BNF-B. MAb 1-12-3 was also able to inhibit 
the Alll-I activity of reconstituted rat BNF-B. 
The following publication describes the further characterization of several 
of the monoclonal antibodies generated by Dr. Sang Park, as well as some anti-
P450E polyclonal antibodies (PAbs) generated at the Animal Care Facility at MIT, 
by using immunoblot ("Western" blot) analysis. This method requires more 
conventional techniques (no radiolabeled antibodies need be generated) than does 
the RIA, and provides information on the number and molecular weight of 
proteins recognized, rather than lumping all cross-reactive proteins together. I 
examined the specificity of the antibodies in reactions with all purified and 
partially-purified P-450 forms available from scup hepatic microsomes. All 
monoclonals and polyclonals tested reacted solely with the antigen, P-450E, and 
with no other purified isozyme or isozyme fraction from scup. 
I then examined scup microsomal samples, which contain a multitude of 
proteins besides the P-450s (including proteins possibly present in trace amounts 
in the antigen preparation). The monclonal antibodies, as expected, were highly 
specific for P-450E. The polyclonal antibodies recognized P-450E, but also 
reacted weakly with some other microsomal proteins. The signal from the non-
P-450E proteins remained constant in microsomal samples from scup treated with 
vehicle only or with various inducers despite marked increases in the P-450E 
band, indicating that these non-inducible proteins are recognized because they 
were minor contaminants of the antigenic mixture. Because the content of these 
cross-reacting proteins was approximately constant in variously induced samples, 
and they did not migrate near or with P-450E, the P Ab could still be used for 
immunoquantitation of P-450E. 
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I also investigated microsomal preparations from a number of other 
teleosts for cross-reactivity of the antibodies with P-450E orthologues. 
Immunoblotting of preparations from various species with anti-P450E antibodies 
allows for a highly specific analysis of P-450E protein content without the tedious 
purification of P-450 protein from each species and antibody generation against 
each purified protein. This is especially important in cases where only a small 
amount of tissue is available, either due to the small size of the organism (e.g., 
Fundulus) or the difficult logistics of obtaining a large number of individuals 
(e.g., species such as the deep-sea rattail Coryphanoides armatus, Stegeman et al., 
· 86) or when numerous species are to be examined (e.g., Bermuda species, 
Stegeman and Woodin, manuscript in preparation). Microsomes from all teleost 
species examined here, including rainbow trout, brook trout, winter flounder and 
Fundulus, exhibited a single reactive band in immunoblots incubated with MAb 
1-12-3. 
Like the MAbs, the anti-scup P-450E polyclonal antibodies also gave a 
highly specific reaction with the P-450E orthologues. Reaction of the PAbs with 
other, non-P-450 teleost microsomal proteins was decreased compared to that 
observed in scup microsomes. This is possibly due to a different distribution of 
these cross-reacting proteins in other species, or to increased structural changes in 
these other proteins compared to the apparent close relationship of the P-450E 
homologues (see section on amino-terminal scup and trout sequences, Chapter 3 
Discussion and Table 3-5). Because isolated proteins were not available from any 
species besides scup, scup P-450E served as a standard in all cases. Differences 
in teleost primary sequences may affect the affinity of the antibody for the P-450E 
orthologue in each individual species. Thus, P-450E protein values must be 
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considered on a relative basis within each species and cannot be directly compared 
across species lines. 
Cross-reactivity of the anti-scup antibodies with mammalian tissue was 
also examined. As noted above, MAb 1-12-3 recognizes purified rat P-450c in 
RIA; this finding was confirmed by recognition in immunoblots. Surprisingly, 
the monoclonal antibody (which recognizes a single band in scup and all other 
teleost microsomes tested thus far) recognizes two bands in induced rat 
microsomes: one band which co-migrates with purified P-450c (rat P450IA1) and 
another, fainter band with a lower apparent molecular weight. This band, or a co-
migrating one, is actually recognized more strongly than is P-450c by one of our 
polyclonal antibody preparations. In an attempt to establish the identity of the 
lower Mr band, I irnmunoblotted rat micro somes with MAb 1-7-1, a monoclonal 
antibody generated against rat P-450c from Dr. Gelboin's laboratory which 
recognizes both P-450c and P-450d (Cheng et al., 84) side by side with the 
polyclonal antibody. P-450d (P450IA2), as recognized by MAb 1-7-1, co-
migrated with the PAb cross-reactive band. 
Inhibition of specific enzyme activities is another characteristic of some 
antibody-antigen interactions. The preliminary report on the MAbs showed that 
some of them could inhibit AHH and ECOD activities (Park et al., 86a). I found 
that MAb 1-12-3 inhibited EROD activity in induced scup, brook trout and 
rainbow trout microsomes to less than 10% of the EROD activity observed in the 
presence of a non-specific MAb. The polyclonal antibodies inhibited scup 
microsomal EROD and AHH by over 90%, inhibited about 60% of ECOD 
activity, and had no effect on aminopyrine N-demethylase (ApND) activity. This 
pattern is consistent with our knowledge of P-450E catalytic function: it is the 
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major (and possibly sole) EROD and AHH catalyst, it is one of at least two ECOD 
catalysts, and it is not directly involved in ApND activity. 
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Monoclonal antibody (MAb) 1-12-3 generated against liver cytochrome P-450E (P-
450E), an aryl hydrocarbon hydroxylase of the marine fish Stenotomus chrysops (scup), 
reacted only with P-450E when tested in immunoblot analysis with five P-450 fractions 
from scup liver. This and six other MAbs against P-450E recognized purified P-450E, 
as well as a single band in .B-naphthoflavone (BNF)-induced scup microsomes that com-
igrated with authentic P-450E. Like MAb 1-12-3, polyclonal anti-P-450E reacted with 
P-450E but not with other scup P-450 fractions and reacted strongly with a band coin-
cident to P-450E in BNF-treated scup microsomes. However, the polyclonal antibody 
(PAb) also faintly recognized additional microsomal proteins. MAb 1-12-3 recognized 
P-450E induced by 3,3',4,4',5,5'-hexachlorobiphenyl and by polychlorinated biphenyl 
mixtures in scup, and a single band induced by BNF or 3-methylcholanthrene (MC) in 
microsomes of other teleosts, including two trout species, killifish and winter flounder. 
The content of the P-450E counterpart in these fish and also in untreated scup coincided 
with induced ethoxyresorufin 0-deethylase (EROD) activity. Induced EROD activity in 
scup and trout was strongly inhibited by MAb 1-12-3, further demonstrating the rela-
tionship between P-450E and induced P-450 in trout. MAb 1-12-3, two other MAbs, and 
anti-P-450E PAb recognized a band comigrating with P-450c in BNF-induced rat mi-
crosomes. MAb 1-12-3 also recognized purified rat P-450c. MAb 1-12-3 and anti-P-450E 
PAb recognized a second band of lower molecular weight than P-450c in BNF rat mi-
crosomes which may correspond to P-450d, the MC- and isosafrole-inducible rat isozyme. 
The results firmly establish the identity of scup P-450E, the relationship of BNF-induced 
P-450 in other teleosts with P-450E, and the immunochemical relationship of P-450E 
with rat P-450c. Furthermore, results with untreated fish suggest that effects of envi-
ronmental chemicals may be detected by immunoblotting with monoclonal anti-P-450E. 
C 1987 Academic Press, Inc. 
The P-450 cytochromes are a family of 
related enzymes which catalyze the trans-
formation of a variety of substrates, from 
endogenous steroids and fatty acids to xe-
nobiotics such as polynuclear aromatic hy-
drocarbons (P AH)3 (1). Vertebrates from 
1 Some of these results have appeared in preliminary 
form in (1986) Fed. Proc. 45, 320. 
2 To whom correspondence should be addressed. 
3 Abbreviations used: AHH, aryl hydrocarbon hy-
0003-9861/87 $3.00 
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fish to mammals have been established as 
having multiple forms of P-450 (2). The 
droxylase; BNF, P-naph thoflavone; ECOD, ethoxy-
coumarin 0-deethylase; ELISA, enzyme-linked im-
munosorbent assay; EROD, ethoxyresorufin 0 -deeth-
ylase; HCB, hexachlorobiphenyl; HRP, horseradish 
peroxidase; MAb, monoclonal antibody; MC, 3-meth-
ylcholanthrene; P Ab, polyclonal antibody; P AH, 
polynuclear aromatic hydrocarbon; PBS, phosphate-
buffered saline; PCB, polychlorinated biphenyl. 
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functions of the P -450s in fish are only now 
being established. Three highly purified 
forms, P-450s A, B, and E, have been iso-
lated from hepatic microsomes of Steno-
tomus chrysops (scup), a North Atlantic 
coastal fish. Reconstituted scup P-450A is 
a major steroid hydroxylase (3) and P-450E 
is the major aryl hydrocarbon hydroxylase 
(ARR) in this fish (4, 5). 
P-450E is of special interest because of 
its potential for activation of PAR procar-
cinogens. When reconsti tuted with epoxide 
hydrolase, lipid, and P-450 reductase, this 
enzyme forms benzo[a]pyrene metabolites 
that are nearly 40% trans-7,8-dihydrodiol 
(4), the precursor to the ultimate carcino-
gen of benzo[a]pyrene, 7,8-dihydrodiol-9,10-
epoxide (6). Properties of P-450E also sug-
gest that it is the major PAR-inducible P-
450 form in scup. The isolated protein has 
a catalytic profile (inhibition by a-naph-
thoflavone, high ARR activity), optical 
properties (Fe2+ -CO absorption maximum 
near 447 nm), and a molecular weight 
(54,000) consistent with PAR-inducible, 
ARR-metabolizing forms (4). Experimen-
tal treatment of scup with 3-methylchol-
anthrene (MC) or ,9-naphthoflavone (BNF) 
induces increased levels of microsomal 
ARR and 7-ethoxyresorufin 0-deethylase 
(EROD) activities, a blue shift in the Soret 
peak of the Fe2+ -CO complex, and specific 
increases in a 54-kDa protein (7). These 
properties are similar to those character-
istic of the major MC-inducible isozyme in 
rats, P -450c (also called P-450 BNF-B 
(8, 9)). Furthermore, some antibodies to rat 
P -450c specifically recognize scup P-
450E (3). 
We recently described the generation of 
monoclonal antibodies to scup P-450E (10), 
one of which (monoclonal antibody 1-12-3) 
strongly recognized rat P-450c in radioim-
munoassay and immunoblots. In the pres-
ent study we examined the specificity of 
these monoclonal antibodies, as well as 
polyclonal antibodies against scup P-450E, 
employing immunoblots with both micro-
somes and purified isozymes. In addition, 
we analyzed the recognition of specific pro-
teins in different species. This is the first 
reported use of monoclonal antibodies in 
immunoblotting to identify and quantitate 
PAR-inducible P -450 forms in aquatic or-
ganisms. The results establish the presence 
of a closely related protein in scup and 
other fish species and confirm an immu-
nochemical relationship, manifested by the 
presence of common epitopes, between the 
BNF-inducible rat and the fish P-450 iso-
zymes. 
MATERIALS AND METHODS 
Animals. Scup (Stenotomus chrysops) were caught 
by angling in Nantucket Sound, Vineyard Sound, and 
Buzzards Bay, Massachusetts. Winter flounder (Pseu-
dopleuronectes americanus) weighing 300 to 360 g and 
with developed gonads were collected by otter trawl 
in local waters off Woods Hole in January. Non-
spawning killifish (Fundulus heteroclitu.s) were col-
lected by seining in Sippewissett Marsh. Brook trout 
(Salvelinusfontinalis) were raised from eggs obtained 
from the Sandwich Fish Hatchery. Immature rainbow 
trout (Salmo gairdneri) were obtained from Thistle 
Springs Trout Farm (Ashton, Ontario) and main-
tained as before (7). Marine fish were maintained in 
flowing seawater and trout in flowing well water on 
a diet of Purina Trout Chow. The diet of the marine 
species was supplemented with chopped squid. Male 
Sprague-Dawley retired breeder rats were purchased 
from Charles River Breeding Labs (Wi lmington, MA) 
and maintained on Rat Chow and water ad libitum_ 
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Treatment. Experimental animals were injected ip 
with either BNF in corn oil or corn oil alone. Adult 
scup of both sexes (200 to 430 g) that were gonadally 
regressed were treated with 35 to 75 mg/kg BNF; after 
5 days livers were pooled and hepat ic microsomes were 
prepared. Similarly, nonspawning adult brook trout 
of both sexes were t reated with 50 mg/kg BNF and 
hepatic microsomes were prepared from pooled livers. 
Rainbow trout received 20 mg/kg MC and 3 days later 
the fish were killed and liver microsomes were pre-
pared. Female killifish (5 to 15 g) were dosed with 50 
mg/kg BNF and killed 3 or 7 days later. Scup were 
a lso treated with the PCB congener 3,3',4,4',5,5'-hex-
achlorobiphenyl at 40 mg/kg, and with Aroclor 1254/ 
1242 at 2 mg/ kg, as described elsewhere (11). Rats 
were dosed ip daily for 3 days with 80 mg/kg BNF 
and killed on the fourth day. 
Enzyme preparation and activity assays. Livers were 
excised and microsomes from all animals were pre-
pared according to established methods (7, 12). Scup 
P-450 fractions A through E were isolated as described 
elsewhere (4). P-450c purified from Long- Evans rats 
was a generous g ift of Dr. Michael Marietta, MIT. 
The specific contents of cytochromes ~and P-450 were 
measured spectrally and by protein analysis (12, 13); 
AHH, EROD, and aminopyrine N -demethylase activ-
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ities were assayed by established procedures (7, 12, 
14). For catalytic inhibition studies, antibody was in-
cubated with the preparation for 20 min on ice prior 
to reaction initiation by addition of NADPH. 
Antibody production and characterization. Poly-
clonal antibodies were generated against purified scup 
hepatic P-450E in New Zealand male white rabbits. 
Each rabbit was primed with 500 11g P-450E in com-
plete Freund's adjuvant (Difco) and boosted 4 and 6 
weeks later with 40 11g in incomplete adjuvant. Rabbits 
were then bled from the ear at weekly intervals. The 
serum was collected and lgG was precipitated twice 
with 40% ammonium sulfate. The precipitate was re-
dissolved in PBS, extensively dialyzed and clarified, 
and chromatographed on a Whatman DEAE-52 col-
umn (15). Void volume fractions with a high A 280 were 
concentrated and stored at - 7o•c. Ouchterlony double 
diffusion on agar plates was carried out using the 
modifications of Thomas et aL (16). 
Monoclonal antibodies against scup cytochrome P-
450E were obtained by conventional hybridoma tech-
niques. Their preparation and initial characterization 
have been described (10). Antibodies obtained in 
serum-free culture fluids and ascites fluids were stored 
in liquid N2 or at -70°C until use. 
bnmuncblot aru:Uysis. Immunoblotting, as originally 
described by Towbin et aL (17), was carried out es-
sentially by the method of Burnette (18). However, 
HRP-labeled antibodies were used and dilutions and 
incubation times were empirically optimized. Micro-
somes and protein fractions were separated on 10% 
SDS-PAGE gels (19) and transferred overn ight onto 
0.45-llm nitrocellulose sheets (Schleicher & Schuell) 
at 4•c (Bio-Rad Transblot). Incubations were carried 
out in the presence of 5% (w/ v) dry milk for nonspecific 
blocking. The primary antibody was diluted in PBS/ 
milk and incubated with the nitrocellulose for 2 h. 
The secondary antibody, either HRP-conjugated goat 
anti-mouse or goat anti-rabbit IgG (Bio-Rad), was 
then incubated with the sheets for 1 h followed by 
HRP color developer containing 4-chloro-1-naphthol 
(Bio-Rad) and H20 2 (Fisher). In some incubations we 
employed a secondary antibody that was not HRP 
conjugated (goat anti-rabbit IgG, Pharmacia), and a 
third incubation with rabbit peroxidase-antiperoxi-
dase complex (Pharmacia) was carried out before color 
development. Development was stopped within 30 min 
by thorough rinsing with distilled water. Sheets were 
scanned with a Helena Labs Quick Scan R & D den-
sitometer (courtesy of S. Watson, Associates of Cape 
Cod). Some nitrocellulose sheets were stained for 
protein with amido black. 
RESULTS 
Isozyme Specificity 
The specificity of antibodies to P-450E 
in immunoblots was tested with purified or 
partially purified scup P-450 fractions A 
through E. Isozymes in fractions A, B, and 
E have been described (3, 4) and are elec-
trophoretically separable and structurally 
distinct proteins. Although not purified to 
homogeneity, fractions C and D contain P-
450s with optical properties distinct from 
each other and from A, B, and E. Mono-
clonal antibody 1-12-3 was highly specific 
for P-450E and did not visibly react with 
any protein in fractions A-D (Fig. lA). 
Recognition of P-450E but not other scup 
liver P-450s was also seen with polyclonal 
anti-P-450E (Fig. lB). Staining of gels with 
Coomassie blue after transfer showed little 
or no remain ing protein, indicating that 
lack of reactivity with other fractions was 
not due to poor transfer to the nitrocellu-
lose. In addition, amido black staining of 
the nitrocellulose consistently indicated 
substantially complete protein transfer in 
the relevant regions of the gel. 
E 0 C 8 A 
MAb 1-12-3 
-E 0 C 
PAb119p 
8 
8 A 
FIG. 1. Immunoblot of MAb 1-12-3 and PAb 119p 
with scup P-450's. (A) Fractions A, B, C, D, and E (40 
pmol each) were applied to SDS gels, transferred to 
nitrocellulose, and incubated with MAb 1-12-3 (1:440) 
followed by HRP-conjugated goat anti-mouse IgG (1: 
200). Staining was with HRP color developer in MeOH 
plus PBS, with H20 2 added immediately before use. 
(B) Fractions A through E, 40 pmol each. Incubations 
were P Ab 119p (1:500), goat anti-rabbit IgG (1:200), 
and rabbit peroxidase anti-peroxidase (1:1000). 
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Titrating a range of purified P-450E 
amounts against MAb 1-12-3 provided 
quantitative results with the immunoblot-
ting procedure. The results in Fig. 2 show 
a linear region up to 8 pmol P-450E and 
"saturation" at higher concentrations. Re-
peated titrations have resulted in a linear 
response up to 5.0 to 8.0 pmol P-450E. 
P-450E in MicrosO?nes 
Analysis of whole microsomes prepared 
from BNF-treated scup liver further dem-
onstrated antibody specificity and showed 
xenobiotic induction of P-450E. Hepatic 
microsomes from BNF-induced scup ex-
hibited only one band, Mr near 54,000, upon 
incubation with MAb 1-12-3 (Fig. 3). The 
intensity of this band in BNF liver micro-
somes reacted with MAb 1-12-3 increased 
with t he amount of microsomal protein 
applied. However, control scup microsomal 
P-450 showed no visible staining even when 
the amounts applied were twice the highest 
amount of BNF-scup microsomal P-450 
analyzed. Six other monoclonal antibodies 
generated against scup P -450E, those des-
ignated MAb 1-8-4, 1-8-6, 1-9-5, 1-33-3, 1-
49-5, and 1-54-8 (10), showed the same 
specificity. Each reacted with purified P-
450E and with only a single band, comi-
grating with P-450E, in BNF-induced scup 
liver microsomes (Fig. 4). 
Treatment of scup with other known 
PAH-type inducers gave results similar to 
those with BNF (Table I). One HCB treat-
ment regime resulted in a higher propor-
30 
8 12 16 20 
P- 4 50 E (pmol) 
FIG. 2. Titration of purified P-450E against MAb 1-
12-3: 2 to 18 pmol of P-450E was blotted. Y axis: area 
under the curve; X axis: pmol P-450E applied. Re-
peated scans were reproducible within 3 to 5% of the 
mean. 
20 2 5 10 
FIG. 3. Immunoblot of MAb 1-12-3 with control and 
BNF-treated scup microsomes. See Materials a nd 
Methods for treatment details. Control scup P-450 (20 
pmol) and 2, 5, and 10 pmol of total P-450 from BNF-
treated scup were applied to SDS gel. Incubation con-
ditions were as in Fig. 1A. · 
tion of P-450E to total P-450 compared to 
the other chemical exposures, but all 
treatments (BNF, HCB, and PCB) resulted 
in significant increases in the content of P-
450E over that in control animals. This in-
crease in proportion of immunochemically 
detectable P-450E accompanied a typical 
induction of the EROD turnover number 
(nmol product/min/ nmol total P-450) in 
these fish (data not shown). 
Cross-Reactivity among Teleosts 
Proteins from other fish species were 
used to examine cross-reactivity of the 
MAb 1-12-3 and PAb probes. Hepatic mi-
crosomes to MC-treated rainbow trout and 
BNF-treated brook trout reacted with MAb 
1-12-3 exhibited a single strong band (Mr 
of about 57,000), but the same amounts of 
microsomal P-450 from control micro-
somes showed little or no staining (Fig. 5A) 
of this band. Polyclonal anti-P-450E 
showed a similar strong recognition of this 
band in BNF-treated trout. However, the 
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FIG. 4. Immunoblot of various monoclonal antibodies against scup P-450E with purified scup P-
450E and BNF-treated scup microsomes. MAbs: (a) 1-54-8, (b) 1-49-5, (c) 1-33-3, (d) 1-9-5, (e) 1-8-6, 
(f) 1-8-4, (g) 1-12-3. For MAbs 1-8-4 and 1-12-3, 8 pmol P-450E or 20 pmol BNF-treated scup micro-
somes was used. All other lanes contained 10 pmol P-450E or 30 pmol microsomal P-450. MAbs 
were 20 !Lg/ml serum-free culture fluid, with other conditions as in Fig. 1A. 
P Ab also detected several faint, higher 
molecular weight bands that appeared with 
similar intensity in both control and 
treated trout (Fig. 5B). 
Immunoblotting of killifish (F. hetero-
clitus) microsomes gave results similar to 
those with trout; MAb 1-12-3 strongly rec-
ognized a single band (Mr of about 54,000) 
in BNF-treated fish. When microsomes 
containing equal amounts of spectrally de-
termined P-450 from BNF and control fish 
were blotted, only a faint band was visible 
in control microsomes (Fig. 5C). For BNF-
treated winter flounder (P. americanus) as 
well, only a single band (Mr of about 55,000) 
appeared on blots probed with MAb 1-12-
3 (data not shown). As with the other spe-
cies, greater amounts of the immunochem-
TABLE I 
QUANTITATION OF !MMUNOBLOT OF CYTOCHROME P-450E AND SCUP LIVER MICROSOMES WITH MAb 1-12-3 
pmol P -450 
Sample applied 
P-450E 1.5 
P-450E 2.5 
P-450E 4.0 
PCB-treated microsomes• 5.0 
HCB-treated microsomes• 5.0 
BNF-treated microsomes• 7.0 
Area• 
125 
381 
505 
280 
556 
375 
pmol P -450E 
calculated 
2.3 
4.2 
2.9 
P-450E as% 
total P-450b 
46 
83 
42 
• The relative area under the curve of densitometric scans. Bands were scanned in the reflectance mode. 
b Spectrally determined P-450; see Materials and Methods. 
• Treatments were as described under Materials and Methods. The BNF sample was from pooled microsomes; 
the others were from individual fish. 
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FIG. 5. Immunoblots with control and induced trout 
and killifish microsomes. (A) MAb 1-12-3 with 15 pmol 
total P-450 per lane, ana lyzed as in Fig. 1A. From 
left: MC-treated rainbow trout, control rainbow trout, 
control brook t rout, BNF-t reated brook trout. (B) P Ab 
118 with 20 pmol total P -450 per la ne, analyzed as in 
Fig. lB. Lane 1, control brook trout; lane 2, blank; 
lane 3, BNF-treated brook trout. (C) MAb 1-12-3 with 
individual killifish microsomes. P-450 (15, 10, and 5 
pmol) from BNF scup microsomes was a pplied in the 
first three la nes. 20 and 10 pmol were used from each 
BNF-t reated sample, a nd 20 pmol was from control 
microsomes. Numbers 20, 27, and 28 were sacrificed 
on Day 3; a ll others were on Day 7. 
ically determined protein in killifish and 
winter flounder corresponded to higher 
microsomal EROD turnover numbers. 
Cross Reactivity with Mammals 
In earlier studies, MAb 1-12-3 recognized 
purified rat P-450c in RIA (10). Consistent 
with this, MAb 1-12-3 strongly recognized 
purified rat P-450c in an immunoblot 
(Fig. 6A). Two of the other six monoclonal 
antibodies recognizing P-450E in immuno-
blots also recognized a single band, pre-
sumably P-450c, in microsomes of BNF-in-
duced rats (Fig. 6B). Surprisingly, MAb 1-
12-3, which recognized only a single band 
in BNF-induced scup liver microsomes 
(Fig. 3), recognized two bands in BNF-
treated rat liver microsomes (Fig. 6C), one 
band corresponding to P -450c and a fainter 
band of lower apparent molecular weight. 
Polyclonal anti-P-450E also recognized 
these two bands, or exactly comigrating 
ones, in BNF rat microsomes. However, the 
P Ab recognized the lower band more 
strongly, with fainter staining of the P-
450c band (Fig. 6D).4 The lower band mi-
grated at the same position as the MC- or 
isosafrole-inducible rat P-450d (ISF-G, 
(9)). This was shown by side-by-side blot-
t ing of rat microsomes with P Ab to P-450E 
and MAb 1-7-1 prepared against ratP-450c 
(Fig. 6D). MAb 1-7-1 recognizes P -450c and 
P-450d, but no other proteins, in rat mi-
crosomes (20). 
Catalytic Inhibition 
As indicated in a preliminary report (5), 
the anti-P-450E polyclonals inhibited 
AHHactivityinmicrosomesandinreconsti-
tutions of P-450E. EROD activity in scup 
liver was also inhibited by more than 90% 
by these polyclonals, while ECOD activity 
was inhibited by only 60% (Table II). 
Aminopyrine N-demethylase activity was 
not affected by the polyclonal antibodies 
(Table II). 
Previous work has also shown that sev-
eral of the MAbs to P-450E inhibit AHH 
and ECOD activity in microsomes and re-
constitutions of P -450E to varying degrees 
(10). The data in Table III show that EROD 
activity in rainbow and brook trout liver 
microsomes is inhibited by MAb 1-12-3 to 
the same extent as is the activity in scup 
liver . The microsomes in each case are 
those which have abundant protein rec-
ognized by MAb 1-12-3 in immunoblots. 
P-450E in Untreated Fish 
The above studies showed a strong and 
specific recognition of P-450E induced by 
PAH-type inducers. Immunoblots of indi-
vidual untreated scup caught in different 
areas around Woods Hole revealed a large 
range in P-450E as a percentage of total 
hepatic microsomal P-450. Individuals col-
lected from a site off of Nantucket Island 
• In preliminary immunoblot studies, this polyclonal 
recognized purified P-450c and the comigrating band 
in rat microsomes. 
62 
KLOEPPER-SAMS ET AL. 
0 0 
~· "" 
$ f 
Q Q 
A I I 
--
a b 
B 
d e 
r-;--
l 
s s r r s s s s 
RAT 
c 
SCUP 
1-12-3 
0 
RAT 
1-7-1 119p 
FIG. 6. Antibodies to P-450E incubated against rat or scup liver microsomes. (A) MAb 1-12-3 
wit h 4.0 pmol each of purified rat P-450c and scup P-450E. (B) Culture fluids as in Fig. 4. MAbs: (a) 
1-54-8, (b) 1-4.9-5, (c) 1-33-3, (d) 1-9-5, (e) 1-8-6, (f) 1-8-4. r = 150 to 175 l'g BNF rat microsomes; s 
= BNF scup microsomes (30-50 pmol P-450). (C) MAb 1-12-3 against 175 l'g BNF-treated rat mi-
crosomes and 15 pmol BNF-treated scup microsomes. Incubations as in Fig. 1A. (D) MAb 1-7-1 
against 200 l'g BNF-treated rat microsomes, and P Ab 119p against 175 l'g BNF-treated rat micro-
somes. 
(Wasque Shoals) exhibited much weaker 
staining compared to those collected at two 
sites in Buzzards Bay (Cleveland Ledge and 
TABLE II 
INHIBITION OF BNF-TREATED SCUP HEPATIC 
MICROSOMAL ACTIVITY BY POLYCLONAL ANTI-P-450E 
Assay conditions 
Enzyme lgG/ P-450 Native• +PAb 119p 
activity (mg/nmol) ( %) (%) 
AHH 30 100 ± 10.7 8.8±0.3b 
EROD 40 100 ± 11.5 7.8 ± 0.5 
ECOD 40 100 ± 5.2 40.3±2.1 
ApNDe 35 100 ± 1.5 105.6 ± 0.1 
• Native values were, in nmol product/ min/nmol P-
450, 2.72 (AHH ), 1.30 (ECOD), and 6.42 (EROD), and 
7.09 ~'mol product/ min/ nmol (ApND). Preincubation 
with BSA or with preimmune lgG gave values within 
10% of the native value, except for ApND, which was 
stimulated by preimmune lgG. 
b Percentage of activity relative to native values. 
The results shown are for rat ios of lgG to P-450 taken 
from titration curves. 
e ApND = aminopyrine N-demethylase. 
TABLE III 
INHIBITION OF EROD ACTIVITY IN H EPATIC 
MICROSOMES OF SCUP AND TROUT SPECIES 
BY MAb 1-12-3 
Assay conditions 
Microsome +NBS + MAb 1-12-3 
source• (%) ( %) 
BNF-treated scup 100± 8.1 b 1.5 ± 0.4 < 
BNF-treated 
brook trout 100± 6.4 n.d.d 
MC-treated 
rainbow trout 100 ± 10.8 7.5 ± 6.7 
• Microsomes were from t he scup and trout prepa-
rations used in Fig. 5. 
b NBS = nonspecific monoclonal antibody. EROD 
values in the presence of NBS are 4.54 (scup), 2.21 
(brook t rout), and 1.92 (rainbow t rout) nmollmin/ 
nmol P-450. Activity determined with 100 mg ascites 
fluid containing NBS or MAb/ nmol P-450 for scup 
and brook trout, and 70 mg ascites/ nmol P-450 for 
rainbow trout. 
<Percentage of activity relative to assay with NBS. 
d Not detectable. Practicallimitof detection is0.0038 
nmollmin/ nmol, or <0.17%. 
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Butler Flats). P-450E constituted 3 and 
11 % of the total P-450 in W asque Shoals 
individuals, compared to 62, 43, and 53% in 
individuals collected in Buzzards Bay (Ta-
ble IV). 
DISCUSSION 
Immunoblotting (Western blotting) is a 
technique which provides information not 
only on antibody-antigen binding, as do 
ELISA and RIA procedures, but also on the 
electrophoretic migration (Mr) and num-
bers of electrophoretically distinct anti-
gens in a sample. Thus, the specificity of 
antibodies can be productively examined 
in purified and complex mixtures by this 
method. 
As is clear from Fig. 1, monoclonal and 
polyclonal antibodies to scup P-450E rec-
ognize a single scup hepatic P-450, the 54-
kDa immunogen P-450E. No other purified 
or partially purified P-450 isozyme is rec-
ognized by these antibodies. In addition, of 
the seven monoclonal antibodies to P-450E 
tested, all failed to recognize any other 
proteins in scup microsomes (Figs. 3 and 
4). This specific reaction with the 54-kDa 
protein indicates that scup microsomes 
contain no cross-reacting proteins excluded 
during purification and thus lacking in 
analyses of purified isozymes or resolved 
fractions. 
TABLE IV 
QUANTITATION OF IMMUNOBLOT OF INDIVIDUAL FERAL 
SCUP MICROSOMES WITH MAb 1-12-3 
pmol P-450 P-450E as% 
Sample applied Area• total P-450b 
P-450E 3.0 836 
CL No. 2• 10.0 1749 62 
CLNo. 6 10.0 1224 43 
BF No. 16< 10.0 1504 53 
WS No.4< 10.0 55 3 
WS No. 7 10.0 282 11 
• The relative area under the curve of the densito-
metric scan. 
b P-450 spectrally determined. 
<Individual fish from CL, Cleveland Ledge; BF, 
Butler Flat; WS, Wasque Shoals. 
Furthermore, the blotting specificity of 
the antibodies strongly suggests that in-
hibition of catalytic activity in microsomes 
and in reconstitutions (5, 10) is due to their 
interactions with P-450E. The P Abs inhibit 
two BNF-inducible activities (AHH and 
EROD), but do not affect aminopyrine N-
demethylase (5) (Table II), and the MAbs 
inhibit EROD activity (Table III). Thus, 
these results firmly establish the identity 
of P-450E as the major hepatic microsomal 
AHH and EROD catalyst in this marine 
species. 
BNF, 3,3',4,4',5,5'-hexachlorobiphenyl, 
and Aroclor 1254 are known to induce P-
450c in rats (21, 22). These compounds in-
duce AHH and EROD activities in a num-
ber of fish species, including scup (2, 11, 
23). As shown here (Table I), these chem-
icals also selectively induce the same pro-
tein, P-450E, in scup hepatic microsomes. 
Together with the earlier evidence indi-
cating parallels between properties of pu-
rified P-450E and properties appearing in 
microsomes after PAH treatment of scup 
(4, 7), these results confirm that P-450E is 
the major PAH- or PCB-inducible isozyme 
in this species. 
The strong specific recognition by mono-
clonal and polyclonal antibodies (Fig. 5) of 
a single protein band induced by MC or 
BNF in two trout species indicates the 
presence of a P-450E counterpart in these 
salmonids. In rainbow trout, the increased 
levels of a single band in MC-treated mi-
crosomes compared to control levels, the 
molecular weight of this protein, and in-
hibition of EROD activity in MC-treated 
trout microsomes by MAb 1-12-3 (Table III) 
all indicate that this protein is identical to 
the BNF-inducible P-450 LM4b character-
ized by Williams and Buhler (24) . The con-
clusion that P-450 LM4b is the rainbow 
trout counterpart to scup P-450E is cor-
roborated by cross-reactivity of PAb to 
trout P-450 LM4 with scup P -450E.5 
As in trout, the single band recognized 
by MAb 1-12-3 in hepatic microsomes from 
the other teleost species tested here, kil-
lifish and winter flounder, corresponded 
6 D. E. Williams, A. V. Klotz, D. R. Buhler, and J. J. 
Stegeman, unpublished observations. 
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with BNF induction and high levels of 
EROD activity. Based on these similarities 
and the specificity of the antibody for scup 
and t rout P-450s, we conclude that the 
protein recognized by MAb 1-12-3 is the P-
450E counterpar t in these animals as well. 
Given the phylogenetic distance between 
the famil ies represented by these fish spe-
cies (25), we predict that MAb 1-12-3, and 
perhaps the other monoclonals which bind 
to scup P-450E in immunoblots, will spe-
cifically recognize the P-450E counterpart 
in species from other families of fish. 
Recognition of rat P-450c by MAb 1-12-
3 in immunoblots (Fig. 6A) is consistent 
with earlier RIA and immunoblot results 
(10). The specificity of MAb 1-12-3 for rat 
P-450c has been fur ther indicated by lack 
of recognition of purified P-450b or P-450 
PCN-E (26) in solid phase RIA (10) and of 
purified for ms designated PB-1, PB-2a (or 
PCN-E), 2b, 2c, 2d, 3, PB-4, PB-5, or 6 in 
an ELISA assay (David Waxman, unpub-
lished data).6 In all these analyses, recog-
nition of P-450c (BNF-B) served as a pos-
itive control. 
Although there is strong recognition of 
ratP-450c by MAb 1-12-3, not a ll the anti-
P -450E monoclonals examined stained the 
rat protein. Of the six additional MAbs to 
scup P-450E, only two also recognize P-450c 
(Fig. 6B). Reciprocal immunoblots using 
monoclonals generated against rat P-450c 
have also indicated structural differences 
between the rat and fish proteins. MAbs 
C4 and C6, which were generated against 
rat P-450c and do not cross-react with rat 
P-450d (27), recognized scup P-450E in 
ELISA and immunoblot analyses (3). 
However, six other MAbs to rat P-450c did 
not recognize scup P -450E in that study. 
Furthermore, MAb 1-7-1 to rat P-450c, 
which recognizes counterparts to P-450c in 
several mammalian species (28, 29), did not 
recognize scup P-450E in RIA, in immu-
noblots, or by enzyme inhibition (10). In 
addition, the NH2-terminal amino acid se-
quence of P-450E shows no homology with 
rat P-450c or any other known mammalian 
6 Some of these isozymes have equivalents in the 
Ryan et aL nomenclature. 2c = P-450h, 2d = P-450i, 
3 = P -450a, PB-4 = P -450b, and PB-5 = P-450e (9). 
forms (4). These findings indicate struc-
tural homology of the PAR-inducible iso-
zymes in these evolutionarily diverse spe-
cies, expressed as at least one and possibly 
more highly conserved epitopes, but also 
demonstrate that there is a substantial de-
gree of structural difference. Because each 
monoclonal binds a single characteristic 
epitope, the collection of antibodies to P-
450E may be useful for detailed probing of 
the structura l relationships between and 
among species. 
The possible recognition of P-450d by 
anti-scup P-450E antibodies, as seen by re-
action with a band in BNF-treated rat mi-
crosomes that comigrates with P-450d, is 
intriguing. Defining the relationship be-
tween rat P -450's c and d and scup P-450E 
may shed further light on the evolution of 
the P -450's. Based on intron/exon patterns, 
eDNA sequence homologies, and chromo-
some positions, Gonzalez et aL proposed 
earlier that genes for mouse isozymes P 1-
450 and P 3-450 (counterparts of the rat 
forms P-450c and P -450d (30), respectively) 
diverged from a single ancestral gene (31) 
at a time subsequent to the appearance of 
fish in phylogeny. If so, then a more "an-
cestral" gene product, e.g., P-450E, could 
be related t o both. More recently, gene 
conversion has been forwarded as a mech-
anism which created a large segment of se-
quence homology between t he two genes 
(32), suggesting that the genes diverged 
much earlier. Anti-scup P-450E polyclonals 
presumably bind to a variety of epitopes 
on the fish protein. These epitopes may in-
clude some common to both rat P-450c and 
P-450d, which could lie in the area of 
greatest homology. Stronger reactivity of 
polyclonal anti-P-450E antibodies with rat 
P-450d than with rat P-450c, as suggested 
by Fig. 6, indicates that further character-
ization of the epitopes should provide 
clearer answers to these relationships. In 
any case, P-450E could be orthologous to 
both P-450c and P -450d. 
The immunoblots of untreated fish sam-
pled directly from the environment explic-
itly show t he presence of PAH- and PCB-
inducible P-450E. In earlier studies (4, 7), 
we noted high levels of AHH and EROD 
activity and other characteristics in feral 
65 
ANTIBODIES TO P-450E OF THE MARINE FISH SCUP 
scup. The correlation between the EROD 
turnover number and the immunoblot-de-
termined percentage of total P-450 present 
as P -450E in these fish was 0.98, and both 
aspects correlate well with the sediment 
and water conditions at the three local 
sites. The New Bedford Harbor (Butler 
Flats) and the Cleveland Ledge sites are 
known to be contaminated with PCBs and 
PAR-containing petroleum (33, 34), 
whereas the Wasque Shoals site is nearly 
30 miles distant from these sites and be-
lieved to be uncontaminated. 
The close relationship between PAR-
inducible P-450s in fish species, evidenced 
by recognition of the putative P-450 LM4b 
in MC-induced rainbow trout and of a sin-
gle protein in other PAR-induced fish, 
suggests that the antibody probes should 
be useful in studies of biochemical re-
sponses of various teleosts to environmen-
tal contamination. These antibodies, in 
fact, have been used successfu lly in anal-
yses of fish from the deep sea (35). The use 
of immunoblotting has distinct advantages 
over enzymatic analysis to detect such ef-
fects, in part because it can be applied to 
denatured samples, an important consid-
eration when field samples must be ob-
tained and processed. 
In summary, the results presented here 
establish immunochemical techniques for 
unambiguous identification of scup P-450E, 
and demonstrate that this protein is the 
PAR-inducible, AHH-metabolizing scup 
P-450 form. These probes will be sensitive 
tool::; in analysis of the regulation and 
function of the major inducible AHH cat-
alyst in scup and other aquatic species. 
Further investigations into the relation-
ships between these proteins in fish and 
other vertebrates should enhance our 
knowledge of the evolution of this impor-
tant family of proteins. 
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AFfERWORD 
Since this manuscript was written, the immunoblotting technique 
described herein has become a routine procedure in our laboratory. We generally 
employ the highly specific MAb 1-12-3. We have now screened at least 20 
species of fish by this technique, and find a single band in every species. This 
immunoreactive protein has a Mr near that of P-450E (sometimes slightly lower, 
sometimes higher), and is inducible by BNF, MC, 3,4,3',4' tetrachlorobiphenyl 
(TCB, Gooch et al., submitted), and environmental contaminants (Stegeman et al., 
85; Elskus and Stegeman, submitted; B.R. Woodin, J.J. Stegeman and P.J. 
Kloepper-Sams, unpublished observations). In addition, MAb 1-12-3 recognition 
of a Norway flounder P-450E orthologue correponds to a pollution gradient and to 
EROD activity (Stegeman et al., 88). MAb 1-12-3 also recognizes a microsomal 
protein in other nonmammalian species (pigeons, sea birds, chicken; Stegeman 
and Woodin, unpublished observations) and at least one other mammal (the Minke 
whale; Goks~yr et al., 88). 
The identity of the second band visible in induced rat liver microsomes 
has not been pursued further. Given the possibility that gene duplication may play 
a role in the origin and relationship of the related P-450c and P-450d isozymes in 
rat (P450IA1 and P450IA2, respectively; Athison and Adesnik, 86), this finding 
should be investigated in the future. Nebert and co-workers have concluded that 
rainbow trout contain a single PAH-inducible P-450 gene, and designate it 
P450IA1 (Heilmann et al., 88). A closer examination of specific portions of this 
(and other future) -teleost sequence(s) may provide additional clues as to the 
evolution of the P-450IA subfamily. 
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In conclusion, these antibodies have been shown to be highly specific, in 
immunoblots and catalytic inhibition assays, for scup microsomal P-450E and its 
orthologues in other teleosts. They will serve as exquisitely sensitive probes in 
studies of the regulation of induction of P-450E as described in the next chapters. 
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INTRODUCTION 
The commonly accepted paradigm for TCDD- and PAH-type induction 
of mammalian P-450s may not be functional in fish. As outlined in Chapter 1, 
binding of the Ah receptor to the xenobiotic ligand (Poland et al., 76) is of 
paramount importance in the mammalian model. Interaction of the receptor-ligand 
complex with specific DNA sequences leads to increased transcription of some 
P-450 genes (Gonzalez et al., 84; Jones et al., 85). Subsequent translation of the 
elevated mRNA pool increases the amounts of the catalysts, thus increasing 
metabolism by these isozymes. Several laboratories have induced AHH and 
AHH-type activities in teleosts (e.g., Melancon et al., 81; For lin, 80), yet 
attempts to identify an Ah receptor in fish have been unsuccessful (Denison et al., 
85; Dr. J.W. Hamilton, Dartmouth College, NH, personal communication) until 
recently (Heilmann et al., 88). Denison and coworkers (85) have suggested that 
the relatively long time required for induction of P-450 activity in fish ruled out a 
receptor-mediated mechanism. 
Heilmann et al. (88) utilized a technique to identify a TCDD-binding 
moiety that had failed to produce specific binding above background levels in 
earlier studies (Denison et al., 85; J. Hamilton, personal communication). 
Cytosol from untreated rainbow trout livers contained a saturable, specific TCDD-
binding peak, which could be displaced with 100-fold excess MC or TCDD. The 
authors estimated the content of this "Ah receptor" to be 7.5 fmol per milligram 
cytosolic protein, similar to the content they had previously measured in some 
strains of Ah-responsive mice. They also noted a peculiar enhancement of the 
TCDD-binding peak in the presence of phenobarbital, an enhancement they mis-
referenced as having occurred in other mammalian studies. Confirmation of this 
TCDD-binding peak in trout and other teleost species in future studies and 
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experiments to determine its biochemical and mechanistic similarities to and 
differences from the mammalian Ah receptor will be crucial to understanding the 
role this moiety may play in the regulation of nonmarnmalian P-450 expression. 
Regardless of the properties of this fish "Ah receptor," it is important to 
examine PAH induction in fish to determine the mechanisms involved in P AH-
mediated P-450 induction and to evaluate the evolution of these regulatory 
mechanisms. In the 'next two chapters, I address questions of transcriptional 
enhancement as a possible mechanism for MC-type induction of P-450 in fish. 
Chapter 3 addresses the temporal pattern of P-450E protein induction in Fundulus 
heteroclitus, including increases in catalytic activity, and Chapter 4 addresses 
P-450E mRN A induction and its temporal relationship to protein induction. 
I initially planned to carry out this work with scup as the experimental 
animal, due to the wealth of background material we had concerning the MFO 
system in scup (Klotz et al., 83 and 86), and because the antibody probes had 
been generated against the scup P-450E protein (Chapter 2). The scup available at 
the outset of my studies, however, exhibited a wide range of EROD activities, 
indicating that some of these animals retained some induced P-450s. (This 
supposition has been substantiated by the fact that healthy scup held for 1 or more 
years in flowing, well-aerated Nantucket Sound water at the Environmental 
Systems Laboratory exhibit consistently low hepatic microsomal EROD activities 
and P-450E protein levels.) Thus, I switched to the estuarine killifish or 
rnummichog Fundulus heteroclitus, another well-studied fish whose P-450 system 
is known to be inducible by PAHs (Stegeman, 79; Binder et al., 85; Elskus and 
Stegeman, 89). These non-migratory animals are relatively easy to obtain from 
local, "clean" sites most of the year and thus generally exhibit low constitutive 
EROD activities. Preliminary studies indicated that the MAb and PAb antibodies 
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generated against scup P-450E would readily cross-react with the Fundulus 
orthologue (e.g., Chapter 2, Figure 5). In addition, Fundulus survive well 
(usually) in laboratory settings with minimal flow, and are able to withstand wide 
ranges of temperature and salinity (Griffith, 74). These last points are more 
significant for the turnover studies described in Chapter 5 (recirculating water 
system used) and for future studies of temperature effects on the induction 
response. Low temperatures can retard the induction response in teleosts, 
possibly producing temporal segregration of regulatory processes (e.g., mRNA 
and protein turnover) which are closely linked in more rapidly responding 
systems. Thus, aspects of basic physiology such as poikilothermy can be 
exploited to examine facets of induction that may be difficult to distinguish in 
mammals. 
This chapter examines induction of the P-450E orthologue in Fundulus 
heteroclitus at the protein level, focusing on EROD as an indicator of P-450E 
enzymatic activity and on measurement of P-450E protein by immunoblotting as 
described in Chapter 2. B-naphthoflavone (BNF) was used throughout these 
studies as a non-carcinogenic model MC-type inducer. BNF binds well to the Ah 
receptor site (Okey et al., 80; Blanket al., 87) and induces the same isozymes and 
activities as MC and other aromatic hydrocarbons in mammals. The goals were to 
establish that P-450E protein and catalytic activity could be induced in Fundulus, 
to generate a time course of both the increase and the decrease in protein and 
enzyme activity following a single dosage of the compound, and to see how well 
protein levels and enzyme activities correlate. Finally, material from these 
experiments would be used to determine whether BNF treatment can induce an 
increase in P-450E mRNA concentration. 
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MATERIALS AND :METIIODS 
Chemicals and General Procedures 
Chemicals were obtained from Sigma (general chemicals), BioRad 
(electrophoretic materials, ion exchange beads), Fisher Scientific (general 
solvents), Burdick and Jackson (high-purity solvents), and other companies as 
noted below. Gel electrophoresis apparatus was obtained from BioRad or Hoefer 
Scientific. Bicinchoninic acid (BCA) was obtained from Pierce. A Shimadzu UV 
260 spectrophotometer was used for kinetic assays, spectral analysis and OD 
readings. L-[ 4,5_3H]-leucine (150 Curies/mmol) was obtained from Amersham. 
Scintillation cocktail was Scintiverse II from Fisher Scientific. 
Animals 
Sexually immature female Fundulus heteroclitus were obtained by 
seining or cast netting at two local sites: Scorton's Creek, Sandwich and Little 
Sippewissett Marsh, Falmouth. Scup (Stenotomus chrysops) were caught by 
angling in local Woods Hole waters in the late summer months, and rainbow trout 
(Salmo gairdneri) were obtained from the Sandwich Hatchery, Sandwich, MA, 
with the cooperation of Lloyd Raymond. Scup were maintained at 20 oc and fed 
alternately with locally-caught squid and Trout chow (Purina). Fundulus were 
maintained in flowing, filtered 13-16° C seawater on a diet of ground Trout Chow 
or Tetramin Flakes (Tetrawerke GmbH, West Germany). Reproductive status is 
known to affect MFO activity in fish (Stegeman and Chevion, 80) including 
Fundulus (McKee et al., 83). Gonadosomatic (GSI, gonad weight/total body 
weight x 100) and hepatosomatic (HSI, liver weight/total body weight x 100) 
indices provide a measure of this status. Thus, GSI and HSI were monitored in 
this group for several weeks prior to treatment to assure consistency in these 
values. 
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Fundulus were given a single intraperitoneal (i.p.) injection of corn oil 
(controls) or 50 mg/kg BNF (Aldrich) in corn oil at time 0, fed regularly and 
sacrificed at the times noted in the Results section. Scup (150 to 300 g) and 
rainbow trout (100 to 200 g) received 40 mg/kg of BNF or an equivalent volume 
of corn oil alone. 
Microsomal Preparation and Protein Studies 
Hepatic microsomes were prepared from fresh liver pieces or from liver 
pulverized in liquid nitrogen. Portions of the pulverized liver powders were also 
taken for RNA isolation (see below). Microsomes were prepared by established 
methods (Stegeman et al., 81), as outlined in Chapter 2. Some microsomes were 
prepared by a minor modification of this method: the final centrifugation step was 
for 70 minutes at 38,200 rpm in a 70.1 Ti rotor, Beckman L8-60M 
Ultracentrifuge. Preliminary results using scup microsomes indicated no 
difference in microsomal P-450 specific content or EROD activity when fresh 
livers and liquid nitrogen frozen, pulverized liver powders were compared (B.R. 
Woodin and P.J. Kloepper-Sams, unpublished observations). EROD activity 
(Klotz et al., 84), spectral cytochrome b5 and spectral P-450 content were 
measured as before (Stegeman et al., 81). Protein concentration was determined 
either by the established method of Lowry et al. (51) or by the newer bicinchoninic 
acid (BCA) assay (Smith et al., 85). Both protein determinations employed 
bovine serum albumin (BSA) to develop daily standard curves in microassays of 
up to 25 ug protein. 
Immunoblots were used to determine P-450E protein content. The 
primary antibody was anti-scup P-450E MAb 1-12-3 (described in Chapter 2). In 
all cases, the secondary antibody was Bio-Rad's affinity-purified, horseradish 
peroxidase-linked, goat anti-mouse immunoglobulin G (lgG). Purified scup 
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P-450E served as standard, and only signals from unknowns falling within the 
linear portion of the standard curves (3 or 4 concentrations of scup P-450E per 
gel) were quantified. Microsomal proteins from control and early time point BNF-
treated Fundulus were separated on large (16 x 18 em) 6 to 13% gradient gels to 
improve clarity of immunoreactive bands; bands from most BNF-treated animals 
could be easily detected on either large or "mini" gradient gels. 
RNA Isolation 
In all steps involving RNA work, from preparation of buffers to RNA 
isolation itself to use of RNA in translation mixtures or Northern blots, 
precautions were taken to avoid RNase contamination or activity. Immediately 
upon fish dissection, livers were weighed and pieces were pulverized under liquid 
nitrogen using a ceramic mortar and pestle. RNA was isolated through a cesium 
chloride (CsCl) cushion by a modification of the procedure briefly outlined by 
Chirgwin et al. (79) for tissue containing high nuclease activity. 
I chose this method based on earlier results with purification of rainbow 
trout, scup, winter flounder and Fundulus genomic DNA. We found that although 
good yields could be obtained from trout tissue by normal methods, high 
molecular weight DNA was rapidly lost from marine teleost tissues during routine 
incubations (E. Metz and P.J. Kloepper-Sams, unpublished observations). This 
indicated that nuclease activity could be a problem during RNA preparation as 
well. Thus, the more time-consuming but rigorous method of lysis in guanidine 
thiocyanate (GTC) buffer and centrifugation through a cesium chloride cushion 
was chosen. If multiple samples were prepared, individual tissues were ground 
under liquid nitrogen and stored in liquid nitrogen until needed. All solutions were 
prepared with diethyl pyrocarbonate- (DEPC, Sigma) treated water, then 
autoclaved or filtered (0.45 or 0.22 micron syringe filters, Nalgene) for sterility. 
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Sterile plasticware was obtained from American Scientific Products (now Baxter 
Health Care). GTC solutions were made fresh for each set of experiments and 
stored in brown glass bottles at 4°C until use. All glassware was washed, rinsed, 
dried, and baked at approximately 230°C for 4 hours. Gloves were worn 
throughout the procedure and care was taken to avoid contamination of the 
samples with nucleases during all nucleic acid work. 
For each sample, about 7.0 ml GTC (GTC: 4 M guanidine thiocyanate 
(Fluka Chemie A.G.)/ 25 mM sodium citrate, pH 7.0/ 0.5% sarkosyl (N-lauroyl 
sarcosine)/ 0.1 M B-mercaptoethanol) was added to a glass homogenization vessel 
at room temperature. Pulverized liver powder (0.5 to 1.0 g) was quickly added to 
the vessel and passed 2-3 times at maximum speed (1160 rpm) to remove any 
clumps and homogenize well. This viscous, yellow/brown mixture was 
transferred to a sterile 50 ml capped centrifuge tube. The homogenization vessel 
and pestle were rinsed twice with 0.5 ml GTC, which was added to the tube. 
Solid CsCl (Special Biochemical Grade, Gallard-Schlesinger Chemical Mfg. 
Corp.) was added at 0.4 g per ml homogenate and the tube inverted slowly by 
hand to completely dissolve the CsCL The dense lysate was carefully layered over 
3.5 ml CsCl Cushion (6.2 M CsCl/ 100 mM EDTA, pH 7.0) in a labeled 
ultracentrifuge tube (Beckman Ultra-Clear, 14 x 89 mrn). Tubes were centrifuged 
at 30,000 rpm, 20 °C for 18 hours in a SW 41 Ti rotor head in a Beckman L8-60M 
ultracentrifuge. 
Using sterile techniques, the supernate was removed until about 1 ml of 
liquid remained. The tube was cut about 1 em above the pellet and discarded. The 
sides of the remaining tube were rinsed three times with 0.5 ml GTC. GTC rinses 
were carefully removed and the pellet was rinsed three times or more with ice-cold 
70% EtOH to remove any remaining GTC. After air drying, the pellet was slowly 
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dissolved in a small volume of TE (10 mM Tris, pH 8.0/ 1 mM EDTA) and 
transferred to a sterile 1.8 ml Eppendorf tube. Sodium acetate (0.1 volume of 3 M 
solution, pH 5.2) and ice-cold 75% EtOH (2.2 volumes) were added and the 
mixture was left on ice or at -20° for several hours or overnight to precipitate the 
RNA. 
The pellet was spun down in a cold (4°C) microcentrifuge (eppendorf 
5415) at 10,000 rpm (12,000 g) for 10 minutes. The supernate was drained off 
and the dried pellet resuspended in 2 ml 80% EtOH, spun again, the rinse 
repeated, and the pellet dried thoroughly. The pellet was then dissolved in a 
smaller volume of TE. Small aliquots of the RNA were diluted in TE or water for 
spectrophotometric readings to determine concentration. Finally, 2.5 volumes of 
75% EtOH were added and the RNA was stored at -20°C. To reprecipitate the 
RNA for subsequent manipulations, 0.1 volume of 3M sodium acetate (pH 5.2) 
was added to a small volume of the RNA/EtOH mixture and left overnight at 
-20°C. The pellet was spun down the following day and resuspended in a minimal 
volume of TE or water. 
In Vitro Translation and Immuno.precipitation 
In vitro translation was accomplished according to the manufacturer's 
directions with rabbit reticulocyte lysate (BRL), 5 uCi L-[4,5_3H] leucine and 10 
ug total RNA per incubation. Translation of globin mRNA served as a positive 
control. Small aliquots of translation products were spotted on 2.4 em GF/C 
filters (Whatman), precipitated with cold 10% trichloroacetic acid (TCA), rinsed 
with 5% TCA and diethyl ether (Mallinckrodt), dried and counted in a Beckman 
LS 1801 scintillation counter. A quench curve was established with Liquid 
Scintillation Tritium Quenched Standards (# 566683, Beckman) and the "H#" 
technique (Beckman operating manual). Triplicate determinations of the H# were 
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made for each vial and used to convert cpm to dpm for each unknown. Counting 
efficiency was generally around 47% for TCA-precipitated translation products. 
Unknowns were counted at least in duplicate. 
Remaining translation products were precipitated essentially according to 
Fagan et al. (83) with non-immune IgG (Biomedical Technologies, Cambridge, 
MA) and anti-P-450E polyclonal antibodies (PAb) in the presence of 
immunoprecipitin. Immunoprecipitin (BRL), a suspension of formalin-fixed 
Staphylococcus aureus cells, was first treated according to manufacturer's 
instructions to reduce protein sloughing and resultant high backgrounds, then 
resuspended to 10% (v/v) in immunoprecipitation buffer (1% Triton X-100/ 1% 
sodium desoxycholate (Difco )/ 0.1% SDS/ 0.5% Trasylol (Aprotinin)/ 50 mM 
Tris, pH 7.5/ 150 mM NaCl). Immunoprecipitation buffer (0.5 ml) was added to 
the in vitro translation mixture, followed by 20 ug non-immune IgG. The mixture 
was vortexed and incubated on ice for 30 minutes. Immunoprecipitin (100 to 110 
ul) was added and the incubation left on ice for 30 minutes more. The pellet was 
spun down for 3 minutes at 9000 rpm in a cold rnicrocentrifuge. 
The supernate was transferred to a fresh tube and the pellet saved as the 
"pre-immune" pellet. Purified scup P-450E (0.05 ug) was added to the supernate 
as a carrier, followed by 20 ug anti-P-450E PAb. The mixture was incubated on 
ice for 30 minutes, 100 to 110 ul immunoprecipitin was added and the mixture 
was incubated an additional 30 minutes. The pellet was spun down as before and 
all pellets ("pre-immune" and "P-450E-specific") were washed as follows: twice 
with immunoprecipitation buffer + 0.5 M KCl, once with immunoprecipitation 
buffer alone, and once with Tris/Nonidet (10 mM Tris Cl, pH 7.5/0.5% Nonidet 
P-40). Pellets were resuspended in 60 ul SDS/BME treatment buffer (0.25 M 
Tris, pH 6.8/ 40% glycerol/ 4% SDS/ 0.32% bromophenol blue/ 5% 
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B-mercaptoethanol) and boiled for 10 minutes to elute antigen and antibody from 
immunoprecipitin. Tubes were spun at 6000 rpm for 10 minutes to pellet the 
immunoprecipitin and the supernates were size separated by electrophoresis on 
large 9% SDS-PAGE gels overnight. Gels were saturated with dimethyl sulfoxide 
(Me2SO, Aldrich), impregnated with 20% (w/w) 2,5 diphenyloxazole/ Me2SO, 
rinsed thoroughly in water, dried under vacuum onto Whatman 3MM paper and 
exposed to Kodak X-Omat AR film at -70°C (Bonner and Laskey, 74). The Mr of 
radiolabeled bands were determined by comparison to MW standards (Sigma) 
included in the gels and stained with Coomassie blue. 
Statistics 
Statistical analyses were carried out by standard methods (Zar, 74). 
Single factor analysis of variance was performed with Statworks (Cricket Ware) or 
Statview 512+ (BrainPower). When ANOV analysis rejected the hypothesis of 
equal means, Student-Newman-Keuls and Dunnett's tests were employed to 
determine which means were significantly different. 
RESULTS 
Induction of P-450E Enzyme Activity 
In an initial Fundulus heteroclitus induction experiment using a 50 mglkg 
dose, EROD activities were highest on the last day sampled, which was the third 
day following exposure (data not shown). All fish survived the treatment with 
corn oil or BNF dissolved in com oil, but the times chosen for sampling were too 
short to determine the peak of activity or establish a time course. Thus, a similar 
experiment was carried out for seven days. Females were chosen for this and all 
subsequent studies as males were generally smaller (generating less liver tissue per 
fish), and there were possible sex differences which could complicate evaluation 
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of the results (Stegeman and Chevion, 80; McKee et al., 83). Fundulus exhibit 
strong secondary sexual dimorphisms (e.g., brilliant yellow abdomen in the male, 
differential coloration and size of stripes) during the mating season, and more 
subtle sexually differentiated characteristics are apparent to the experienced eye 
year-round. Thus, only females were treated and gonadal identity was confirmed 
after sacrifice. 
Basic parameters of the experimental fish from the 7 day experiment are 
shown in Table 3-1. As before, all fish survived treatment. The hepatosomatic 
index (HSI), an indicator of general health and condition, was between 3 and 4, 
typical values for laboratory Fundulus kept on a diet of Trout chow or Tetramin. 
The gonadosomatic index (GSI) indicates the gonadal and thus reproductive status 
of the animal. Fundulus spawn in the summer months, but development of the 
gonads can be strongly affected by water temperature and light cycles. A spent or 
immature fish would typically have a GSI of below 1, while extremely "ripe" 
females show GSis of 15 or more. These animals had gonads that were beginning 
to develop, as indicated by GSis of 3 to 5. Microsomal yield is an indication of 
both the degree of contamination of the isolated microsomal fraction with other 
subcellular materials and of the yield compared to the starting material. In my 
hands, a yield of 15 to 20 mg protein per gram liver is typical for Fundulus. 
82 
TABLE3-1: 
7 Day Fundulus Experiment: HSI, GSI, and Microsomal Yield 
time, 
dose 
Day 1 
control 
BNFb 
Day3 
control 
BNF 
Day7 
control 
BNF 
HSI GSI 
C% liver/body wt ) C% 2"0nad/body wt ) 
3.49 ± 0.82 (7)a 
2.85 ± 0.96 (8) 
3.98 ± 0.89 (7) 
3.45 ± 2.04 (9) 
4.04 ± 0.61 (8) 
3.50 ± 1.67 (9) 
3.51 ± 2.34 
3.72 ± 1.51 
4.68 ± 1.96 
5.02 ± 2.27 
3.95 ± 0.79 
4.16 ± 1.31 
microsomal yield 
(m2" protein/~ liver) 
15.5 ± 2.6 
19.8 ± 2.7 
15.8 ± 3.9 
13.2 ± 3.9 
10.1 ± 4.3 
14.4 ± 3.7 
HSI = hepatosomatic index (liver weight/total body weight x 1 00) 
GSI = gonadosomatic index (gonad weight/total body weight x 100) 
a(N) = number of individuals analyzed. Values given are mean± sd. 
bDosage: On Day 0, 29 females received a single i.p. injection of approximately 
100 ul at 50 mg/k:g BNF dissolved in com oil. Control females (N = 22) received 
the same volumes of com oil only. Fish were maintained in tanks containing 15 
liters standing seawater, with up to 13 individuals per tank, and fed ground Trout 
Chow every other day. Water (15°C) was changed on alternate days. 
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Table 3-2 shows results of microsomal assays from these animals. BNF 
and other MC-type inducers are not known to induce cytochrome bs, another 
microsomal heme-containing protein, in mammals. As expected, the specific 
content of cytochrome bs was not significantly different with time or with 
treatment. The specific content of spectral P-450 was increased in the BNF-treated 
animals on Day 3 and Day 7. This increase in "total" P-450 is often seen with 
MC-type inducers in mammals and fish, but is not as marked in Fundulus as in 
some other species, such as scup and winter flounder. 
Increases in EROD activity, which is known to be catalyzed specifically 
by scup P-450E or its orthologue in other teleosts (Klotz et al., 83; Kloepper-
Sams et al., 87), corresponded with increases in P-450 content. Compared with 
controls, the mean EROD activity was elevated in BNF-treated fish by Day 1, was 
significantly higher by Day 3, and increased still further by Day 71 . These trends 
were seen whether EROD activity was expressed on a protein basis (specific 
activity, nmol product formed per minute per mg microsomal protein) or a P-450 
basis (turnover number, nmol product formed per minute per nmol spectral 
P-450). Thus, the EROD catalyst (P-450E) made up a greater proportion of the 
P-450 population, as measured by spectral means, in the BNF-treated animals, 
and also a greater proportion of the microsomal protein complement in these fish. 
This experiment established that the 50 mg/kg dose could, without mortality or 
visible sublethal effects, induce the PAR-inducible P-450 isozyme in Fundulus. 
This experiment also showed that the response of fish to BNF is slower 
than that of rodents to a similar dose of the same compound. Because EROD 
activity was still increasing at the last time point chosen, the peak of activity could 
not be established. Consequently, a longer term experiment was carried 
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TABLE 3-2: 
Fundulus heteroclitus Induction Experiment, Microsomal Characteristics 
bs, P-450, EROD,b 
time dose pmoVm~ nmoVmg nmoVmin/m~ 
Day 1 control 42.7 ± 5.5 (6)8 0.171 ± 0.049 0.272 ± 0.050 (5) 
BNF 39.3 ± 9.6 (8) 0.178 ± 0.058 0.468 ± 0.148 
Day3 control 29.2 ± 14.3 (7) 0.101 ± 0.057 0.139 ± 0.152 
BNF 46.4 ± 20.0 (9) 0.228 ± 0.074 * 0.790 ± 0.331 ** 
Day7 control 49.3 ± 16.0 (8) 0.137 ± 0.073 0.293 ± 0.175 
BNF 70.8 ± 12.9 (9) 0.283 ± 0.045 ++ 1.58 ± 0.40 ++ 
8(N) =number of individuals analyzed. Values given are means± standard deviations. 
hEROD= ethoxyresorufin 0-deethylase activity 
* = P < 0.01 c (control) vs BNF group of that day, 
** = P < 0.001 c vs BNF group of that day, 
EROD, 
nmoVmin/nmol P-450 
1.76 ± 0.68 
2.71 ± 0.86 
1.57 ± 1.09 
3.48 ± 0.84 * 
2.31 ± 0.90 
5.63 ± 1.24 ++ 
++ = P < 0.001 c vs BNF group of that day, and of this BNF group compared to Day 1 c, and to Day 1 BNF. 
\1') 
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out, following the same treatment protocol. BNF-treated and control fish were 
sampled at the same time of day on Days 0, 1, 4, 7, 12, 16 and 20. 
Again, the specific content of cytochrome b5 did not change significantly 
with either time or treatment (Table 3-3). The specific content of spectrally-
determined P-450 was significantly elevated only in the Day 7 BNF-treated group. 
Levels of EROD activity did not change over time in the control fish, but increased 
dramatically in BNF-treated animals (Table 3-3). This was true whether EROD 
activity was expressed as specific activity (Table 3-3) or as turnover number 
(Figure 3-1). As before, the mean EROD activity in BNF-treated fish was higher 
on Day 1 than that of control fish, but EROD activity was not significantly 
different from Day 0 or other control groups until Day 4. The levels of activity 
then remained significantly elevated in the BNF-treated animals through Day 20. 
Specific activity in BNF-treated fish peaked by Day 7, then declined to 35% of the 
maximal value by Day 20. Turnover numbers also declined to 45% of the 
maximal value by Day 20. 
Induction of P-450E Protein Levels 
As described in detail elsewhere (Park et al., 86a; Chapter 2; Kloepper-
Sams et al., 87), monoclonal antibody (MAb) 1-12-3 recognizes only P-450E in 
immunoblot analysis of scup microsomal preparations. It also recognizes a single 
BNF-inducible protein, with a Mr of about 55,000, in Fundulus hepatic 
microsomes (see Chapter 2, Figure 5). Immunoreactive protein content was low 
in control Fundulus and increased up to 19 fold in BNF-treated animals (Figure 
3-1). Because the total P-450 content was elevated only on Day 7 (which may 
account for the slight dip in EROD turnover number [nmol/min/nmol P-450] on 
day 7), the content of another isozyme(s) must have declined. 
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TABLE 3-3: 
Fundulus heteroclitus Induction Experiment (20 day), Microsomal Characteristics 
time bs3 P-450b ERO])C 
Control Animals 
Day 0 58.1 ± 13.8d 0.128 ± 0.025 0.135 ± 0.111 
Day 1 80.5 ± 16.6 0.200 ± 0.065 0.220 ± 0.105 
Day 4 56.6 ± 12.9 0.182 ± 0.025 0.184 ± 0.143 
Day 7 72.4 ± 14.5 0.176 ± 0.039 0.143 ± 0.068 
Day 12 62.9 ± 20.1 0.173 ± 0.075 0.234 ± 0.236 
Day 16 68.6 ± 22.3 0.176 ± 0.055 0.204 ± 0.179 
Day20 nd nd nd 
Control Group Means 
66.8 ± 18.0 0.173 ± 0.052 0.187 ± 0.145 
a Spectrally-determined cytochrome bs, pmoVmg protein 
b Spectrally-determined P-450, nmoVmg protein 
bs 
nde 
73.4 ± 24.3 
64.8 ± 15.7 
84.0 ± 14.8 
64.5 ± 9.9 
75.1 ± 24.2 
70.2 ± 12.1 
c EROD = ethoxyresorufm o-deethylase activity, mnol product/min/mg protein 
d All values are means ± sd, N = 6 
e nd = value not determined 
P-450 
BNF Animals 
nd 
0.213 ± 0.094 
0.200 ± 0.038 
0.290 ± 0.076** 
0.157 ± 0.038 
0.177 ± 0.059 
0.176 ± 0.034 
Values significantly <lifferent from Day 0 control values by Dunnett's test (Zar, 74), * P < 0.05, ** P < 0.01 
EROD 
nd 
0.363 ± 0.166 
1.34 ± 0.26** 
1.51 ± 0.34** 
t'--
1.01 ± 0.39** 00 
0.910 ± 0.365** 
0.534 ± 0 .149* 
Figure 3-1 
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FIGURE 3-1: Temporal response of Fundulus microsomal P-450E protein and 
EROD activity following BNF treatment, 20 day experiment 
Fundulus were given 50 mg/kg BNF on day 0 and sacrificed as 
indicated. P-450E (closed diamonds) was quantitated immunochernically and 
EROD activity (open squares) was measured fluorometrically. Means from 6 
animals per group are shown. Control P-450E means from Day 0 to Day 16 
ranged from 4.7 to 9.7%, and control EROD means ranged from 0.80 to 1.25. 
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If we assume that spectral analysis measures .1QliU microsomal P-450 
content and that MAb 1-12-3 has the same affinity for the Fundulus orthologue as 
for the standard (scup P-450E), then P-450E comprised around 5% of the total 
P-450 in control Fundulus, and rose to an average of 75% of the total P-450 in 
Fundulus that were highly induced by BNF (Figure 3-1). The BNF-induced rise 
in EROD activity corresponds directly with increases in content of the EROD 
catalyst itself. The same direct correspondence is observed when EROD activity 
per mg protein and P-450E specific content are compared (correlations> 0.9 for 
EROD and P-450E protein values for individual samples, on both "per mg" and 
"per nmol P-450" bases). Thus, the trend in P-450E and EROD activity increases 
was apparent within the P-450 population (turnover number and percent P-450), 
as well as more generally in the microsomal preparation. 
RNA Isolation 
Having established the time course of EROD activity and P-450E protein 
induction, it was necessary to show that there are measurable differences in 
P-450E specific mRNA levels in uninduced and induced animals. As mentioned 
in the Materials and Methods section, I suspected that RNase activity would be 
high in the tissues of marine fishes, and so I chose a method of RNA isolation 
originally designed for use with pancreatic tissue (Chirgwin et al., 79). RNA was 
quantitated by taking spectrophotometric readings at 260 and 280 nm (Maniatis et 
al., 84). An optical density (OD) of 1.0 at 260 nm corresponds to 40 ug/ml single 
stranded RNA. The ratio OD 260/280 provides an estimate of the purity of the 
nucleic acid. Pure RNA should have an OD 260/280 of about 2.0. Proteins have 
a peak at 280 nm due to the contribution of aromatic amino acid residues, and 
protein-contaminated samples of RNA will have a 260/280 ratio lower than 2.0. 
Phenol contamination will also reduce this ratio. Typical teleost liver RNA yields 
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and OD 260/280 readings are shown in Table 3-4. Samples from individual 
experiments were combined in this tabulation. The high OD 260/280 readings in 
all cases indicate that the RNA samples were quite pure, with little contamination 
by protein or phenol. RNA yield increased slightly for both Fundulus and scup 
preparations with time, presumably due to operator improvement in isolation 
technique. This range of yields is consistent with published yields from similar 
tissue in other species based on mammalian liver and cell culture estimates (Alberts 
et al., 83). 
TABLE 3-4: 
Teleost RNA Isolation 
Sample OD yield, 
date CN) 260/280 (m~~ liver) 
Fh 8/86 (2) 2.1, 2.1 1.4, 2.0 
Fh 2/87 (3) 2.0 ± 0.1 1.9 ± 0.0 
Fh 4/87 (17) 1.9 ± 0.5 5.7 ± 1.3 
Fh 6/88 (13) 1.9 ± 0.1 7.0 ± 2.2 
scup 7/87 (16) 2.1 ± 0.0 4.2 ± 1.1 
scup 12/87 (5) 2.2 ± 0.1 4.3 ± 2.0 
scup 6/88 (9) 2.0 ± 0.1 7.4±3.8 
Fh = Fundulus heteroclitus 
(N) =number of RNA samples prepared, generally from pulverized 
hepatic tissue. 
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RNA in vitro translation and immunprecipitation 
Translation 
Once RNA of high purity and good yield was obtained, it could be tested 
in an in vitro translation system, with the ultimate goal of quantitating P-450E 
mRNA. Scup and Fundulus RNA samples were translated using the micrococcal 
nuclease-digested rabbit reticulocyte lysate mixture provided by BRL, and the 
manufacturer's protocol was closely adhered to. The method was optimized for 
RNA concentration and magnesium ion concentration. First, various 
concentrations of the rabbit globin mRNA provided in the kit were translated and 
TCA-precipitable counts were plotted versus concentration (Figure 3-2). The 
relationship between counts and amount of mRNA used in the assays was linear, 
with a correlation coefficient of 0.996. The concentration dependence of 
translation of total RNA isolated from BNF-treated scup was also examined 
(Figure 3-3A). Very low or very high concentrations of total RNA result in 
decreased incorporation of label. As Figure 3-3A indicates, 15 ug total RNA 
resulted in fewer dpm than did 12 or 9 ug RNA. The large deviation at 18 ug 
makes it difficult to intrepret the result at this higher concentration, but it seems 
clear that 9 ug is adequate. Thus, all subsequent translations were carried out with 
10 ug total RNA. Some RNAs may require additional magnesium ions for 
efficient translation. Thus, scup total RNA was translated in the presence of an 
additional 0.5 mM and 1.0 mM Mg++. As Figure 3-3B clearly demonstrates, 
added magnesium reduced the efficiency of translation. Therefore, additional 
magnesium ions were not routinely added to the reaction mixture. 
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Figure 3-2 
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FIGURE 3-2: Effect of mRNA concentration on [3H]-leucine incorporation 
Rabbit globin RNA were translated in vitro according to BRL Translation 
Kit instructions for 60 minutes at 30°C in the presence of 5 uCi [3H]-leucine. 
Radioactive translation products were TCA-precipitated on GF-C filters and 
counted. The mean of the duplicate blank values (12,454 dpm; 0 ug RNA) was 
subtracted from all other values. Duplicate samples were counted at each 
concentration and plotted. They-axis units are in dpm x 104. Linear regression of 
the line: r2 = 0.994. 
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Immunoprecipitation 
Teleost RNA translation products were precipitated in the presence of 
imrnunoprecipitin (a suspension of S . aureus cell walls containing protein A) with 
a non-specific and a P-450E specific antibody. The utility of a polyclonal anti-
scup P450E (Kloepper-Sams et al., 87) antibody in immunoprecipitation was 
established in preliminary experiments with RNA isolated from BNF-treated scup. 
Lane 3 of Figure 3-4A shows that a number of tritiated products are present after 
translation of the total population of mRNAs, with numerous high molecular 
weight peptides as well as smaller peptides. Thus, little or no degradation of 
mRNAs encoding translation products of various sizes or of translation products 
themselves occurred. Non-specific lgG precipitated several peptides from this 
larger pool, whereas anti-P-450E precipitated only a single in vitro translation 
product of 54,000, identical to the known Mr of purified P-450E (Klotz et al., 83; 
Figure 3-4A). Although several peptides were precipitated by the non-immune 
antibody, no attempts were made to obtain "cleaner" control precipitates because 
the non-immune IgG did not precipitate any peptides at or near the Mr of P-450E. 
Fundulus RNA was isolated from the livers of Day 0 (control) and Day 4 
(control and BNF) animals from the 20 day BNF induction experiment. By Day 
4, P-450E and EROD values were clearly elevated by BNF treatment (Table 3-3 
and Figure 3-1) and P-450E mRNA levels were expected to be greater in BNF-
treated than in control fish. A fluorogram of immunoprecipitated translation 
products from Day 0 and Day 4 Fundulus is shown in Figure 3-4B. As with 
scup, the non-immune IgG precipitated numerous products from each sample 
(lanes 1, 4 and 5). These bands occur in both control and induced Fundulus 
samples at the same intensity, indicating that these are non-specific, non-induced 
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FIGURE 3-3: Conditions affecting the efficiency of translation of teleost RNA 
3-3A: 6 to 18 ug of total RNA from BNF-treated scup was translated in 
vitro as described in Figure 3-2. Duplicate samples were counted for each 
concentration and their values plotted after subtraction of the blank (blank mean 
dpm = 10760 ± 1264). A line is drawn through the mean values of the duplicate 
readings. Y-axis values are dpm x 104. 
3-3B: 15 ug of total scup RNA was translated (as described in Figure 
3-2) in the presence of additional Mg++. Blank values as in Figure 3-3A. Y-axis 
values are dpm x 104. Linear regression of the line: r2 = 0.953. 
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FIGURE 3-4: Scup and Fundulus RNA in vitro translation products 
Total RNA was isolated from scup and Fundulus, translated in vitro with 
[3H]-leucine, and immunoprecipitated. 
3-4A: Translation products from RNA isolated from scup 1 day after 40 mg!kg 
BNF treatment. Lane 1: products precipitated with a non-immune IgG; lane 2: 
precipitation with polyclonal anti-P-450E; and lane 3: total translation products. 
3-4B: Translation products from RNA from Day 0 control (lanes 1 and 2), Day 4 
control (lanes 3 and 4), and Day 4 BNF-treated Fundulus (lanes 5 and 6). Lanes 
1, 4 and 5: precipitation with non-immune IgG, lanes 2, 3 and 6: precipitation 
with polyclonal anti-P450E. 
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RNA translation products. Anti-scup P-450E did not precipitate any detectable 
products from the Day 0 or Day 4 Fundulus control RNA samples (lanes 2 and 3). 
The antibody did precipitate a single tritiated band of Mr 56,000 from the Day 4 
BNF-treated sample (lane 6). The specificity of the antibody in immunoblots and 
catalytic inhibition (Stegeman et al., 85; Kloepper-Sams et al., 87 and Chapter 2), 
and in precipitating the scup translation product (Figure 3-4A), indicates that the 
peptide precipitated from BNF-treated Fundulus RNA is the counterpart or 
orthologue to scup P-450E. 
DISCUSSION 
The similarities between fish P-450E and the major MC-inducible 
isozyme in mammals (e.g., rat P-450c, mouse PI450; Ryan et al., 79; Negishi 
and Nebert, 81) include substrate specificity, Mr, and maximal Fe2+-co 
absorbance (Klotz et al. , 83), and highly specific immunochemical cross-
reactivities (Park et al. , 86a; Kloepper-Sams et al. , 87). Such similarities 
suggested that the regulation of P-450E would also mirror that of the better-studied 
mammalian forms. However, attempts to locate an Ah receptor, a vital component 
in the mammalian induction model, have failed in fish species (Denison et al., 85) 
until recently (Heilmann et al., 88). Because researchers skilled in the 
development and modification of Ah receptor assays had not been able to detect a 
similar moiety in fish species, I decided to address questions of the regulation of 
P-450 induction from another angle: to determine the time course of P-450E 
protein and activity increases, investigate whether P-450E mRNA levels also 
increased, and if so to determine the relationship between these events. Whether 
or not the TCDD-binding peak detected by Heilmannn et al. (88) has regulatory 
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properties similar to those of the mammalian Ah receptor, the question of 
mechanisms of induction in lower vertebrates must still be addressed. 
The first step in determining the molecular mechanisms of regulation was 
to establish the time course of induction of P-450E activity and protein expression. 
After this was determined, I could examine RNA levels prior to and during initial 
increases in enzyme levels (see Chapter 4). Although total P-450 content did not 
change or increased only slightly with BNF treatment (Table 3-2 and Table 3-3), 
both EROD activity and immunodetectable P-450E content rose dramatically 
within 4 days and remained elevated for 20 days (Table 3-3 and Figure 3-1). 
Although temporal profiles for induction of catalytic activities have been 
shown for fish, this is the first study specifically quantitating levels of an induced 
P-450 isozyme over an extended time. The rise and fall of P-450E protein and 
EROD activity (Figure 3-1) track each other so closely that it is clear that the 
elevated level of the catalyst is responsible for EROD activity over the entire 
period. (Catalytic inhibition studies corroborate this statement: monoclonal 
antibody 1-12-3, which recognizes only P-450E in teleost microsomal 
preparations, inhibits EROD activity in all teleosts tested, including Fundulus 
EROD activity, while not affecting other MFO activities (Stegeman et al., 85; 
Kloepper-Sams et al., 87; unpublished observations).) 
In other experiments, PAR-induced P-450 activities in fish returned to 
control levels after even longer periods. For example, sheepshead (Archosargus 
probatocephalus) held in the winter at 14°C retained elevated levels of AHH and 
EROD activities 4 weeks after MC treatment (James and Bend, 80). Similarly, 
rainbow trout treated with 100 mglkg BNF and held at 10°C had maximal EROD 
activity at 3 days, followed by a steady decline but not a complete return to control 
values by 6 weeks after treatment (Andersson et al., 85). We suggest that elevated 
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levels of the P-450E orthologue were responsible for the maximal and continued 
high activity levels in those studies as well. 
Most mammalian studies have examined temporal relationships of rat or 
mouse PAR-inducible enzyme activity only until a peak or plateau in AHH or 
EROD activity was established, usually between 24 and 48 hours. Negishi and 
Nebert (81) found that B6 (Ah-responsive) mice treated with 250 mg!kg MC had 
elevated AHH activities by 12 hours, which reached a maximum at 48 hours and 
remained at this high value at 72 hours. In MC-treated rats, Fagan et al. (86) 
found that AHH was half-maximal by 14 hours, peaked at 24 hours and remained 
stable through 48 hours. In one of the few experiments that also examined the 
decline in monooxygenase activity following exposure to MC compounds, Boobis 
et al. (77) measured AHH activity in mice treated with a single injection of 80 
mg!kg BNF. AHH activity peaked at 40 hours and returned to basal levels by 72 
hours. These authors reported similar results with rats. 
A broad comparison between the mammalian and the fish literature 
indicates that comparable doses of P AH compounds produce a slower response in 
fish that is maintained longer. Interestingly, in the presence of Aroclor 1254 or 
3,4,5,3' ,4',5'-hexachlorobiphenyl (HCB), rat P-450c is induced for longer 
periods than those listed above (Parkinson et al., 83a and 83b; Hardwick et al., 
85). Slow metabolism of the inducer has been advanced as a possible cause of 
this persistence. TCDD, which induces mammalian AHH and EROD activity for 
up to 35 days after treatment (Poland and Glover, 73), is known to persist in the 
body for long periods. BNF and P AH are very rapidly metabolized and eliminated 
in fish (Stegeman et al., 84; Goddard et al., 87), arguing against slow metabolism 
of the inducer as a cause of persistent induction in fish. The prolonged persistence 
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of the P AH-inducible catalyst may be characteristic in teleost species, particularly 
at low temperatures. 
The next step in investigating the molecular mechanisms of P-450E 
regulation was to establish a method of P-450E mRNA measurement. The GTC 
method of RNA isolation consistently provided teleost RNA of high yield and 
purity (Table 3-4). In the rabbit reticulocyte system used here, an increase in 
translation product corresponds to elevated mRNA encoding that gene product. 
Given the specificity of the antibodies (Kloepper-Sams et al., 87; Chapter 2) and 
the results obtained with immunoprecipitation (Figure 3-4), we are confident that 
translation products precipitated by the anti-P-450E antibodies corresponded to 
pep tides translated from P-450E mRN A. 
The identical Mr of scup and Fundulus microsomal P-450E proteins and 
their respective translation products are consistent with similar studies of Me-
inducible mammalian P-450s in which the Mr of immunoprecipitated translation 
products are near the Mr of the corresponding proteins (e.g., Bresnick et al., 81; 
Fagan et al. , 86). The first protein found to retain a membrane-insertion signal 
peptide was rabbit P-450 form 2 (Black and Coon, 86). Black and Coon 
compared the amino-terminal amino acid residues of several P-450s and found 
them to be extremely hydrophobic, with the exception of some mitochondrial 
P-450s and the cytosolic, bacterial P-450cam. The two known teleost amino-
terminal sequences are also very hydrophobic and are highly conserved (Table 
3-5). The scup and trout amino-terminal sequences are more highly conserved, 
with a single amino acid substitution in 9 residues, than are the mammalian 
sequences. This is interesting from an evolutionary "unit time"/ functional 
restriction viewpoint, as ancestral scup and trout diverged from one another long 
before these closely-related mammals did. As one teleost sequence was 
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TABLE 3-5: 
Amino-Tenninal Sequences of Selected P450IA1s 
scup P-450Ea (M) VLMILPVIG 
trout P1450b M VLMILP I IG 
rat P-450cc M PSVYGFPAF 
mouse PI450 M PSMYGLPAF 
rabbit P-450 6 M V S D F G L P T F 
a The scup P-450E sequence was obtained by Edman degradation of the 
apoprotein (Klotz et al., 83). The (M) indicates that methionine was not detected 
by amino acid determination, but is probably present in the protein. 
b The trout sequence was deduced from the nucleotide sequence. The eDNA 
was sequenced by Heilmann et al. (88) using the dideoxy method of Sanger et al. 
(77). 
c The mammalian P-450 sequences were determined by Edman degradation of 
the purified forms. Sequences as reported by Black and Coon (86) and references 
therein. 
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determined from purified P-450E protein (Klotz et al., 83), and the other one was 
deduced from the nucleotide sequence of the 5' coding region of a fish P450IA1 
eDNA (and thus, derived from the P-450 mRNA sequence; Heilmann et al., 88), 
it is likely that neither fish protein undergoes cleavage and loss of the hydrophobic 
signal peptide region. Again, this is consistent with the findings from mammalian 
studies. Thus, a pre-P-450E protein is probably not synthesized and major post-
translational modifications of the peptide sequence are not likely to occur in these 
teleost species (scup, trout, and Fundulus). 
In this chapter, I have established the time course of induction of P-450E 
protein and EROD activity in Fundulus following treatment with a single, non-
lethal dosage of BNF. As expected if P-450E is the major BNF-inducible EROD 
catalyst, temporal increases in P-450E and EROD activity are highly correlated. I 
also determined conditions for isolation of total teleost RNA, translation of this 
RNA in an in vitro system, and precipitation of RNA translation products with 
non-specific and specific antibodies. Anti-P-450E precipitates a single band from 
scup and Fundulus translation products with the Mr of the mature P-450E in both 
species. This band is present in samples prepared from RNA of BNF-treated scup 
and BNF-treated Fundulus, but was not detectable in RNA from control animals 
of either species. This result further indicates that the precipitated translation 
product is in fact the inducible P-450E. These studies establish the foundation for 
investigations of the temporal relationships between P-450E protein and mRNA 
levels, as described in the following chapter. 
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1 Short term experiments are described in detail in Chapter 4. 
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INTRODUCTION 
Chapter 3 established induction of teleost P-450E on the protein level: 
P-450E protein content and enzymatic activity rose concomitantly in Fundulus 
heteroclitus following exposure to the MC-type inducer BNF. Following in vitro 
translation of hepatic RNA from BNF-treated Fundulus, a single translation 
product was precipitated by anti-scup P-450E antibodies, and its Mr agreed well 
with that of the authentic protein (as recognized by the P-450E-specific antibody 
MAb 1-12-3). This precipitable peptide was only apparent with RNA isolated 
from BNF-treated animals, further indicating that this mRNA corresponds to the 
P-450E message. In this Chapter, the temporal changes in mRNA levels are 
investigated and compared to changes in P-450E protein levels in the initial stages 
of the induction process in order to address the question of transcriptional 
regulation of P-450E expression in these animals. In addition, mRNA levels are 
examined over a longer time period to determine whether the presence of the 
mRNA is responsible for the maintenance of protein expression. 
A specific eDNA probe of P-450E nucleic acid content, pfP1450-3', is 
utilized in several of the following experiments. The isolation and characterization 
of this probe is described prior to the discussion of the induction experiments 
themselves. 
MATERIALS AND ME1HODS 
General Methods 
Materials were obtained from the sources listed in Chapter 3, or from 
individual suppliers as noted. Animal collection and care, chemical treatment, 
preparation of hepatic microsomes and hepatic RNA, and statistical analyses were 
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carried out as described in Chapter 3. The precautions listed in Chapter 3 for RNA 
isolation were adhered to for all nucleic acid work described here. For the 48 hour 
and 13 day BNF induction experiments, two to three Fundulus livers were pooled 
in order to obtain sufficient tissue for RNA isolation and microsomal preparations 
from identical starting tissue. 
Plasmid Isolation 
A recently isolated and characterized (Heilmann et al., 88) 1.4 kb 
(kilobasepair) 3'-specific trout PI450 eDNA (pfPJ450-3') was used to probe 
Fundulus RNA. The eDNA was prepared by growing E. coli DH-alpha cells 
(courtesy of Dr. D.W. Nebert, NIH) harboring a 4 kb pUC19 plasmid (named 
"pUC19-pfPJ450-3' ")containing the eDNA fragment and isolating the plasmid 
by cesium chloride/ethidium bromide centrifugation (lsh-Horowicz and Burke, 
81). Alternately, a plasmid preparation was obtained from Dr. J.J. Lech (Medical 
College of Wisconsin). Growth of the E. coli and purification of the plasmid was 
carried out in conjunction with Darlene Bianca in Dr. Douglas Frasher's laboratory 
(WHOI) and is summarized below. 
The E. coli were streaked on plates containing Luria medium 
supplemented with ampicillin and incubated overnight at 37 °C. Single colonies 
had developed by the next morning, so the plates were sealed with Parafilm and 
stored at 4 °C. A few days later, a single colony was picked from a plate and used 
to inoculate 1 liter of Luria broth plus ampicillin. The bacteria were grown 
overnight, shaking, at 37°C. 
Cells were spun down (10 minutes, 0°C, 6000 rpm, Beckman JA10 
rotor head) and the pellet was resuspended in 40 ml of Solution I (50 mM glucose/ 
25 mM Tris, pH 8.0/ 10 mM EDTA). Solution II (80 ml, 1% SDS/ 0.2N NaOH, 
prepared immediately prior to use) was added, the tube swirled and left on ice 5 
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minutes. Ice cold Solution III (40 ml, 5M KOAc, pH 4.8) was added, the tube 
inverted to mix and left on ice 15 minutes. After addition of 10 ml distilled water, 
the mixture was spun at 10,000 rpm for 20 minutes to pellet the precipitate. The 
supernate was poured off through cheesecloth and its volume measured. 
Isopropanol (0.6 volumes) was added to the supernate and the tube inverted to 
mix. After centrifugation at 8000 rpm for 10 minutes, the supernate was removed 
and the white pellet was partially dried in a Speedvac concentrator. TE (5 ml, pH 
8.0) was added to the dried pellet, which dissolved after thorough shaking. After 
transfer to a 12 ml plastic tube, a small amount of 2M Tris base was added to 
neutralize the solution, and 1 g cesium chloride was added per mlliquid. The tube 
was spun at 10,000 rpm for 5 minutes at room temperature to pellet any 
precipitated protein. This pellet was washed with a few ml TE and respun. Both 
supernates were combined and 400 ul ethidium bromide (EtBr, 10 mg!ml stock) 
was added. The tube was spun again at 10,000 rpm for 5 minutes to precipitate the 
flecks of EtBr which bound to protein and other material. The clear "day glo" 
orange supernate was transferred carefully to a new tube, leaving behind a deep 
red pellet. The density of the solution was adjusted to 1.60 g!ml, with a refractive 
index (R.I.) of 1.394, by the addition of solid CsCl. This solution was 
centrifuged in 12.5 ml QuickSeal (Seton) tubes in a Ti70 rotor head, 40,000 rpm, 
20°C, for about 40 hours (Beckman L8-60M ultracentrifuge). 
A wide reddish band was removed from the middle of the tube via a 18.5 
gauge needle and 10 ml syringe. After addition of a CsCl(fE solution and 100 ul 
EtBr, the mixture was adjusted to a R.I. of 1.386 and centrifuged at 40,000 rpm 
for about 24 hours. The reddish band was removed as before and the EtBr was 
repeatedly extracted with an equal volume of NaCl-saturated isopropanol until the 
upper (isopropanol) layer was clear and colorless, then once more. The DNA was 
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dialyzed in boiled, sterile dialysis tubing against at least three changes of TE to 
remove CsCl. An OD 260 reading was taken to determine the approximate 
concentration (at 260 nm, 1 OD = 50 ug/ml double-stranded DNA), and the 
plasmid was stored at 4 oc or -70°C. 
pfPt450-3' Isolation and Labeling 
In order to obtain the P-450 eDNA fragment, the plasmid was digested 
with restriction enzymes, fragments separated by gel electrophoresis, and the 
eDNA band cut, eluted and precipitated. Two restriction enzymes, Eco RI and Pst 
I, digest the plasmid containing the P-450 fragment at unique sites, resulting in the 
1.4 kb eDNA fragment and a larger piece of pUC19. The digestion protocol 
summarized below was modified from Gingold (84 ), with gel electrophoresis 
carried out according to Maniatis et al. (84). A final volume of five times the 
plasmid volume was calculated and employed in order to avoid problems with 
possible contaminants in that preparation. pUC19-pfPI450-3' was combined with 
0.1 vol lOx Restriction Enzyme (RE) buffer (lx RE: 100 mM Tris, pH 7.5/50 
mM NaCl/ 10 mM MgC12f1 mM DTT, a mixture which appears suitable for both 
restriction enzymes) and sterile water. This mixture was twice mixed and briefly 
spun down in an Eppendorf 5415 microcentrifuge. Restriction enzymes (NE 
Biolabs or BRL) were added (5 U/hr/ug Pst I and 2U/hr/ug Eco Rl) quickly and 
the solution mixed and spun down as above. The plasmid was digested for 1 to 1 
1/2 hours at 37 °C and the reaction was stopped by the addition of 0.1 vol DNA 
Stop/ Loading buffer (20% (w/v) sucrose/ 10% (w/v) type 400 Ficoll/ 100 mM 
EDTA/ 1% (w/v) bromophenol blue). After mixing and spinning down, the 
digested DNA was stored on ice until it was prepared for loading onto a 0.8% 
agarose gel. 
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A horizontal gel apparatus was prepared during the digestion. Agarose 
(type I, low EEO, Sigma) was melted in boiling 1x DNA Agarose Gel Running 
Buffer (lOx stock: 0.9 M Tris/ 25 mM Na2EDTN 0.9 M boric acid, pH 8.2) and 
poured into the gel apparatus after cooling to 60-70 °C (Maniatis et al., 84). The 
gel set within 1 hour and was overlaid with 1 x Running Buffer. Sample (digested 
plasmid) and standards (1 kb DNA ladder and/or Hind III')... digest, both from 
BRL, diluted in a loading buffer of 1% SDS/ 0.1% bromophenol blue/ 100 mM 
EDTN 50% glycerol) were heated for 5 minutes at 65°C to denature the DNA and 
stored on ice, then loaded onto the gel with a capillary micropipetter (VWR). The 
gel was electrophoresed overnight at 40 V constant voltage. 
The gel was stained with EtBr, destained in lx Running Buffer or water, 
and visualized under UV light (Transilluminator, Fotodyne, courtesy of Dr. Norm 
Wainwright, Associates of Cape Cod; or Dr. Douglas Prasher, WHOI) and 
photographed. The lower band (the 1.4 kb pfP1450-3' fragment) was excised, 
cut into small cubes and loaded into the large cup of an Isco Electroeluter (Gaastra 
and J~rgensen, 84). The outer buffer chambers contained 2x Electroelution Buffer 
and the inner chambers contained 1x Electroelution Buffer (lOx stock: 68 mM 
Tris/ 11 mM citrate/ 2 mM EDT A, pH 8.2). The membranes were Spectraphor 
dialysis tubing (3,500 MW cut-off) which had been boiled in 2% sodium 
bicarbonate/ 1 mM EDT A, rinsed, then boiled in 1 mM EDT A and stored at 4 °C. 
Fresh membranes were used for each elution; sample cups were fitted with new 
membranes and tested for leaks prior to addition of the agarose cubes. The 
fragment was eluted for 4 to 6 hours at 3 watts into the small sample collection 
cup. The membrane tubing was examined briefly with a hand-held UV lamp to 
localize the DNA fragment, which was on or near the membrane on the anode 
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side. The orange material was carefully collected by washing off membrane and 
extracted to remove agarose and EtBr. 
The DNA fragment was extracted twice with an equal volume of room 
temperature TE-saturated phenol (BRL), then extracted twice with 3 volumes (1:1) 
water/ diethyl ether (Mallinckrodt), precipitated with 0.1 vol 3 M sodium acetate/ 
10 mM MgCl2 plus 3 vol 95% EtOH and stored several hours or overnight at 
-20°C (Gaastra and Jorgensen, 84). The DNA was spun down in a cold 
microcentrifuge and the pellet was air-dried and washed twice with ether. After 
thoroughly drying the pellet, it was dissolved in 50 ul TE and an aliquot was 
diluted in TE. The OD 260 of this aliquot was measured to obtain an approximate 
concentration. A small volume of the diluted DNA was electrophoresed on a high 
voltage agarose mini-gel system to confirm its size and integrity, and its EtBr 
staining intensity was compared to that of a standard (Hind III A. DNA) of known 
concentration to confirm its concentration. The DNA was stored at 4 °C or -70°C. 
One microgram of the P1450 eDNA was nick-translated in the presence 
of [32p]-dCTP according to the manufacturer's instructions (BRL Nick 
Translation Reagent Kit). The 45 ul reaction volume consisted of : a) a mixture 
containing 0.02 mM of each of the three unlabeled nucleotide triphosphates 
(dATP, dGTP, dTTP) in Tris buffer, b) approximately 1 ug pfP1450-3' eDNA, 
and c) 156 pmol (125 uCi, 800 Ci/mmol at 10 mCi/ml, Amersham) or 100 pmol 
(300 uCi, 3000 Ci/mmol at 10 mCi/ml, ICN) labeled dCTP (deoxycytidine 5'-
[alpha-32p] triphosphate, triethylammonium salt) in a sterile 1.8 ml Eppendorf 
tube. DNA Polymerase II DNase I was added, the mixture was gently shaken, 
centrifuged briefly, and incubated at 15°C for 1 hour. Stop Buffer (0.1 vol of 300 
mM EDTA) was added and the labeled DNA was separated from unincorporated 
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nucleotides by ethanol precipitation (Crouse and Amorese, 87) as described 
below. 
The DNA was precipitated with 0.5 volumes of 7.5 M ammonium acetate 
(NI40Ac) at room temperature and spun down after 20 minutes. The pellet was 
rinsed with 95% EtOH, resuspended in 50 ul TE (pH 7.5) and reprecipitated. The 
pellet was again rinsed, resuspended in 50 ul TE, and stored in the freezer (-20°) 
until use. Aliquots were taken at each step for total and TCA counts, to determine 
radiolabel incorporated into the eDNA and specific activity of the labeled eDNA. 
To obtain "total" counts, 1 ul volumes were added directly to 3 ml Scintiverse and 
counted. For TCA counts, 1 ul was combined with 100 ul of 200 ug/rnl BSA 
carrier in a test tube, 2 rn1 ice cold 5% TCA was added and the mixture was 
vortexed and left on ice 10 minutes. The cloudy white precipitate was filtered 
through a GF-C disk (Whatman) on a sintered glass filter. The disk was rinsed 
once with 5 rn11% ice cold TCA and twice with 2 rn1 95% EtOH. The disk was 
air-dried, Scintiverse was added and the sample was counted in a Beckman LS 
1801 liquid scintillation counter. Because [32p] has a very high counting 
efficiency even at high H#s, no quench correction was necessary. 
Isolation of Genomic Teleost DNA 
Genomic teleost DNA was isolated by a modification of Hewish and 
Burgoyne (73a and 73b), as briefly described by McMahon et al. (manuscript 
submitted). As discussed in Chapter 3, this method was chosen due to the high 
degree of nuclease (DNase) activity present during the more routine DNA isolation 
procedures. Approximately 1 gram of whole liver powder, which had previously 
been pulverized and stored in liquid nitrogen, was mixed with 10 rn1 of ice-cold 
DNA Homogenization Buffer (1 x Burgoyne's buffer*/ 2 mM EDTA/ 0.5 mM 
EGT AI 0.34 M Sucrose) by vigorous shaking in a sterile 50 rn1 capped centrifuge 
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tube. The mixture was homogenized by hand in a chilled Dounce glass 
homogenizer (type "A") 10 to 15 times and overlaid onto 10 ml of ice-cold DNA 
Cushion Buffer (1 x Burgoyne's buffer/ 0.1 mM EDTN 0.1 mM EGTA/ 0.5 M 
sucrose) in a fresh 50 ml tube. The tube was centrifuged 10 minutes at 2000 rpm 
and 0°C to spin nuclei through the cushion. Generally, a whitish/yellow pellet 
resulted. The supernate was poured off and the pellet drained briefly. Then 10 ml 
of DNA Isolation Solution (150 mM NaCV 10 mM EDTA/ 10 mM Tris, pH 7.5) 
was added and the tube was shaken vigorously to resuspend the pellet. In quick 
succession, 0.4 ml 10% SDS, 5 ml TE-saturated phenol, and 5 ml (24: 1) 
chloroform/isoamyl alcohol were added and the tube was inverted by hand 15-20 
times to mix thoroughly. The tube was then shaken for 1 hour at room 
temperature. 
After a 10 minute, 2000 rpm, spin at room temperature, the upper 
(aqueous) layer was gently transferred to a new tube, leaving behind the interface. 
The DNA was reextracted two times with an equal volume of (1:1) phenol: 
chloroform ~nd one time with an equal volume of chloroform. Solid ammonium 
acetate was then added to a concentration of 1.5 to 2M. Two volumes cold 100% 
EtOH were added and the tube was inverted several times to precipitate the DNA. 
A sharp rap on the benchtop settled the DNA, which was then wound out on a 
sterile glass rod, dipped into 70% EtOH followed by 100% EtOH to rinse, and 
briefly air-dried. The DNA was then unwound and dissolved in 5 ml TE (pH 
8.0). RNase was added to 100 ug/ml and the DNA was incubated 1 hour at 37°C. 
Proteinase K was added to 200 ug/ml, and the mixture was incubated at least 3 
hours or overnight at 37°C. 
The DNA was again reextracted (e.g., 2 times with (1: 1) 
phenol:chloroform, 1 time with chloroform), precipitated by the addition of 
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ammonium acetate to 2 M, and wound out, rinsed, and dissolved in a smaller 
volume of1E. Genomic DNA was stored at 4°C. 
*Burgoyne's buffer (Hewish and Burgoyne, 73a and 73b): 60 mM KCl! 
15 mM NaCl/ 15 mM Tris, pH 7.5/1.5 mM spermine/ 5 mM spermidine). 
Southern (Genomic) Blots 
Scup, rainbow trout, and Fundulus hepatic genomic DNA (15 ug of 
each, precipitated with 0.5 vol 7.5 M ammonium acetate plus 2.5 vol95% EtOH 
and resuspended in fresh 1E) were digested overnight with Pst 1 (80 U) or Eco 
Rl (30 U) or both, separated on an 0.8% agarose gel, and stained with EtBr as 
described above for purification of pfPI450-3' eDNA. After visualization and 
further destaining, the gel was placed in 0.25 M HCl for 10 minutes, rinsed, and 
incubated in Denaturing Solution (1.5 M NaCl/ 0.5 M NaOH) for 1 to 2 hours. 
The gel was rinsed again, then left in Neutralizing Solution (1.5 M NaCl/ 1 M 
Tris, pH 8.0) for 1 hour. Transfer to 0.45 micron nitrocellulose (Schleicher and 
Schuell) was carried out in lOx sse (20x sse stock: 3.0 M NaCl/ 0.30 M citrate, 
pH 7.0) essentially as described by Maniatis et al. (84). The residual gel showed 
no bands after extensive staining with EtBr. The nitrocellulose was baked and 
stored at 4 °C until use. 
The nitrocellulose was pre-hybridized for 2 hours at 65°C in 6x sse, 
0.5% SDS, 5x Denhardt's Solution (SOx stock: 1% (w/v) Ficoll/ 1% (w/v) 
polyvinylpyrrolidane/ 1% (w/v) BSA) and 100 ug/ml sheared E. coli DNA 
(Sigma). The filter was transferred to hybridization mixture of the same 
composition with the addition of 10 mM EDTA and 2 x 107 cpm [32p] eDNA, 
and incubated at 65°C overnight. Washes consisted of 2x sse, 0.5% SDS and 2x 
sse, 0.1% SDS. The nitrocellulose was dried, labeled with [14C]-glycine ink 
114 
spots and autoradiography performed at -70°C. Kodak X-Omat film was placed 
between two Cronex Lightning Plus shields (Dupont) as described by Maniatis et 
al. (84). 
Northern CRNA) Blots 
For Northern blots, RNA was isolated from liver homogenates as 
described previously (Chapter 3) and 15 ug total RNA per lane was loaded onto 
1.0% agarose/ formaldehyde gels by a modification of the procedure of Gerard 
and Miller (86). Gel electrophoresis was carried out in a hood. Agarose was 
melted in water and cooled to 60°C. The dissolved agarose was stirred while 
formaldehyde (37% = 12.3 M) and RNA Running Buffer (Sx stock: 5 mM 
MOPS/ 0.2 M EDTA, pH 7 .0) were added to final concentrations of 2.2 M and 
lx, respectively. The mixture was poured immediately into a horizontal gel 
apparatus and samples were prepared. RNA samples were combined with a 
mixture to obtain a final composition of 0.5 x Running Buffer/ 2.2 M form-
aldehyde/ 50% deionized formamide. The gel was pre-electrophoresed for 30 
minutes at 60 V. Meanwhile, the samples were heated at 65°C for 10 to 15 
minutes to denature the RNA, plunged into ice, and 0.1 vol Loading buffer (50% 
(v/v) glycerol/ 0.4% (w/v) bromophenol blue/ 0.4% (w/v) xylene cyanol/ 1 mM 
EDTA) was added to each. RNA molecular weight standards (RNA ladder, BRL) 
were generally included in the same gel. Samples and standards were loaded with 
a micropipettor and the ~el was run at 60 V for 1 hour, then 100 V for several 
hours. Buffer was exchanged between the chambers half-way through the run. 
The gel was stained in a foil-covered glass dish for 5 minutes (5 ug/ml 
EtBr in water) and destained in water in the dark for up to 2 hours. Photographs 
were taken and the RNA was transferred to nitrocellulose (0.45 micron, Schleicher 
and Schuell or Millipore) overnight with lOx sse. The nitrocellulose was air dried 
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without rinsing, then baked in a conventional oven at 75°C for 2 hours, and 
stored, desiccated, at 4°C until use. Nitrocellulose strips corresponding to 
standard lanes were excised from the filter after baking, soaked in 5% acetic acid 
for 15 minutes, stained with methylene blue (0.5 M NaAcetate/ 0.04% methylene 
blue) for 15 minutes, and destained in water. 
Prior to hybridization, the nitrocellulose was floated in 5x sse for at least 
2 minutes, then placed in a hybridization bag (BRL). The nitrocellulose was pre-
hybridized, shaking, for 1 to 2 hours at 42°C in 50% deionized formamide, 5x 
Denhardts, 0.5% SDS, 5x sse and 100 ug/ml sheared E. coli DNA. This mixture 
was replaced with hybridization mixture (pre-hybridization mixture plus 2 x 107 
cpm or 5.8 x 107 cpm [32p] pfPI450-3' eDNA) and the nitrocellulose was 
incubated, shaking, at 42°C for about 20 hours. Washes consisted of 2x sse, 
0.5% SDS; 2x sse, 0.1% SDS; lx sse, 0.1% SDS; and 0.5x sse, 0.1% SDS, the 
latter washes at 55° C. Alternatively, washes consisted of 2x sse, 0.5% SDS, 5 
min rm temp; 2x sse, 0.1% SDS, 15 min rm temp; 2x sse, 0.1% SDS, 55°C, 15 
min; 1x sse, 0.1% SDS, 55 °C, 15 min; 0.5x sse, 0.1% SDS, 55° C, 15 min. 
Autoradiography was carried out as described above for Southern blots. Bands 
were scanned with a Helena Labs Densitometer (courtesy of Dr. Stanley Watson, 
Cape Cod Associates, Falmouth, MA) in the transmission mode. 
RESULTS 
Plasmid and eDNA Isolation and Characterization 
An approximately 4.1 kb pUC19 plasmid containing a PI450 eDNA 
from MC-treated rainbow trout, pfP1450-3', has been prepared and described by 
Heilmann et al. (88). Figure 4-1 illustrates the main features of the plasmid and 
insert. pUC19 contains a fragment of the pBR322 plasmid which carries an 
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FIGURE 4-1: Non-artist's rendition of plasmid pUC19-PI450-3' 
The plasmid is double stranded DNA, with a total size of about 4.1 kb. 
The P-450 insert can be cleaved from the pUC19 portion by digestion with Pst I 
and Eco Rl, each of which cuts this construct only once. In the pUC19 plasmid, 
the multiple cloning site contains the following restriction sites: Eco RI, Sst I, 
Kpn I, Sma I, Bam HI, Xba I, Sal I, Pst I, Sph I , Hind Ill. The P-450 eDNA is 
inserted between the Eco RI and Xba I sites, destroying the intervening sites. 
(amp = ampicillin resistance gene, lactamase; ori = origin of replication). 
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ampicillin resistance gene (B-lactamase ), an origin of replication, and a portion of 
the lac Z gene. A multiple cloning region containing a number of unique 
restriction enzyme sites is located in the lac region. pfP1450-3' is a subclone 
containing the 3' end of pSG 15, a clone containing the 3'-most 2060 bases of the 
eDNA (Heilmann et al., 88, Figure 2). pSG15 includes about two-thirds of the 
trout P450IA1 coding region and extends about 600 nt into the 3' noncoding 
region. The approximately 1.4 kb pfP1450-3' has been inserted into the pUC19 
multiple cloning site; it can be isolated from the plasmid by digestion with the 
restriction enzymes Pst I (in the poly linker region) and Eco RI, each of which has 
a unique restriction site. Growth of the bacterial culture in Luria medium plus 
ampicillin selects for E. coli harboring the desired plasmid, as its presence confers 
ampicillin resistance. 
A small amount of the plasmid was digested with each restriction enzyme 
alone (single cut = linearization) and both together (two cuts = fragmentation) 
under the conditions outlined in Materials and Methods. The digests were 
electrophoresed on a 0.8% agarose gel and stained with EtBr. Digestion with 
either enzyme alone resulted in linearization of the plasmid, with a single band of 
approximately 4 kb (Figure 4-2, lanes 4 and 6). The very faint, higher MW bands 
(lane 6) are probably concatamers of uncleaved plasmid. Simultaneous digestion 
with Eco Rl and Pst I resulted in two smaller bands, of approximately 2.6 and 
1.4 kb (lane 2). The lower band corresponds to the eDNA fragment, while the 
upper band represents the remainder of the pUC19 plasmid. Thus, this 
simultaneous digestion protocol can be used to successfully obtain the PI450 
eDNA fragment from the plasmid. 
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FIGURE 4-2: Restriction digestion of plasmid pUC19-pfPI450-3'. 
The plasmid was digested with 5 U/hr/ug Pst I and/or 2 U/hr/ug Eco RI 
as described in the Materials and Methods section. Standard fragment size, in 
kilobasepairs, is shown for lanes 1 and 8. 
Lane1: 1 kb DNA ladder standard (5 ug, BRL); lane 2: Eco RI and 
Pst I digest; lane 4: Pst I digest; lane 6: EcoRI digest; lane 8: A. Hind III digest 
(~ 3 ug, BRL). 
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To obtain sufficient material for labeling, the above digestion protocol 
was scaled up for 14 ug plasmid and the resulting fragments were separated on an 
agarose gel as before. The same banding pattern was observed, and the lower 
band was excised, electroeluted, extracted and precipitated to remove EtBr and 
phenol. The eDNA fragment was examined spectrophotometrically for 
concentration and OD 260/280 ratio, and separated on a mini-gel to confirm its size 
and concentration in relation to known standards prior to nick-translation. As 
expected, the PI450 eDNA constituted a single band of 1.4 kb size (data not 
shown). 
The eDNA fragment was initially nick-translated in the presence of biotin 
7-dATP (BRL) and separated from unincorporated nucleotides on Sephadex G-50 
(Pharmacia) to provide a non-radioactive probe for use in hybridizations. Use of 
this biotin-labeled probe in the Blue-Gene detection system (BRL) according to the 
manufacturer's instructions was unsuccessful, resulting in high and variable 
backgrounds and no specific banding when used to probe a Northern blot of 
Fundulus RNA. Subsequent labeling was accomplished by nick-translation in the 
presence of [32P]-labeled dCfP, a more conventional and sensitive method. Table 
4-1 shows the results of a single nick-translation reaction. In this case, 
approximately 21% of the labeled dCTP was incorporated into the eDNA 
fragment, resulting in a specific activity of about 6.2 x 107 cpm/ug. The 
radiolabeled eDNA was used in hybridizations within one half-life of labeling. 
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Table 4-1: Nick Translation ofpfPI450-3' 
ll)a~----~cp~m~h~--~u~C~ik.~--------C~o~m~m~e~nt~s ____________ __ 
T1 
TCA1 
T2 
TCA2 
T3 
TCA3 
T4 
TCA4 
T5 
997,558 
21,417 
738,357 
4,635 
292,667 
34,365 
4,029 
546 
1.238.605 
131.5 
97 
0.5 
35 
0.5 
28.2 
Total starting material, desired 125 uCi 
Unincorporated nucleotides (nt) 
TCA counts should be very low: 
supernate should be free nt only 
Ideally, T2 + T3 = T1 (97 + 35 = 132) 
T4 and TCA4 should be very low: 
removed most free nt in the first ppt 
21% incorporation. 6.2 x lO:Z cpm!u~ 
a TID = identity of sample, T = total counts, TCA = acid-precipitable counts 
1 = nick trans mix + Nfl40Ac + EtOH, sampled during incubation (290 ul) 
2 = #1 precipitated, supernate sampled 
3 =resuspended pellet+ Nfl40Ac + EtOH, sampled during incubation ( 263 ul) 
4 = #3 precipitated, supernate sampled 
5 = pellet resuspended in 50 ul TE 
b Raw cprn for each 1 ul aliquot 
c Microcurie values, after volume correction (e.g., T5 counts x 50 ul total 
volume equals 6.2 x 107 cpm, or 28.2 uCi) 
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Southern Blot Analysis 
To determine whether labeling of the eDNA probe with [32P]-dCTP had 
been successful, and to test for cross-reactivity of the probe, labeled pfPI450-3' 
was hybridized with several teleosts species in a Southern blot prior to its use in 
Northern hybridizations. Agarose gel electrophoresis of scup, trout, and 
Fundulus DNA prior to restriction enzyme digestion resolved a single, tight band 
of high molecular weight material for each, indicating that in all three cases 
genomic DNA had been isolated, with negligible degradation to smaller fragments 
(which would occur as smears of EtBr-staining material). Overnight digestion 
with the two restriction enzymes followed by gel elGctrophoresis yielded DNA 
from each species that appeared as a smear on an agarose gel, indicating that DNA 
fragments of many sizes had been generated (data not shown). This digested, 
size-separated DNA was transferred to nitrocellulose and hybridized with the 
[32p]-labeled trout eDNA. Distinct bands were observed in each lane (Figure 
4-3). 
Each species showed a unique pattern of cross-reactivity with the trout 
eDNA. Rainbow trout hepatic DNA (lanes 4-6) served as a positive control, as the 
eDNA was derived originally from trout liver mRNA. In the Pst I and Pstl/Eco 
Rl digested samples, two strong bands of approximately 2.5 and 4.5 kb were 
visible, indicating the possibility of two trout genes. Scup DNA, tested due to the 
wealth of background information on scup P-450E, gave a single discrete band of 
about 6.6 kb when digested with both REs, with a signal as strong as that seen for 
the trout (lanes 1-3). The strength of the signals indicates similar recognition of 
the trout and scup genes by the P}450 probe. This supports immunological 
(Chapter 2; Kloepper-Sams et al., 87) and sequencing results (see Table 3-5) 
indicating that the P-450 protein orthologues in these two species are structurally 
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related. The Fundulus DNA digested with Pst I and Pstl!Eco RI exhibited a single 
labeled band at about 3.4 kb, but also showed some smearing, a condition which 
may have been due to overloading of the lanes or degradation of the DNA by 
nucleases (lanes 7-9). Nevertheless, the general conclusion from this study is that 
the trout eDNA is an acceptable probe to use in analyzing the RNA from these 
three teleost species, including RNA from treated and control Fundulus. 
Induction of P-450E Activity and Protein Levels - Short term Study 
Once the methods of measuring P-450E mRN A were established, I 
conducted a short term Fundulus induction experiment to elucidate the temporal 
relationship between increases in P-450E mRNA and protein levels. Fish were 
treated with 50 mg!kg BNF as before (Chapter 3) and sampled every six hours for 
the first 24 hours, then every eight hours for the next 24 hours. As in the 
experiments described in Chapter 3, hepatic P-450 and bs specific content, EROD 
enzyme activity, and P-450E protein were all assayed to ensure that the RNA 
samples represented values from inducible/induced animals. Over this short time, 
as expected, the specific content of spectral P-450 and b5 did not change in control 
or BNF-treated fish (Table 4-2). EROD activity in BNF-treated animals was 
significantly elevated compared to control values by 32 hours and continued to rise 
over the rest of the time course. As in the 20 day (long term) experiment, the 
temporal trend of EROD activity levels was similar when expressed as turnover 
number (nmol/min/nmol P-450) and specific activity (nmol/min/mg protein). The 
magnitude and temporal pattern of EROD specific activity in the short term ( 48 hr) 
experiment fit well into the EROD activity pattern observed in the long term (20 
day) experiment. The consistency of the pattern of EROD activity in the short and 
long term experiments indicates that the increases observed in the short term 
experiment reflect induced expression of P-450E. 
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FIGURE 4-3: Southern blot of scup, trout, and Fundulus genomic DNA, 
hybridized to [32P]-labeled trout pfP1450-3' eDNA 
Genomic DNA was isolated, cleaved with restriction enzymes and 
separated on a 0.8% agarose gel. Hybridization conditions are described in the 
Materials and Methods section. Molecular weight markers were run in lane 10 and 
stained separately. (A. Hind III digest (BRL) was electrophoresed as in Figure 
4-2, lane 8.) Lanes 1-3: scup DNA, lanes 4-6: rainbow trout DNA, lanes 7-9: 
Fundulus DNA. Lanes 1, 4, and 7: Pst I; lanes 2, 5 and 8: Eco Rl plus Pst I; 
and lanes 3, 6 and 9: Eco RI. 
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TABLE4-2: 
Monooxygenase parameters in Fundulus following BNF treatment, 48 hours 
time N P-450b ERQDC 
Control Group Meansd 
50.1 ± 12.3 0.175 ± 0.048 0.179 ± 0.073 
Pools from BNF-treated Animals 
hrO nde nd 
hr6 3 49.0 ± 6.7 0.161 ± 0.033 
hr 12 3 40.6 ± 5.3 0.133 ± 0.046 
hr 18 3 51.6 ± 2.4 0.164 ± 0.066 
hr24 3 54.9 ± 22.5 0.178 ± 0.067 
hr32 2 59.4 ± 6.0 0.174 ± 0.011 
hr40 2 40.9± 8.1 0.143 ± 0.061 
hr48 3 45.4 ± 12.4 0.149 ± 0.023 
a Spectrally-determined cytochrome bs, pmoVmg protein 
b Spectrally-determined P-450, nmoVmg protein 
nd 
0.189 ± 0.049 
0.177 ± 0.052 
0.230 ± 0.057 
0.253 ± 0.102 
0.341 ± 0.027* 
0.345 ± 0.081 * 
0.557 ± 0.101 ** 
c EROD = ethoxyresorufm 0-deethylase activity, nmol product/min/mg 
d At hours 0, 6, 12, 18, 24, 40, and 48, rnicrosomes were prepared from com 
oil-treated animals (n = 3 or 2 per timepoint). No significant differences were 
found by ANOV analysis between the means of the groups, and all values were 
combined. 
e nd = value not determined 
Values significantly different from pooled control values by Dunnett's test 
(Zar, 74): * P < 0.05, ** P < 0.01 
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P-450E protein levels were elevated at the later time points examined. 
P-450E on a per mg microsomal protein basis was significantly higher than control 
values at 48 hours (P < 0.05) and P-450E as a percent of total spectral P-450 was 
significantly elevated at 40 (P < 0.05) and 48 (P < 0.01) hours after BNF 
treatment. The EROD and P-450E values exhibited a coincident rise (Figure 4-4) 
and, as was seen in the long term experiment, no lag was apparent between the 
increases in EROD activity and P-450E protein levels. 
Induction of P-450E mRNA Levels - short term study 
In vitro translation and immunoprecipitation analyses were conducted 
with Fundulus RNA from each time point of the 48 hour experiment. Visual 
observation and densitometric scans of fluorograms (values from a representative 
fluorogram, Figure 4-5) showed that the content of P-450E-specific translatable 
RNA remained below the limits of detection in the corn oil controls. The hepatic 
RNA from all BNF-treated animals, however, gave detectable signals. A single 
band was evident by 6 hours after treatment and the response increased 
dramatically up to 40 hours , then declined slightly. Other analyses of RNA from 
these fish showed a plateau at 40 to 48 hours (data not shown). 
Because the translation/immunoprecipitation method did not show 
detectable signal in control animals, it seemed wise to attempt a more direct, and 
perhaps more sensitive, method. As a second method of measuring mRNA levels, 
I directly probed size-separated RNA from control and induced fish with 
radiolabeled pfPJ450-3', the eDNA derived from trout PI450 mRNA. 
Total RNA from control and BNF-treated Fundulus exhibited two EtBr-
staining bands after formaldehyde/ agarose gel electrophoresis. These two bands 
correspond to the 28S and 18S rRNA moieties, which are the predominant RNA 
species in total RNA samplesl. The [32P]-labeled trout PJ450 eDNA hybridized 
127 
Figure 4-4 
4.5 15 
[:J EROD 
0 0 
It) It) 
"<t 3.5 "<t I I 0.. 0.. 
0 10 ca 
! b ~ 0.. 
·§ 2.5 Vl .... 
r::: 
::::t 0 
0 (.) 
8 ~ 
r::: 5 0.. 
6 1.5 f§ 0 It) ~ "<t 
~ I 0.. 
0.5 0 
0 1 0 20 30 40 50 
Hours after Treatment 
FIGURE 4-4: Relationship between Fundulus P-450E protein levels and EROD 
activity following BNF treatment, 48 hour experiment 
P-450E protein (closed diamonds) and EROD activity (open squares) 
were measured as described in the Materials and Methods section. Control 
P-450E means ranged from 1.6 to 2.2%, and control EROD means ranged from 
0.80 to 1.8. 
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FIGURE 4-5: Immunoprecipitated in vitro translation products (P-450E) from 
Fundulus following BNF treatment , 48 hour experiment 
Ten micrograms RNA from each time point was translated and precipitated 
with polyclonal anti-P450E as described in Chapter 3. Fluorograms were scanned 
with a densitometer, and the curves were integrated and values reported as 
arbitrary units. Control animal samples (closed diamonds) all had values below 
30, the limit of detection. BNF-treated animals are shown by open squares. 
Values from one representative analysis are shown; the experiment was repeated at 
least in triplicate with the same and duplicate RNA samples with similar results. 
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to a single band of Mr between 2 and 4 kb in each lane (Figure 4-6). The signal 
was faint but detectable in the control sample, and increased with time after BNF 
treatment. A densitometric scan of the blot showed that the specific mRNA levels 
were greater than control values at 6 hours, then rose continuously and leveled off 
at about 40 hours (Figure 4-7). These results were similar to those obtained 
previously with in vitro translation and immunoprecipitation. 
A comparison of P-450E mRNA levels, derived from either in vitro 
translation measurements or hybridization to the trout eDNA, with P-450E protein 
or EROD activity levels indicated a considerable temporal lag between the initial 
rise in RNA and the increases in either P-450E protein or activity. A plot of 
P-450E protein against P-450E mRNA as measured by Northern hybridization 
(Figure 4-7) indicates that P-450E protein did not rise until 32 hours after 
treatment with BNF, while P-450E mRNA was increased above control levels by 
6 hours after treatment. A similar result was observed when EROD activity rather 
than protein values were plotted against RNA from the in vitro translation or 
Northern blot analyses (data not shown). 
Decline in P-450E mRNA Content 
To determine whether a secondary peak in P-450E mRNA content, or 
maintenance of moderate levels of the mRNA could be responsible for the 
continued presence of P-450E protein and activity levels beyond 48 hours after 
BNF treatment (e.g., Figure 3-1), Fundulus were treated with 50 mg/kg BNF as 
before and sampled at 0, 1, 2, 4, 5, 8, and 13 days. P-450E mRNA levels were 
measured at each time point, and microsomal P-450E protein and EROD activity 
were analyzed on days 0, 2, 5, 8, and 13. The microsomal parameters were 
examined primarily to confirm that induction was occurring in these Fundulus. 
Consistent with our earlier findings, hepatic microsomal EROD activity rose 
130 
1 2 3 4 5 6 7 8 
FIGURE 4-6: Northern blot of Fundulus RNA, hybridized to [32-P]-labeled 
pfPt450-3' trout eDNA 
Total RNA was isolated from BNF-treated fish as outlined in Chapter 3 and 
the blot performed as described in the Materials and Methods section. 
Lane 1: 0 hour control; lane 2: 6 hour BNF; lane 3: 12 hour BNF; lane 
4: 18 hour BNF; lane 5: 24 hour BNF; lane 6: 32 hour BNF; lane 7: 40 hour 
BNF; and lane 8: 48 hour BNF. 
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FIGURE 4-7: Temporal relationship between Fundulus P-450E mRNA and 
protein levels following BNF treatment 
P-450E mRNA (open squares) values are derived from densitometric scans 
of the Northern blot shown in Figure 4-6. P-450E protein levels (closed 
diamonds, as shown in Figure 4-4) are relative to spectral P-450. 
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dramatically within 5 days and remained above control levels 13 days following 
treatment (data not shown). P-450E protein levels exhibited the same trend 
(Figure 4-8A). P-450E mRNA was measured by both in vitro trans-
lation/immunoprecipitation (Figure 4-8A) and Northern blot analysis (Figure 
4-8B). P-450E mRNA peaked at the one-day time point and declined rapidly, 
with no (Figure 4-8A) or little (Figure 4-8B) signal at 8 and 13 days following 
BNF treatment. Therefore, mRNA accumulation or stability over extended times 
does not occur and cannot account for the long-term presence of P-450E protein 
and EROD activity. 
The Fundulus treated for this 13 day experiment were held over winter 
and injected with BNF in early May. Although their GSI values were higher than 
those of immature animals used in earlier experiments, they achieved the same 
levels of EROD activity and P-450E protein levels as their immature counterparts. 
The issue of inducibility of mature vs immature teleosts is addressed in more detail 
in Chapter 5, as animals used for the dual label experiment were treated at the same 
time, and sufficient fish were analyzed for MFO parameters for statistical analysis. 
DISCUSSION 
As discussed in Chapter 3, the physical and functional similarities between 
P-450E and its mammalian orthologues suggested that the regulation of P-450E 
might resemble that of the better-studied mammalian forms. Chapter 3 established 
the time course of protein induction and the experiments outlined here address the 
question of transcriptional enhancement in lower vertebrates. Using specific anti-
P-450E antibodies and the trout P4501Al eDNA probe (Heilmann et al., 88), I 
have found evidence that transcriptional enhancement is a possible induction 
mechanism in fish. My results led me to examine later time points in the 
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FIGURE 4-8: Decline in P-450E mRNA levels 
P-450E mRNA levels were measured by in vitro translation and 
immunoprecipitation or by Northern hybridization with a [32P]-cDNA, as 
described in the Materials and Methods sections in Chapter 3 and this Chapter. 
A: P-450E mRNA was determined as in Figure 4-5. Means are shown (open 
squares). P-450E protein was measured by immunoblotting with MAb 1-12-3 
(means: closed diamonds). 
B: P-450E mRNA was determined by hybridization of fractionated total RNA 
with the eDNA pfPI450-3'. Means are shown (open circles). 
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induction process, and I have determined that post-transcriptional factors must also 
be important in maintaining high levels of expression of induced P-450E. 
Before discussing these results in more detail, I will address the methods 
used to obtain these results. Because the translation/immunoprecipitation method 
developed in Chapter 3 was not sensitive enough to detect P-450E mRNA in 
control Fundulus (which do have detectable EROD activities), I used a second 
technique for P-450E mRNA measurement: direct hybridization of RNA with a 
teleost P4501Al probe. Although I initially attempted a non-radioactive labeling 
technique for generation of a detectable P-450 eDNA probe, this resulted in high 
background and no detectable signals. With the current rapid improvements in 
non-radioactive detection systems, further investigation into the use of non-
radiolabeled eDNA probes seems warranted, but at the time these experiments 
were being performed, the best option was to return to the well-documented 
method of probe labeling via nick translation. The efficiency of incorporation of 
[32-P]-dCTP into the eDNA by the nick translation method (approximately 21% in 
Table 4-2, near 40% in another nick translation experiment with higher specific 
activity starting material) is consistent with literature values for percent 
incorporation of such compounds into DNA fragments (Amersham booklet). 
The non-radioactive, biotin-labeled eDNA did not give detectable signals 
when hybridized to Fundulus RNA in a Northern blot. Since it was possible that 
problems with detection were due to RNA degradation rather than to probe 
labeling, I hybridized the newly-generated [32-P]-labeled eDNA to genomic DNA 
from three different species with the more "robust" Southern blot technique. 
Besides providing evidence that this probe specifically recognizes genomic 
sequences in three teleost species, and should therefore be suitable for Northern 
blot procedures, the Southern blot hybridization analysis provided insight into the 
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nature of the P4501Al gene in these species. Rainbow trout may have more than 
one such gene in their genome, while both scup and Fundulus appear to be limited 
to a single cross-reactive gene. More work needs to be done to properly address 
such questions. 
Relationships between P-450E protein, activity, and mRNA levels were 
revealed by examining various time points in the induction process. The results 
presented in Chapter 3 from the 20 day induction experiment and here from the 48 
hour experiment indicate the close relationship between P-450E protein and EROD 
catalytic activity. The 48 hour experiment was undertaken to examine protein and 
mRNA levels at the initial stages of the induction process. As expected, spectral 
b5 and P-450 levels did not change over the 48 hour period (Table 4-2). 
However, increases in both EROD activity and immunochemically detectable 
P-450E levels indicated that the BNF-treated animals were responsive (Figure 
4-4). It was exciting to see that by the first time point examined, 6 hours after 
exposure to BNF, P-450E mRNA was elevated (Figure 4-5) above control levels. 
The samples had been balanced for TCA-precipitable counts and the relative 
intensity and Mr of the banding patterns obtained by immunoprecipitating with a 
non-specific antibody was similar for all time points assayed (data not shown). 
Thus, the proportion and types of other translatable mRNA present in the total 
RNA remained constant. Hybridization of the trout PI450 eDNA probe to a 
Northern blot containing size-separated RNA from Fundulus at 0 and 48 hours 
after treatment confirmed the trend of the in vitro translations (Figure 4-6). 
Therefore, we conclude from both in vitro translation analysis and direct 
hybridization that P-450E mRNA is elevated in BNF-treated animals by 6 hours 
after treatment. 
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Recent reports indicate that post-transcriptional control may be important 
in the accumulation of P450IA mRNAs. Rat P-450d (P450IA2) mRNA can 
accumulate in primary hepatocyte cultures following TCDD treatment, with no 
changes in transcription rate (Pasco et al, 88). A similar study of rat hepatocyte 
cultures presented evidence for post-transcriptional control in MC-induction of 
both P-450c and P-450d, although transcriptional control could account for 
P-450c mRNA increases in vivo (Silver & Krauter, 88). Nebert and coworkers 
found inconsistencies between mouse P1450 and P3450 transcriptional rates and 
mRNA levels in a number of extrahepatic tissues (Kimura et al., 86). To confmn 
that the accumulation of Fundulus P-450E mRNA I have observed is due to de 
novo synthesis rather than mRNA stabilization, transcriptional rates should be 
measured in isolated nuclei. The data presented are consistent with a mechanism 
based at least partially on transcriptional enhancement having an important role in 
the induction of the major MC-inducible form of P-450 in teleosts. 
P-450E-specific mRNA levels rise in advance of increases in P-450E 
protein or activity (Figure 4-7). A lag between mRNA and protein accumulation is 
consistent with studies of induction in mammalian P-450 systems. It is difficult to 
measure the lag between initial mRNA and protein or activity increases observed in 
Fundulus, but it appears to be about 26 hours. While it is possible that the 
sensitivity limits of the analyses employed or variability within the control groups 
may be obscuring the earliest rises in P-450E protein content or activity, it is 
probable that this lag is real. The lag is more pronounced than that seen in 
mammals, which could be due to temperature effects, physiological differences in 
protein synthesis, or other factors. In any case, the results are fully consistent 
with a receptor-mediated mechanism in fish. This is contrary to the suggestion 
made by Denison et al. (85) that some other, non-receptor-mediated mechanism 
138 
might explain the long period of 4 to 7 days before maximal monooxygenase 
activity is reached in fish. 
While P-450E mRNA levels appeared to peak or plateau within 2 days 
after BNF treatment (Figure 4-5), immunodetectable P-450E protein continued to 
accumulate for abou~ 7 days (Figure 3-1). Thus, I carried out an additional study 
of P-450E mRNA and protein content at times following establishment of the 
induction response. Because P-450E mRNA levels were not examined beyond 48 
hours in the first RNA experiment, it could not be ruled out that the mRNA had 
been stabilized beyond 48 hours (or, more unlikely, exhibited a second peak in 
content) and was maintained at some sufficiently high level to act as a template for 
new P-450E protein synthesis. The results (Figure 4-8) showed that the 
maintenance of P-450E protein levels through at least 13 days was not due to a 
second peak in mRNA levels or to stabilization of a moderate level of mRNA. The 
P-450E mRNA levels declined rapidly, with no evidence of a secondary spike. 
Therefore, transcription may be the rate-limiting component early in P-450E 
induction, with other factors playing a dominant role in maintaining the protein. 
Mammals can show endogenous P450IA 1 activity despite undetectable or 
nonfunctional Ah receptors (e.g., differentiated F9 cells, cited by Kimura et al., 
87), and perhaps P-450E in lower vertebrates, including fish, is regulated through 
another, as yet undefined mechanism. 
The persistence of the teleost P-450E catalyst is in contrast to the quick 
return to control levels achieved by mammalian PAR-inducible proteins. As this 
persistence cannot be explained by an unusually long-lived P-450E mRNA, it 
seemed important to examine the turnover of teleost microsomal proteins and 
P-450E. This aspect is explored in Chapter 5. 
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FOOTN01ES 
1 Interestingly, when scup total RNA was electrophoresed on 
formaldehyde/ agarose gels next to samples of rat or chick RNA and stained with 
ethidium bromide, the fish large rRNA migrated farther on an agarose gel than did 
the corresponding chick or rat 28S rRNA, indicating that the fish rRNA may have 
a smaller size. In their investigations of diploidization, Leipoldt and coworkers 
electrophoresed RNA from a variety of species under denaturing conditions on 2.5 
to 3.0% polyacrylamide gels (Leipoldt et al., 84). Although the authors do not 
explicitly address this result in the text of the article, some fish species such as 
Barbus tetrazona, Leuciscus cephalus, and others appeared to have lower 
molecular weight "28S" rRNA bands, compared to mouse cytoplasmic RNA size 
markers. I did not electrophorese Fundulus RNA simultaneously with other 
RNAs, but future studies should investigate the relative sizes of teleost and 
mammalian rRNAs, to determine whether this observation holds true for scup 
only, or for other marine teleosts as well. 
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INTRODUCTION 
I had two major reasons for embarking on a study of the turnover of 
P-450E apoprotein and heme in induced Fundulus heteroclitus. First, very little is 
known about protein turnover or hepatic heme metabolism in fish. Thus, basic 
knowledge of the kinetics and mechanisms of turnover could be gained from these 
studies. Second and more specifically, I was interested in the time course of 
increase and decrease in expression of P-450E following induction, and how it 
might compare to similar expression in mammals. The results reported in Chapter 
4 suggest that while P-450E mRNA levels decline rapidly following exposure to a 
chemical inducer, P-450E protein (and catalytic activity) levels remain elevated 
over much longer periods of time (e.g., Figure 4-8). One possible reason for this 
would be a long P-450E half-life, or slow turnover. Thus, the experiments 
described in this Chapter were designed 1) to establish some baseline data on the 
uptake and incorporation of labeled amino acid and arninolevulinic acid in teleosts, 
and provide radiolabeled material for testing immunoprecipitation procedures, and 
2) to begin to address questions of both P-450E apoprotein and heme turnover in 
fish via a dual label experiment. 
General Protein Turnover 
The theories concerning protein synthesis and degradation have been 
detailed by several authors. The following discussion, which outlines some of the 
major problems and ideas behind various methods, is based on articles by Zak et 
al., 79; Berlin and Schimke, 65; Arias et al., 69; and Gan and Jeffay, 67. The 
rate of protein synthesis is considered to be zero order (not dependent on protein 
concentration), while degradation is seen as a first order reaction (dependent on the 
current protein concentration). 
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In general, real proteins do exhibit flrst order decay kinetics. Blood 
hemoglobin is an exception: it degrades rapidly when red blood cells are degraded 
and thus shows "life span" kinetics. In turnover experiments using radiolabeled 
precursors, the rate of change of a protein's radioactivity is proportional to the 
difference between the specific radioactivity of the precursor (amino acid) and of 
the product (protein). However, the specific activity of the amino acyl tRNA pool 
may not equal that of the intracellular free amino acid pool or the plasma free 
amino acid pool. In fact, there may two or more discrete pools of available 
charged tRNAs, each with a unique specific radioactivity. Thus, unless amino 
acyl tRNAs are measured, it is not possible to know precursor concentrations. 
The theoretically most straight-forward analysis should measure the specific 
activity of the incorporated label and of the actual precursor population. This is 
not a simple operation, and much effort has gone in to devising new labeling 
conditions and techniques. 
An additional problem must also be addressed. The simple assumption 
that decay ofradiolabel in a protein corresponds to the protein's half-live is almost 
always an overestimate of the half-life, because radiolabeled tracers are not 
eliminated instantaneously from the body, but may be reutilized. The more likely 
the reuse of the precursor, the greater the overestimate. Various methods have 
been developed the circumvent this problem. The use of [14C]-guanidino-arginine 
decreases the extent of reutilization of label, as high levels of arginase in the 
mammalian liver will convert the labeled guanidine carbon to a portion of the 
readily-excreted urea molecule (see discussion of Arias et al., 69, below). A more 
recent improvement, which avoids the incorporation of extrahepatic arginine (e.g., 
mobilization of reutilized label from tissues lacking high levels of arginase), is the 
injection of [14C]-bicarbonate. In hepatocytes, bicarbonate is incorporated direcdy 
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into the urea cycle by carbamoyl phosphate synthase and incorporated into protein 
as arginine (and other amino acids such as aspartate). The label will again end up 
in urea, rather than being reutilized. Arias et al. (69) employed these methods to 
address the question of whether endoplasmic reticulum (ER) proteins degrade 
simultaneously (the "unit membrane" hypothesis) or independently (the "mosaic" 
model). When they injected [14C]-guanidino-arginine rather than normal [14C]-
arginine, they found that the "mean half-life" of proteins in each subcellular 
compartment was decreased (e.g., SER 2.1 vs 5.2 days, RER 2.0 vs. 5.8 days, 
total microsomes 3.0 vs. 5.2 days). 
Arias et al. (69) also developed a dual label technique for the 
determination of whether there existed different rates of protein degradation in a 
given set of proteins. This involved injection with a radiolabeled compound (e.g., 
[14C]-leucine) at the beginning of the experiment, followed by injection shortly 
before termination of the experiment with the same compound labeled with a 
different isotope (e.g., [3H]-leucine). (The theory behind this technique, which 
bypasses the need for knowledge of precursor specific activity, is detailed by Zak 
et al., 79). By this analysis, cytochrome bs, NADPH-cytochrome c reductase, 
and other microsomal protein fractions had very different half-lives, supporting the 
view that the ER is comprised of proteins with different rates of synthesis and 
degradation. Treatment with phenobarbital (PB) stimulated the synthesis of some 
ER proteins but not others, and did not appear to influence degradation rates of 
bulk proteins. Based on these results, Arias et al. (69) concluded that the findings 
by other researchers of protein stabilization (reduction in degradation) following 
PB treatment may be attributable to an increase in reutilization due to an increase in 
synthesis. 
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In a direct application of the technique developed by Arias et al. (69) to 
the study of P-450 isozymes, V oorman and Aust (88) injected TCDD pre-treated 
rats with [3H]-leucine three hours prior to addition of a second inducer (isosafrole 
or 3,4,5,3',4',5'-hexachlorobiphenyl) and injected [14C]-leucine shortly before 
termination of the experiment. The greater retention of 3H relative to 14C in 
immunoprecipitated P-450d from isosafrole- and HCB-treated animals (3HJ14C -
2.6 and 2.7) compared to retention in animals not exposed to a second inducer 
(3Hf14C - 1.5) led the authors to conclude that the increase in P-450d half-life 
resulting from treatment with these inducers (also observed in previous studies) is 
due to decreased degradation of P-450d. The formation of an isosafrole/P-450d 
complex may be the basis of the stabilization mechanism. 
Parkinson et al. (83a) find fault with the application of Arias et al.'s (69) 
dual label technique, because it is usually taken as an endpoint determination, 
giving no information on the shape of the radioactive decay curve. They point out 
that this is a problem particularly when highly reutilizable amino acids, such as 
leucine, are used. These researchers turned instead to bicarbonate as a non-
recycleable precursor. Parkinson et al. (83a) examined the change in radiolabel in 
Aroclor 1254-treated rats during a period of prolonged induced steady-state levels 
of each P-450 isozyme. Turnover was determined by measuring isotope decay 
(tl/2 was estimated from the slope of a straight line fitted by linear regression 
analysis to a semilog plot of specific radioactivity vs time). 
For each P-450 isozyme, turnover of the heme moiety was significantly 
more rapid than that of the apoprotein moiety in Parkinson et al.'s (83a) work. 
Both P-450 (b +e) (P450IIB(l + 2)) and P-450c had heme half-lives of about 28 
to 29 hours, compared to an apoprotein half-life of 37 to 38 hours (P < 0.01). All 
the P-450 apoproteins examined exhibited shorter half-lives than did the "average" 
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hepatic microsomal protein (total microsomal protein showed biphasic kinetics, 
with a rapid phase of 5-8 hr and a slow phase of 82 hr) . The authors also 
compared these half-life calculations (based on isotopic decay determinations) with 
half-lives calculated from the time it takes for an induced protein to reach one half 
its new steady state level (Berlin and Schimke, 65)1. The latter values were 
obtained from a time course study of Aroclor induction of the corresponding 
isozymes (Parkinson et al., 83b). Values calculated for both methods showed 
close agreement for P-450 b + e (37 hr by kinetics, 38 hr by isotope decay), 
P-450c (37 hr for both), and epoxide hydrolase (121 and 132 hrs, respectively). 
General Heme Turnover 
As discussed in Chapter 1, heme may be intimately involved in the 
regulation of P-450 expression. Contradictory results have been obtained 
concerning relative rates of P-450 heme turnover and apoprotein turnover. While 
Parkinson et al. (83a) found that the heme moiety has a shorter half-life compared 
to the rat P-450c apoprotein, Sadano and Omura (82) found that heme has the 
same half-life as the MC-P-450 apoprotein (both 15 hr in PB-induced rats) and 
shorter than the PB-P-450 apoprotein (heme at 15 hr, apoprotein at 25 to 30 hr). 
These differences may be due to induction regimes or labeling protocols. Sadano 
and Omura (82) found that the heme moieties incorporated in P-450 isozymes have 
more rapid turnover than do the heme components of other cellular proteins. 
In contrast to the problems caused by possible amino acid reutilization in 
the synthesis of proteins, the heme precursor ALA provides a good label. ALA is 
a specific substrate for ALA synthase in the hepatic heme biosynthetic pathway, 
and during degradation heme is converted to bilirubin and the porphyrin ring is not 
reutilized. Druyan et al. (69) found insignificant incorporation of ALA into non-
heme proteins in the rat liver. The turnover of microsomal cytochrome bs was 
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determined by counting radioactivity in purified bs isolated from microsomes of 
rats up to 17 days after treatment. Turnover determined by [3H]-ALA counts was 
2.4· days, while it was 2.5 days according to labeling with [14C]-guanidino-
arginine. Thus, turnover of heme and protein may be coincident in at least a 
subpopulation of microsomal proteins. Of course, if reports of heme shifting 
between different P-450 molecules are correct (e.g., Sadano and Omura, 83), this 
would add a complicating factor. 
Protein Turnover in Fish 
A literature search of "fish," "protein turnover," and "heme" revealed 
that very little work has been published in these areas. Most protein studies have 
emphasized turnover of total protein in muscle, or compared muscle protein 
synthesis to that in other tissues in the body. The following discussion briefly 
describes some of the techniques used and the results obtained from some of these 
fish studies; note that in general total radioactive counts, or at most acid-soluble 
vs. acid-insoluble counts, were measured. Only in the last papers mentioned 
(Vodnicik et al., 84; Sadler et al., 85) is any fractionation beyond the tissue level 
attempted. 
Various methods have been used to address protein turnover in fish. 
There is surprisingly little or no concern expressed in the publications regarding 
possible amino acid reutilization or other problems. The question of precursor 
measurement has also not been satisfactorily answered. It is very difficult to 
determine the content of the actual protein precursor, which is the appropriately 
charged amino acyl tRNA. Some researchers measure the extracellular and the 
intracellular amino acid content, and estimate that the actual content should fall 
between these values (e.g., Fauconneau and Amal, 85a and 85 b). In an attempt 
to quantify teleost amino acid metabolism (oxidative metabolism vs protein 
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synthesis), Fauconneau and Arnal (85b) gave rainbow trout a single injection of 
[14C]-leucine to the caudal vein and measured [14]-C02 excreted in a respiratory 
chamber. The trend of leucine incorporation (lowest in the muscle and higher in 
the liver and digestive tract) is the same as that observed in mammals, but the 
quantitative differences were not as great as those in mammals. Whole fish protein 
synthesis was lower than that in mammals. Approximately 60% of leucine 
metabolized in whole fish was directed toward protein synthesis, while 36-37% of 
the leucine was catabolized. 
L-leucine is taken up in fish by a combination of facilitated diffusion and 
active transport (reference in Persell and Haschemeyer, 80). Persell and 
Haschemeyer examined initial in vivo amino acid uptake in the liver of the toadfish 
Opsanus tau. These researchers used inulin as a marker of the extracellular space 
for standardization of the leucine counts. They found that amino acid transport 
and protein synthesis were both strongly temperature dependent, slowing down at 
lower temperatures. 
Haschemeyer and coworkers (Pocrnjic et al. , 83) employed 
phenylalanine swamping in further studies of toadfish protein turnover to provide 
a constant source of radiolabeled precursor. In mammalian studies, this method is 
useful for measuring rates of protein synthesis in tissues having very rapid protein 
turnover (Garlick et al., 80). Phenylalanine is preferred over leucine because large 
quantities of the latter have been shown to play a role in the control of muscle 
protein synthesis and breakdown. High rates of protein turnover were observed in 
the head kidney, gill, and spleen, as well as the liver. There was a large effect of 
temperature on phenylalanine incorporation into protein, with a Q10 of 6 to 7. 
Pocrnjic et al. (83) speculated that the drop in protein synthesis with lower 
temperatures may be due to temperature effects on the elongation rate of the 
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growing polypeptide and/or on ribosome recruitment. Unfortunately, the final 
time point in these studies is a mere 10 minutes after injection of the amino acid 
(while decline is still linear), limiting their usefulness to investigations of the most 
rapidly changing proteins. 
A few studies have addressed, at least peripherally, turnover of P-450 
proteins in fish. Vodnicik et al. (84) examined the incorporation of [35S]-
methionine into trout microsomal proteins. Trout were induced with 150 mg!kg 
BNF, injected with the radiolabe118 hours later, and sacrificed at various times 
following the addition of the label. The pattern of label incorporated into proteins 
in the total microsomal fraction was compared to that for untreated animals. Mean 
incorporation was higher in BNF-treated animals, but was not significantly 
different from incorporation in control animals. Three bands, of Mr 59,000, 
57,000, and 50,000, appeared in autoradiograms of SDS PAGE gels of BNF-
treated trout microsomes. Trout PI450 has a Mr of near 58,000 (Williams and 
Buhler, 84). It was not established which, if any, of these proteins contained 
heme, and their identity was not further investigated. Thus, this study provides 
circumstantial evidence of de novo P-450 protein synthesis in induced animals. 
I decided to attempt a Fundulus dual label experiment patterned after the 
method described by Parkinson et al. (83a), as the fish papers I found did not 
address label incorporation into specific proteins. In addition, many of the fish 
methods involved restraining the animals during the course of the experiment (not 
feasible for treatment and long-term maintenance of some 40 to 60 individual 
Fundulus), or labeling for a very short time interval. Although Parkinson et al. 
(83a) were investigating mammalian P-450 turnover, the inducer used - Aroclor 
1254 - caused a prolonged P-450 protein induction response, on a similar temporal 
scale to the effects I observed with BNF treatment of Fundulus (Chapter 3). I 
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could not replicate the protocol exactly, however. The use of [14C]-bicarbonate in 
mammals is based on the rapid elimination of label due to high levels of arginase, 
as described above. In teleosts, nitrogen is excreted primarily as ammonia through 
the gills (Forster and Goldstein, 69). The small amount of urea excreted by 
teleosts is derived primarily from nucleotides via the uricolytic pathway, and 
although most teleosts probably have a complete set of ornithine-urea cycle 
enzymes, the activity of the rate limiting enzyme carbamoyl phosphate synthase is 
usually very low (van Waarde, 83). Given these physiological differences, I 
decided to return to the "simple" methods and inject the radiolabeled amino acid 
(leucine) itself, rather than a pre-amino acid precursor. Although ALA appears to 
be a very specific label of mammalian heme, with little or no reutilization into other 
compounds, there exists no baseline knowledge of its uptake and degradation 
pathways in fish. All results must be considered with the possible reutilization of 
labeled leucine (and less likely, of ALA) in mind, as reutilization of hepatic leucine 
or uptake of extrahepatic leucine may complicate the interpretations of these 
studies. 
Heme Turnover in Fish 
Little is known about heme metabolism in teleosts. Fernandez et al. (87) 
sought ALAS (ALA synthase, the rate limiting enzyme of mammalian hepatic 
heme synthesis) activity in rainbow trout tissue. They found evidence for two 
forms, a 110,000 dalton cytosolic form and a 70,000 dalton (possibly inner 
membrane) mitochondrial form. It is not clear from their descriptions whether the 
cytosolic form is active in vivo, or is simply an immature precursor awaiting 
transport to the mitochondria. In fact, May et al. (86) state that the question of 
whether a cytosolic form of ALAS is active or not is a moot point, since the 
substrate succinyl-CoA is not present in the cytosol. Gooch and Matsumura (83) 
150 
measured ALAS in goldfish (Carassius auratus) whole liver homogenates. There 
was no significant difference between control and BNF-treated activities: both 
were near 10 nmol product/g liver/hr. Analysis of ALA synthase activity in scup 
homogenates (Dr. Neal Cornell (NIAAA and WHOI), unpublished observations) 
gave the following results: 2 individuals had activities of 6.0 and 9.5 nmol/g 
liver/hr (0.071 and 0.106 nmol/mg protein/hr), values similar to the Gooch and 
Matsumura (83) fmdings. The ALAS activity for liver homogenate from a starved 
(e.g., partially induced) rat - measured by Dr. Cornell simultaneously with the 
scup samples - was 36 nmol/g liver/hr. 
Preliminary results from this laboratory indicate that scup liver 
homogenates have the capacity to incorporate ALA into heme and protoporphyrin 
(Dr. Mark E. Hahn, unpublished observations). The rate of ALA incorporation in 
scup liver homogenates is approximately one-third of the rate measured 
simultaneously in rat homogenates (13.9 vs 44.2 nmol ALA equivalents/g liver/hr 
at 30 °C). Thus, it appears from these preliminary studies that the production of 
ALA (rate of ALAS activity) is slower than all other enzymatic steps of scup 
hepatic heme biosynthesis (rate of incorporation of ALA by a multi-step process 
into heme). This is consistent with the mammalian literature, which indicates that 
ALAS is the rate-limiting enzyme in hepatic heme biosynthesis. 
Heme oxygenase is the rate limiting enzyme of heme degradation in 
mammals (heme is metabolized to biliverdin). An additional enzyme, biliverdin 
reductase, converts mammalian biliverdin to bilirubin, which is then conjugated 
and excreted. Reptiles and birds excrete biliverdin and fish appear to belong to 
two categories, with the excretion of bilirubin and/or biliverdin possible. In a 
survey of bile from numerous fish species (Fang, 87), yellow bile generally 
contained conjugated bilirubin, while green or yellow-green bile contained 
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unconjugated biliverdin and occasionally some bilirubin. Teleosts challenged with 
excess biliverdin did not convert it to bilirubin, as mammals can (Fang, 87); 
starvation increased the ratio of biliverdin to bilirubin. These results indicate that 
biliverdin reductase in fish may be limiting under some conditions, leading to 
biliverdin excretion. M. Maines and J.J. Stegeman (unpublished observations) 
found very low levels of biliverdin reductase in scup hepatic cytosols (20-30 fold 
lower than in rats), while microsomal heme oxygenase was also low (but only 
about 10 fold lower than in rats). The possible effects of P-450 inducers on these 
activities in teleosts is not known. 
In an experiment which measured incorporation of label into the heme 
moiety of microsomal proteins, [14C]-ALA was injected i.p. into rainbow trout 
held at 6°C at an unspecified time ("after .... suitable time for induction") after 
treatment with Aroclor 1254 (60 mg/fish, fish 300-800 g, Sadler et al., 85). Peak 
[14C] incorporation (as dpm/mg microsomal protein) was observed at 20 to 25 
hours after injection. The induced animals exhibited a temporal trend in labeling 
parallel to that of control animals (given ALA only). Although no difference is 
discussed in the text, the mean dpm/mg from Aroclor-treated animals was close to 
the mean dpm/mg value for control animals only at early time points. By 24 
hours, the Aroclor mean was lower and it maintained a parallel, lower value 
through 96 hours. Sadler et al. (85) compare their results to a rat study where 
peak ALA incorporation occurred 2 hours after i. v. administration. They note that 
while ALA is incorporated in rats predominantly into hepatic heme proteins, in the 
trout ALA was incorporated predominantly in the kidney, the site of fish 
erythropoiesis. Given this fact, and the different routes of administration, direct 
comparisons cannot be readily made. 
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MATERIALS AND 11E1HODS 
General Methods 
Materials were obtained from the sources listed in Chapters 3 and 4, or 
from individual suppliers as noted below. Animal collection and care, preparation 
of and injection with BNF solutions, and preparation of hepatic microsomes were 
all carried out as described in Chapter 3, with the modifications described below. 
Protein detenninations, spectral bs and P-450 specific content measurements, and 
EROD assays were performed as described in Chapters 2 and 3. 
The immunoblot procedure described in Chapter 2 was modified by the 
addition of another step. After electrophoretic transfer of proteins to a 
nitrocellulose filter, the filter was reversibly stained for 5 minutes with Ponceau S 
(working solution: 0.2% (w/v) Ponceau S/ 3.0% (w/v) TCA/ 3.0% (w/v) 
sulfosalicylic acid). The filter was rinsed with water, pink/reddish protein bands 
were visualized, and the nitrocellulose was placed in PBS/milk blocking solution 
and the normal procedure continued. Previous use of Ponceau S under these 
conditions indicated that it caused no interference with subsequent signal 
development (B.R. Woodin, unpublished observations). 
Antibody Production and Immunoprecipitation of Microsomal P-450E 
A greater quantity of anti-P-450E polyclonal antibody was needed to 
establish conditions for immunoprecipitation of P-450E from relatively large 
microsomal samples, and an antibody preparation with reduced recognition of 
other microsomal proteins was desired. Thus, I prepared additional polyclonal 
antibody from the remaining serum from rabbit 119 as outlined in Chapter 2 
(ammonium sulfate precipitation, dialysis, chromatography on a DE-52 anionic 
exchange column, and ultrafiltration of the first 280 nm peak). Approximately 440 
mg of IgG was isolated by this procedure. This new antibody preparation was 
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examined for P-450E specificity and cross-reactivity by immunoblotting purified 
scup P-450E and control and BNF-treated Fundulus microsomes against several 
antibodies. The new antibody recognized scup P-450E and a dominant single 
band (the P-450E orthologue) in the Fundulus microsomes. Although it also 
recognized a few other Fundulus microsomal proteins, these bands were much 
less intense relative to the P-450E orthologue than were other non-P-450E proteins 
recognized by the other polyclonal preparations. As with the other antibodies, the 
staining of these non-specific proteins was identical in the control and induced 
microsomes. This new polyclonal antibody preparation was chosen for use in the 
immunoprecipitation of microsomal P-450E. 
Hepatic microsomal P-450E was precipitated for determination of 
radioactive counts, to obtain data on the specific activity of the protein itself. The 
development of several possible immunoprecipitation techniques is described in 
the Results section below. The final method used is a modification of the method 
described in Chapter 3 for precipitation of P-450E RNA translation products (from 
Fagan et al., 83). The modification included a microsomal solubilization step prior 
to addition of the primary PAb. Potassium cholate (0.5%) and Emulgen 911 
(0.2%) were added to 0.9 nmol spectral P-450 and the mixture was incubated on 
ice for 45 minutes prior to dilution by addition of immunoprecipitation buffer to 
1.4- 1.6 ml. Anti-P-450E PAb was added at 5 ug/pmol P-450 and scup P-450E 
(as carrier) was added to 0.056 ug. 200 ul (10% (w/v)) immunoprecipitin was 
added to each tube. All incubations on ice were of 45 minutes duration, and 
centrifugation after washes was for 5 minutes at 5000 rpm in a Sorvall RC2-B 
high speed centrifuge (SS34 rotor head). Washed pellets were resuspended in 
SDS PAGE sample treatment buffer and boiled to release the antibody-antigen 
complexes from the immunoprecipitin. After immunoprecipitin was spun down, 
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supernates were either applied directly to SDS PAGE gel electrophoresis, or added 
to 6 ml Scintiverse II and analyzed for radioactive counts. To determine whether 
the presence of sample treatment buffer would affect dpm calculations of tritiated 
samples, I added different volumes of sample treatment buffer (0 to 150 ul) to 
solutions spiked with [3H]-toluene (NEN) and counted cpm and dpm. Although 
the H # increased and cpm values decreased with increasing volumes of sample 
treatment buffer, the calculated dpm remained the same. Thus, the counting 
program corrects well for quench under these conditions. 
Experiment 1: f~HJ-Leucine Experiment 
Animal Treatment and Preparation ofMicrosomes 
On Day 0, 24 Fundulus heteroclitus were given a single i.p. injection of 
50 mg!kg BNF in corn oil (5 mg/ml, 100 uV10 g). On Day 4, fish were weighed 
to the nearest 0.1 g and the volume of tritiated leucine needed based on label 
concentrations and dose was calculated (5 ul/g; about 4.2 uCi/g). Twenty fish 
were injected i.p. with L-[ 4,5-3H]-leucine (Amersham, 156 C/mmol, check) in 
fish saline using a 25 gauge needle, and placed in a closed circulating, filtered 
water system. At appropriate times (2 and 23 hours after injection with leucine), 
10 fish were sacrificed, livers weighed and pooled in homogenization buffer (150 
mM KCl/ 50 mM Tris-Cl, pH 7.4 to 7.5) on ice. In addition, the 4 remaining 
BNF-treated animals were sacrificed concurrently with the 2 hour (hr) leucine fish, 
to provide a positive (unlabeled) control. Pooled livers were brought to 3 ml/g wet 
weight with homogenization buffer and homogenized 8 times at high speed (1160 
rpm). Bodies and ovaries were weighed later. Aliquots were taken for 
determination of "total" and TCA-precipitable counts of whole liver homogenates, 
and the remaining homogenates were used to prepare microsomes as usual. 
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Microsomes, resuspended to 2 ml per g liver, were aliquoted for "total" and 
"TCA" counts and stored in liquid nitrogen. 
Sample Countin~ and dpm Calculation 
Aliquots were taken from each sample as follows: a) 2 x 75 ul 
homogenate were transferred directly to a scintillation vial ("total" counts), b) 2 x 
100 ul homogenate were transferred to an Eppendorf tube for acid precipitation 
("TCA" counts). Larger aliquots were initially examined, to determine if such 
small volumes would provide detectable and consistent measurements. The values 
obtained for both large and small volumes were similar, and therefore the smaller 
volumes were used here and in subsequent experiments. 
Counts were determined according to the method described by Parkinson 
et al. (83). Briefly, for total counts, 12 mlliquid scintillation cocktail was added 
directly to the 75 ul aliquot and the sample was vortexed for 30 seconds and 
counted. For TCA counts, 400 ul cold 12.5% TCA was added to the 100 ul 
aliquot. The mixture was vortexed, then left on ice until ready to proceed. At this 
time, the sample was centrifuged in a Sorvall high speed centrifuge for 10 min, 
0°C, 2500 rpm (SS34 rotor). The pellet was washed twice with 1 ml 10% cold 
TCA and twice with 1 ml anhydrous diethyl ether. The pellet was then 
resuspended in 300 ul 1 M NaOH and left at room temperature overnight. The 
sample was heated for 2 hours at 60°C, cooled to room temperature, and 
neutralized. Generally, two 150 ul aliquots of each sample were neutralized with 
638 ul 0.25 N HCL 12 ml ScintiVerse II was added and the sample was counted. 
The program designed to count [3H]-leucine incorporated into RNA translation 
products (Chapter 3) was used here. 
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Experiment 2: Dual Label ([3Hl-leucine and [14CJ-ALA) Experiment 
Materials and Treatment 
On Day 0 (May 5) fish were weighed and treated with 50 mg/kg BNF 
i.p. (5 mg/ml, 100 ul/10 g). On Day 4, these fish were treated with a mixture of 
[14_C]- delta-arninolevulinic acid (ALA, Amersham, 56 mCi/mrnol) and [3H]-
leucine (Amersham, 144 Ci/mmol). Two hundred fifty rnicroCuries of ALA was 
dissolved in 200 ul 0.1 N HCl; 64 ul (80 uCi) of this solution was added to a total 
of 6 m1 fish saline containing approximately 4.9 mCi [3H]-leucine. The remaining 
ALA stock was flushed with nitrogen gas and stored at 4 °C for later use. A small 
aliquot of the fish saline containing both [3H]-leucine and [14C]-ALA was taken 
and counted. The dpm of each isotope was calculated from this 1 ul of stock. The 
tritiated leucine resulted in 1,349,999 dpm in channel one (0-400), or 74% of the 
expected dose. The [14C] resulted in 28,992 dpm in channel two (400-670), or 
98% of expected dose. As the leucine was taken from a vial previously used for 
other experiments, it is not surprising that the estimated activity was higher than 
the actual activity (e.g., for each previous experiment, slightly more volume than 
needed was removed from the vial, excess volume was wiped off the pipette, and 
the correct volume was used in the experiment). The [14C]-ALA was obtained 
from a new vial, with the solid compound freshly dissolved in HCl and aliquoted 
as a known volume. Therefore, the close agreement with the estimated [14C] 
value indicates that these volumes were accurately measured. 
Fish were weighed to the nearest 0.5 g and injected with 7.5 ul/g (a final 
dose of approximately 4.5 uCi/g leucine and 0.1 uCi/g ALA). The animals used in 
this experiment had been held over the winter and were developing "red mouth" 
disease, and some were not in good shape when they were injected. A few 
animals died immediately prior to and one died after radiolabel injection. Thus, 
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there were not enough fish for three pools to be prepared at the fmal time point 
(190 hr). In studies of the effects of feeding on the contribution of rainbow trout 
muscle cytosol as the source of tRNA, amino acyl tRNA synthetases, and other 
translation factors for protein synthesis, Junghahn and Jiirss (88) found that 
starvation decreased the "stimulating activity" of the fish cytosols. Given this and 
other background information, Fundulus were fed Tetramin during the 
experiment. At appropriate times (30 min, 90 min, 8 hr, 30 hr, 96 hr, and 190 hr) 
after injection with the dual label, fish were sacrificed and livers were excised and 
weighed. Three to four livers were pooled to obtain> 1 g per sample, and three 
samples were prepared at each time point except at 190 hours, when 2 samples 
were prepared. 
Pooled livers were brought to 4 ml/g wet weight in homogenization 
buffer and the procedure outlined above followed for homogenate and microsomal 
preparation. The final microsomal spin was for 2 hr at 18,000 rpm in a high speed 
Sorvall, rather than an ultracentrifuge, and microsomes were resuspended to 2 
ml/g. Slightly smaller volumes were taken for total (70 ul) and TCA (90 ul) 
counts. Sample preparation was carried out as above, but a dual label dpm 
counting program was used to simultaneously determine [3H] and [14C] values. 
Both [3H] (dpm corrected for current date) and [14C] quenched standard sets 
(Beckman) were counted to establish quench curves for the two isotope channels. 
Channel 1 was defined as 0 to 400, channel 2 as 400 to 670. Multiple H # values 
(n=4) were calculated for each sample, and samples were counted for 20 or 30 
minutes or to a 2 sigma value of 1.00%. MFO parameters were measured in these 
samples as before. 
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Statistics 
Means and standard deviations were calculated and ANOV A analyses 
were carried out as previously described (Chapter 3 and 4). In addition, if the 
single factor analysis of variance showed differences between groups, the Student-
Newman-Keuls test was applied to see where the differences could be found. 
This multiple range test was used rather than the Dunnett's test, so each group 
could be compared with all other groups (time points), rather than controls versus 
various BNF-treated groups as in previous analyses. 
RESULTS 
Immunoprecipitation of Microsomal P-450E - Early Attempts 
Before I could proceed with a dual label experiment to address questions 
of P-450E apoprotein and heme turnover in Fundulus, a way of measuring 
radioactivity incorporated into P-450E had to be established. Due to the 
availability of anti-P-450E antibodies, I chose immunoprecipitation as the method 
for separating P-450E from other microsomal proteins. Several steps were taken 
to achieve this goal. First, microsomes were solubilized under conditions 
amenable to antibody-antigen interactions. Solubilization of Fundulus hepatic 
microsomes with potassium cholate and Emulgen 911 according to the protocol 
used for scup P-450E purification (Klotz et al. , 83) was followed by a 2 1/2 hour 
centrifugation to separate the supernates and pellets. The pellets contained less 
than 10% of the P-450E found in the supernate, which contained amounts 
consistent with the expected P-450E in each sample. 
The next step was to establish antibody-antigen interactions leading to 
immunoprecipitation. I initially wanted to use a MAb, because the available anti-
scup P450E MAbs are highly specific for the Fundulus orthologue. It is difficult 
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for monoclonal antibodies to form precipitates unless the antigen is multivalent 
(contains identical repeated antigenic determinants). Thus, I obtained Sepharose 
4B-linked affinity purified goat anti-mouse IgG (Organon Teknika-Cappel, 
Malvern, PA). This bead complex should recognize IgMs as well as IgG classes 
and it should be possible to elute bound immunoglobulins from the matrix in a 
biologically active state. Mter elution of solubilized Fundulus hepatic microsomes 
and MAb 1-8-4 (an IgM which has a high avidity for P-450E, see Chapter 2, 
Figure 4) from the Sepharose-antibody column according to the manufacturer's 
protocol, I immunoblotted the eluate against MAb 1-12-3. Positive controls, 
aliquots of starting material alone, resulted in a single band in each lane at the 
appropriate Mr for P-450E. Eluates reacted with MAb 1-12-3 only as faint 
fragments at or near the dye front, with no signal apparent in the middle molecular 
weight range. Thus (although some of the P-450E signal may have been blocked 
by antibody, see below), I decided to return to immunoprecipitation using 
polyclonal antibodies (PAb) and immunoprecipitin (formalinized S. aureus 
containing protein A), as described in Chapter 3 for precipitation of P-450E RNA 
translation products. Modifications of the immunoprecipitation technique are listed 
in the Materials and Methods section. 
The size of the immune complex depends on the relative concentrations 
of the two components, so the proper ratio of antibody to antigen was determined. 
Typically, a bell-shaped curve is produced, with maximal precipitation complexes 
forming near equivalence (Alberts et al., 83). To establish this ratio and use the 
same PAb preparation in routine microsomal precipitations, however, greater 
amounts of PAb were required. Thus, I prepared additional polyclonal antibodies 
(see Materials and Methods). BNF-treated Fundulus microsomes were solubilized 
and incubated with the new polyclonal antibody preparation at ratios of 0.1 to 30 
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ug PAb/pmol spectral P-450. Immunoprecipitin was added to each mixture to 
precipitate the antibody-antigen complex. The pellets were washed, then boiled to 
release the complex and centrifuged to pellet the immunoprecipitin. The 
supernates were electrophoresed on SDS PAGE minigels, transferred to 
nitrocellulose and stained with Ponceau S. 
Generally, this protein stain is used to confirm that all samples 
transferred well and that no bubbles occurred in the area of interest. In this case, 
however, Ponceau S staining indicated the presence of enormous amounts of 
protein in the 50,000 molecular weight range. Staining after incubation with MAb 
1-12-3 and the secondary antibody and color developer resulted in typical signals 
for the positive controls (non-precipitated Fundulus microsomes), but no signal in 
this region for the precipitated samples. When the immunoblotted nitrocellulose 
was directly compared with the Ponceau-staining pattern, and with the Coomassie 
blue-stained residual gel, the area showing a LACK of immunoblot staining 
coincided with the area occupied by this protein. Given the concentration of this 
protein and its Mr (IgG heavy chain monomers have a Mr of 50,000; Tijssen, 85) 
in this denaturing gel system, this protein is probably the antibody heavy chain. A 
second dominant protein-staining band was present at a lower Mr and presumably 
corresponds to the antibody light chain (light chain monomers have Mrs of 20-
25,000). In any case, the results of this experiment are inconclusive. It is 
possible that the PAb precipitated the P-450E, but its presence was masked by the 
massive amounts of immunoglobulin heavy chains in this analysis. (This may 
have been the cause of a negative result with the MAb-Separose bead complex, as 
well.) Therefore, I decided to carry out an induction experiment in the presence of 
a radiolabeled compound to generate material which could be detected by 
radioactive methods. 
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Experiment 1: Basic Parameters and [3HJ-Leucine lncotporation 
Based on the results presented in Chapter 3, steady state levels of BNF-
induced P-450E are most likely to occur between 4 and 12 days after treatment 
with the inducer (Figure 3-1). Therefore, Fundulus were injected with [3H]-
leucine 4 days after treatment with 50 mg/kg BNF and sacrificed 2 and 23 hours 
later. A "BNF" pool (no leucine injection, n=4) was prepared at the same time as 
the 2 hour leucine-treated animals. At each time point, leucine-treated livers were 
combined to obtain a large pool of labeled material. Results of microsomal 
analyses and total and TCA counts are shown in Table 5-1. There is no difference 
between the mean GSI and HSI parameters, indicating that [3H]-leucine treatment 
did not affect these parameters in the short term. All other values are for pooled 
samples, so statistical comparisons are not possible. However, given our 
previous knowledge of Fundulus MFO characteristics at this time following BNF 
treatment, and comparing the "BNF" value to the 2 hr and 23 hr values, it appears 
that [3H]-leucine treatment did not cause alterations in MFO parameters. 
Microsomal yield is higher in both leucine-treated pools, but all 3 values fall within 
the norm for Fundulus preparations. 
Radioactive counts are shown in the lower portion of Table 5-1. Liver 
homogenate counts were calculated relative to the liver wet weight prepared. At 2 
hr, TCA counts represented 78% of the total counts, while at 23 hr they 
represented 90% of the total counts. This would be expected of the homogenate 
pool, if some free leucine was still available after 2 hr, but most of the amino acid 
was incorporated into protein by 23 hr. Loss of total label during the experiment 
(corresponding to oxidative degradation of the amino acid and elimination of label 
from degraded proteins) was also apparent: the ratio of 23 to 2 hr counts is 0.51 
for total counts and 0.59 for TCA counts. 
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Table 5-1: [3H]-Leucine Labeled Fundulus - Single Label Experiment 
Parameter BNF 
Basic Assays 
HSI 
GSI 
6.3 ± 1.4 (4)a 
3.6 ± 1.0 (4) 
Microsomes 
bsb 
P-45QC 
ERQI)d 
ERODe 
P-450E/ng 
P-450E/P-450 
usomal yield 
Radioactive Counts 
liver homogenates 
total, dpm/g 
TCA,dpm/g 
liver microsomes 
52.4 
326 
1.69 
5.19 
156 
48% 
15.3 
2 hrLeu 
5.7 ± 1.2 (10) 
3.5 ± 1.4 (10) 
55.4 
294 
1.74 
5.92 
139 
47% 
21.9 
1.24 X 107 
9.71 X 1()6 
23 hrLeu 
5.7 ± 2.7 (10) 
3.2 ± 0.9 (10) 
61.0 
297 
2.23 
7.51 
136 
46% 
21.1 
6.32 X 106 
5.69 X 106 
total, dpm/mg 1.27 x 105 4.82 x 104 
~T~C=A~.d~p=m=/=m~g~-------------1~.-34~x~1Q2 ________ 4~·~96~x~l~01 __ __ 
a (n) = number of individuals in each pool 
b Spectral cytochrome bs, pmoVmg protein 
c Spectral P-450, pmoVmg protein 
d Ethoxyresorufin 0-deethylase, nmoVmin/mg 
e Ethoxyresorufin 0-deethylase, nmoVmin/nmol P-450 
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Liver microsomal counts, calculated relative to mg protein in the 
microsomes, present a slightly different picture. At both times, TCA count values 
were approximately the same as total count values (106% and 103%), indicating 
that all leucine found in the microsomes was incorporated into protein. This is 
also expected, because any free leucine should not be found in the microsomal 
fraction, but should be localized predominantly to the cytosol (leucine non-
specifically, loosely, associated with organelles would probably be washed off 
during subcellular fractionation). The 23/2 hr ratio was lower in the microsomal 
preparation compared to the whole homogenate: 0.38 for total counts and 0.37 for 
TCA counts. This indicates that release of incorporated leucine may have been 
more rapid in the microsomes than in the total homogenate (e.g., the "average" 
microsomal protein half-life was shorter than the "average" total protein half-life). 
Finally, I wanted to know the size distribution of radiolabel in the 
microsomes- is it possible that P-450E was labeled? 10 pmol of spectral P-450 
(- 34 ug protein) from the 2 and 23 hr samples were electrophoresed on a large 
SDS-PAGE gel and autoradiography performed. The 2 hour sample exhibited 
multiple bands, and the 23 hour sample had two major bands, of 54,700 and 
50,600 Mr. The higher Mr band could be P-450E. Taken together, the MFO 
parameters, total and TCA radiolabel count patterns, and autoradiography results 
suggest that the labeling protocol chosen for this study should be sufficient for 
protein labeling in the dual label experiment, and that this concentration of [3H]-
leucine should be adequate for detectable labeling in BNF-induced Fundulus. In 
addition, radiolabeled microsomal proteins (probably including labeled P-450E) 
were now available for further immunoprecipitation experiments. 
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Experiment 1: Immunru>recipitation 
Once basic MFO parameters and leucine incorporation had been analyzed 
for the single label experiment, I returned to the question of immunoprecipitation. 
The method eventually developed is essentially that described in Chapter 3, 
modified to include microsome solubilization prior to antibody addition. As 
before, a range of antibody ratios was used (0.1 to 20 ug antibody/ pmol P-450), 
and two concentrations of P-450E carrier were added. The best precipitate 
complex occurred at 5 ug antibody per pmol total spectral P-450 (Figure 5-1). 
This ratio was used in all subsequent immunoprecipitations. Results were also 
improved when a greater amount of P-450E carrier was utilized (Figure 5-1). 
This immunoprecipitation protocol was repeated using 2 to 3 mg total 
protein for the 2 hr [3H]-leucine sample and the 2 hr "BNF only" sample (no 
radiolabel added) in duplicate. One sample of each replicate was separated on a 
wide comb large SDS-PAGE gel and autoradiography performed, the other sample 
was counted as usual. Counting results are presented in Table 5-2. The 2 hr 
[3H]-leucine sample contained [3H] counts significantly above background. The 
pellet contained some counts, but was well below the amounts for the supernate. 
Additional wash steps after removal of the supernate would probably reduce pellet 
radiolabel content. (There was obviously sample treatment buffer [blue color] 
within the immunoprecipitin pellet [white color].) The "BNF" sample contained 
counts similar to background counts (sample treatment buffer alone). The 
autoradiogram of the immunoprecipitated 2 hr [3H]-leucine sample showed a 
single band, with an approximate Mr of 57,000. Thus, this irnmunoprecipitation 
procedure appears to isolate a single labeled protein with a size near that of 
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Figure 5-1 
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FIGURE 5-1: Ratio of P Ab 119 to P-450 protein. 
Immunopreciptitation was carried out as described in the Materials and 
Methods section with Fundulus rnicrosomes from the 2 hr [3H]-leucine pool and 
various concentrations of the "new" polyclonal antibody preparation. Two 
concentrations of scup P-450E were added as a carrier (0.05 ug and 0.025 ug). 
Results obtained with 0.05 ug scup P-450E content are shown as open squares, 
results with 0.025 ug as closed diamonds. (P-450E was 47% of the total P-450 in 
this sample.) 
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Fundulus P-450E. Given the known specificity of this PAb preparation, namely 
that it does not recognize any other microsomal proteins besides P-450E near that 
Mr. it is concluded that this band represents labeling of Fundulus P-450E. 
Therefore, this procedure could be employed for analysis of amino acid and heme 
incorporation into P-450E in the dual label experiment, providing a means for 
separating labeled P-450E from remaining microsomal proteins. 
Table 5-2: [3H]-Leucine in Immunoprecipitated Microsomes 
amount, spectral P-450 
sample ID 
dpm, 
supernate'l 
dpm, 
pelleta_ 
750 pmol, 2 hr leu 1154 385 
750 pmol, BNFb 78 46 
back~ound~ ________ _,5.<..<1.__ ____ __:..:n,_,..dd_ 
a Samples were immunoprecipitated, washed, boiled in sample treatment buffer 
to dissociate the antibody/antigen complex from the immunoprecipitin (and itself), 
and spun down to separate immunoprecipitin from the freed antibcxly and antigen. 
Thus, "supernate" values represent antibody and antigen, and "pellet" values 
represent immunoprecipitin. 
b 2 hr BNF "positive" control (BNF only, no leucine injection) 
c sample treatment buffer only 
d nd = not determined 
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Experiment 2: Basic Parameters 
The second labeling experiment, designed to provide information on 
protein and heme turnover in induced Fundulus, was carried out for 190 hr after 
injection with a dual label. Fundulus were treated with 50 mg!kg BNF, and 
injected with [3H]-leucine and [14C]-ALA 4 days afterwards. Analysis of MFO 
activities in these animals is shown in Table 5-3. Cytochrome bs and P-450 
specific contents were significantly different for two time points: bs specific 
content at 96 hr was greater than bs content at 30 or 8 hr, and P-450 content at 190 
hr was lower than content at 8 hr. 
These animals, which were treated in early May, had relatively high GSI 
values. There were no significant differences between the groups, but the 
averages for all except the 190 hr time point ranged from 8.9 to 12.5. The average 
at 190 hr was 6.2. All these values are greater than those for the animals treated 
and analyzed in Chapters 3 and 4 (e.g., compare Table 3-1). The HSI averages 
ranged from 3.1 to 4.8, and thus fell in the normal range of values. There has 
been some debate as to whether "ripe" or gonadally mature female teleosts are 
capable of a normal P-450 induction response to xenobiotics such as P AH and 
BNF (McKee et al., 83; Hansson and Gustafsson, 81; Stegeman et al., 82; 
Stegeman and Woodin, 84). It seems clear from the P-450E protein values that 
these fish were induced to the same extent as their immature or regressed 
counterparts (compare P-450E% column in Table 5-3 with Figure 3-1). 
Interestingly, microsomal yield was significantly lower in the 96 and 190 hr 
samples compared to the first two times sampled, 0.5 and 1.5 hr (data not shown). 
The microsomal yield at the early times was similar to the yield in Experiment 1 
(all- 21 uglg liver), indicating that perhaps injection with [3H]-leucine does cause 
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Table 5-3: Monooxygenase Parameters in "Dual Label" Fundulus 
Hr b2. prnol/rng P-450. prnol/rng P-450E/ng P-450E% 
0.5 66.8 ± 7.5 271 ± 78 194 ± 39 73.1 ± 8.0 
1.5 69.9 ± 2.1 284 ± 21 185 ± 25 65.5 ± 12.6 
8 64.4 ± 0.6 358 ± 45 201 ± 14 56.4 ± 4.3 
30 58.6 ± 4.6 261 ± 24 189 ± 10 72.9 ± 9.0 
96 84.2 ± 9.3* 312 ± 25 134± 8* 43.3 ± 4.8* 
12Q 68.3 + 13.6 21Q + 44* 62 + 11* 29.6+ Q.8* 
*=differences according to Student-Newman-Keuls analysis following 
significant differences in ANOV analysis. For each column, the symbols mean: 
bs: 96 hr different from 30 & 8 hr (P < 0.05) 
P-450: 190 hr different from 8 hr (P < 0.05) 
P-450E/ng: 96 hr different from all others (P < 0.05), and 
190 hr different from all others (P < 0.01 except 96, P < 0.05) 
P-450E %: 96 hr different from 0.5 & 30 hr (P < 0.01) & 1.5 hr (P < 0.05) 
190 hr different from 0.5, 1.5, 8, & 30 hr (P < 0.01) 
NOTE: HSI and GSI: no significant differences between the groups 
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an at least transient increase in microsomal yield. Any link between reduced 
hepatic microsomal yield at the later time points and reduction in GSI is unknown. 
Despite the assumption that P-450E protein content would remain stable 
over the entire duration of the experiment, P-450E content was significantly 
different from other values (lower) at 96 and 190 hr after radiolabel injection (96 
hr- 8 days post BNF treatment, 190 hr- 12 days post BNF treatment), whether 
expressed on a per mg microsomal protein basis or a per nmol spectral P-450 
basis. It is possible that the declining portion of the induction response - the return 
to control levels - was accelerated by an increase in water temperature. Although 
the animals were kept in 16°C flowing water from Day 0 to Day 4, after injection 
with [3H] and [14C] they were maintained in a closed, recirculating system in the 
laboratory and the water was allowed to come to room temperature (-20°C). 
Therefore, although all radioactive counts are included below, the requirement for 
steady state conditions for analysis of half-life is only rigorously met from 0.5 to 
30 hr. 
Experiment 2: Incorporation of [.3.HJ and [14Q 
Radioactive counts for samples from the dual label experiment were 
calculated as in Experiment 1. Aliquots for homogenate and microsomal fractions 
(both total and TCA counts) gave no coherent channel 2 readings ([14C]). 
Therefore, only [3H] dpm counts, corresponding to total leucine (total counts = 
free plus incorporated leucine) and incorporation of leucine into protein (TCA 
counts = incorporated leucine), are plotted in Figure 5-2. Figure 5-2A shows 
counts from the liver homogenates at each time point, Figure 5-2B shows 
microsomal counts. In each case, maximal radiolabel incorporation occurred at 
1.5 hr, followed by a rapid decline. Thereafter, counts remained fairly constant 
from 30 to 190 hr. It is possible that turnover is biphasic, with a rapid phase 
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from 1.5 to between 8 and 30 hr, and a much slower phase (proteins with a longer 
half-life) beyond 30 hr. The initial decline in microsomal protein is more rapid 
than the initial decline in homogenate protein (comparison of TCA counts), 
indicating that "average" microsomal proteins turn over faster than do "average" 
total proteins. The slight (not statistically significant) increase in labeled protein at 
190 hr in all samples tested may be due to a decline in microsomal yield at 96 and 
190 hr. For example, if labeled proteins were preferentially retained but other 
proteins were lost, an apparent increase in dpm/mg could result. (This is actually 
unlikely, as most research has indicated that newly synthesized proteins have the 
same probability of degradation as do older proteins.) The protein half-life can be 
calculated for the fast and slow phases according to Parkinson et al. (83a). When 
a straight line is fitted to a semilog plot of specific radioactivity (TCA counts, 
dpm/mg) vs time, the microsomal fast phase (1.5 to 30 hr, r2 = -0.877) half-life is 
9.3 hr and the homogenate fast phase (1.5 to 30 hr, r2 = -0.950) half-life is 16 hr. 
The slow phases then have half-lives of 190 hr and 140 hr, respectively (both 
measured at 30 and 96 hr only). 
Equal amounts of spectral P-450 (0.90 nmol) were used as starting 
material for immunoprecipitation, at a ratio of 5 ug PAb/pmol P-450. The 
expectation was that [14C] would be detectable in these samples, due to the greater 
specific content of heme in P-450s as compared to bulk microsomal proteins (70% 
of microsomal heme is incorporated into P-450 isozymes, Muller-Eberhard and 
Vincent, 85). A detectable signal was obtained for both isotope channels. This 
was not due to "spillage" of tritium counts into the second window: the 3HJ14C 
ratio shifted with time. 
[3H]-leucine per nmol P-450E achieved its peak at 1.5 hr (Figure 5-3), 
as was observed for "average" microsomal protein (Figure 5-2B, TCA counts) . 
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Figure 5-2: Incorporation and disappearance of [3H]-leucine in Fundulus liver 
homogenate and liver microsome fractions. 
BNF-treated fish were sacrificed at various times (0.5 to 190 hr) after 
treatment with radiolabel. Radioactivity was measured before (open squares) and 
after (closed diamonds) TCA precipitation as described in the Materials and 
Methods section. Means (n=3 in all but the 190 hr group, where n=2) ± sd are 
plotted at each time. 
A. Liver homogenates, dpm/g liver (values x 105) 
B. Liver microsomes, dpm/mg microsomal protein 
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Figure 5-3 
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FIGURE 5-3: [3H]-amino acid incorporation into Fundulus P-450E 
Fundulus were pretreated with 50 mg/kg BNF and injected with [3H]-
leucine and [14C]-ALA. Hepatic microsomes were isolated at the times indicated 
and immunoprecipitated with anti-P450E PAb as described in the Materials and 
Methods section. Supernates were counted for [3H] and [14C] dpm after the 
samples were boiled and immunoprecipitin pelleted. Values were determined as 
follows: blank dpm (34 dpm) was subtracted from each raw dpm value, and the 
resulting number was divided by the nmol P-450E used in the incubation to arrive 
at dpm/nmol P-450E. Maximal incorporation occurred by 1.5 hr (100% = 3134 
dpm/nmol P-450E). Means of multiple determinations are shown ± sd, except for 
at 190 hr (a single determination). 
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Rather than the expected constant decline following maximal incorporation, a 
second increase appeared by 190 hr. Possible explanations for this observation 
are described in the Discussion section. A calculation like those reported above 
was made for P-450E protein from 1.5 to 30 hr (r2 = -0.873), with a resultant 
half-life of 32 hr. It takes Fundulus approximately 4 days to achieve the induced 
steady state level of P-450E after a single i.p. injection of 50 mg/kg BNF (Figure 
3-1 ). A rough estimate of the time required for P-450E to reach one half its steady 
state level, as described by Berlin and Schimke (65), provides a half-life of 43 hr 
(based on P-450E/total P-450 values) . Thus, there is a reasonable agreement 
between the two methods. It must be stressed that only the earlier time points 
were employed for the determination of half-life by isotope decay. Figure 5-3 
suggests that some puzzling phenomenon may be occurring at later times (a 
stabilization of a subpopulation of P-450E? differential precipitation of P-450E at 
different concentrations?) 
Incorporation of [14C]-ALA into P-450E over time resulted in a more 
consistent picture (Figure 5-4). [14C] achieved maximal incorporation by 8 hr, 
indicating a lag between incorporation of leucine into the apoprotein and 
incorporation of the heme moiety (maximal leucine incorporation occurred at 1.5 
hr). The subsequent decline in [14C] dpm/P-450E was relatively slow, with a 
calculated ti/2 (half-life) of 104 hr (calculated from 8 to 190 hr, r2 = -0.932). This 
determination included more time points than did the protein determination, but 
also included those later in the experiment, which may be susceptible to problems 
(see below). 
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Figure 5-4: [14C]-heme incorporation into Fundulus P-450E 
Fundulus were treated and microsomal P-450E precipitated as described 
in Figure 5-3. The same samples were analyzed for both amino acid and heme 
labeling; calculations were performed as outlined in Figure 5-3. Maximal incor-
poration of ALA occurred by 8 hr (blank was 26 dpm, and corrected 100% = 531 
dpm/nmol P-450E). Means of multiple determinations are shown ± sd, except for 
at 190 hr (a single determination). 
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Discussion 
In studies of induction of mammalian xenobiotic-inducible P450IA1 by 
BNF, protein and enzymatic activity levels exhibit the same trend as does the 
corresponding mRNA: an initial sharp increase to a maximal value, followed by a 
rapid decline to control levels (Boobis et al., 77). The pattern is somewhat 
different in teleost species examined thus far. It has been known for some time 
that induction of Ami and EROD activities in fish can persist for weeks (James 
and Bend, 80; Andersson et al., 85). The studies described in Chapters 3 and 4 
confirm that this prolonged catalytic activity is highly correlated with the presence 
of the AHHJEROD catalyst itself, the P-450E protein (e.g., Figure 4-4 and Figure 
3-1). These studies also demonstrate that P-450E mRNA levels decline relatively 
rapidly, approaching control levels by 4 days after treatment (Figure 4-8). This 
suggests that while mammalian P450IA 1 protein has a relatively rapid turnover, 
fish P450IA 1 may not. Therefore, it was of interest to address questions of teleost 
P-450E protein and heme turnover. 
The Introduction to this Chapter outlines some of the theories and 
experimental methods in use for the measurement of protein and heme turnover. 
Unfortunately, the most promising amino acid precursor for liver studies -
bicarbonate - is not feasible for use in teleosts, due to basic differences in 
excretory physiology between mammals and fish. I employed [3H]-leucine 
(frequently used in fish protein turnover studies, whcih generally measure bulk 
protein turnover in various organs) as an amino acid precursor. 
Experiment 1 was conducted to supply radiolabeled material for 
improved interpretation of immunoprecipitation results and also as a preliminary 
labeling study. Only two time points were chosen, but they proved to be at critical 
periods - 2 hr was near peak label incorporation, and 23 hr was near the end of the 
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most rapid phase of label loss, as determined in Experiment 2. Leucine was 
readily taken up into the TCA-precipitable (protein) fraction in both whole 
homogenates and microsomes. As expected, some free leucine was present in the 
homogenate, but none was detectable in the microsomal fraction (microsomal TCA 
counts- total counts). The added pulse of leucine (or any side effects caused by 
the injection) did not appear to affect the :MFO parameters measured, for at least 23 
hr after injection (Table 5-l). The presence of labeled material facilitated 
interpretation of immunoprecipitation results, and allowed me to establish an 
antibody to antigen ratio (5 ug PAb/pmol P-450) in the reactions (Figure 5-l). 
Autoradiography showed that P-450E, or a protein of similar molecular weight, 
had incorporated the leucine label and could be precipitated as a single band of the 
expected Mr with the new polyclonal antibody preparation. 
Experiment 2 was designed to give more detailed information on protein 
turnover, particularly P-450E turnover, and on initial heme turnover results. 
Before discussing these results, however, it is interesting to note that BNF was 
able to elicit a typical P-450E induction response in females having high GSI 
values. P-450E was elevated to levels similar to those found in BNF-treated 
immature females (compare Table 5-3 with Figure 3-1). It is not known what the 
circulating estradiol levels were in the blood of these females prior to and during 
xenobiotic treatment, but the animals were obviously closer to a mature 
reproductive status than were the animals used in the earlier September and 
February studies (post-spawning and regressed status). It is possible that a 
combination of conditions such as day length, temperature, and steroid levels at 
the time of xenobiotic exposure in these laboratory-held animals caused them NOT 
to exhibit the more common LACK of strong induction seen when sexually mature 
females are challenged by these chemicals (Gray, 88, and references therein). 
178 
Experiments specifically designed to address questions of suppression of the 
induction response in teleosts by female sex steroids are underway (Adria Elskus, 
personal communication). 
The levels of [14C] were too low in homogenates and microsomal 
preparations to obtain detectable counts, but [3H]-leucine was incorporated into 
protein as previously observed in Experiment 1. Peak incorporation occurred at 
1.5 hr, and the rapid phase of protein turnover was calculated according to the 
method of Parkinson et al. (83a) to be 9.3 hr for microsomes and 16 hr for 
homogenates. The slower phases were calculated to have t112s of 190 and 140 hr, 
respectively. These results are comparable in trend to those of Parkinson et al. 
(83a), where the average rat microsomal protein had fast and slow t112s of 5-9 and 
82 hr, faster than the average homogenate protein. Arias et al. (69) obtained a 
determination of 3 days for average rat microsomal protein half-life. 
The results obtained by immunoprecipitating P-450E protein are 
puzzling. Although a peak of [3H] occurred simultaneously with the peak in 
average microsomal protein (1.5 hr, Figure 5-2 and Figure 5-3), [3H] counts again 
increased by 190 hr. There are several possible explanations for these results, 
including methodological difficulties and reutilization of the radiolabel. Due to a 
decline in P-450E% at the last two time points, less P-450E was present in the 96 
and 190 hr sample immunoprecipitation incubations. I corrected for this by a 
simple calculation which assumes linearity of the response. However, a difference 
in total protein concentration, or in the ratio of the antibody to the antigen itself 
may result in a non-linear relationship (the antibody to total P-450 ratio was the 
same for each incubation, but the antibody to P-450E ratio was in excess for the 
last two time points). Repetition of these immunoprecipitation assays with a range 
of P-450E contents at constant protein concentration, and conversely with a range 
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of protein contents at constant P-450E levels could help eliminate this possible 
source of error. 
Reutilization is another possible problem. The incorporated label could 
be identified by hydrolysis and thin layer chromatography of the sample to 
determine whether label occurs only as leucine, or as other amino acids. Use of 
Arias et al.'s (69) dual label technique, or another precursor in the place of leucine, 
are possible methodological alternatives. GSI decreased in the animals with time, 
which may indicate accumulated stresses of the closed system or long-term effects 
of the injections. Finally, the rise in water temperature may have increased protein 
synthesis, leading to enhanced reutilization (such as that observed in PH-
stimulated rats by Arias et al., 69; Sadano and Omura, 82). In conclusion, it is 
not possible to make a realistic estimate of the turnover of P-450E apoprotein with 
these few data points. (The "unrealistic" estimate of tl/2• 32 hr, is in close 
agreement with the estimated time to reach a half-maximal induced state, about 43 
hr.) It is also possible that this second peak in [3H] incorporation is real, and 
reflects a stable sub-population of P-450E protein. 
The incorporation of [14C]-ALA lagged behind [3H]-leucirie 
incorporation (8 vs 1.5 hr). Parkinson et al. (83a) observed a similar lag between 
apoprotein and heme uptake in Aroclor-treated rats. Sadler et al. (85) observed 
maximal incorporation of ALA into trout microsomal proteins at 20 to 25 hr (at 
6°C). The estimated half-life for heme, using the same calculation method as 
described above, was 104 hr in Fundulus . The [14C] values seemed more 
consistent than the [3H] values, with lower deviations from the mean values and a 
more expected pattern (no secondary increase in levels). In mammalian species, 
ALA is considered to be a good label of heme, due to its specific incorporation into 
heme and the subsequent degradation of heme without label recycling. The 
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infrequent reports of heme "switching" in mammalian P-450s suggest that the 
results obtained here may not be wholly artifactual: heme switching may account 
for the longer half-life observed for heme compared to apoprotein in Fundulus 
P-450E. 
It would be of interest to measure heme content in microsomes prior to 
and after P-450E precipitation, and compare these numbers with the radioactive 
counts obtained (specific radioactivity on a heme, rather than protein, basis). This 
would confirm that immunoprecipitation of P-450 isozymes from solubilized 
microsomes with polyclonal antibodies does not cause the loss of heme from the 
apoprotein (Parkinson et al., 83a; Meier et al., 84). The samples precipitated and 
separated on SDS-PAGE each exhibited a single band at between 55 and 60 kD 
Mr. and only one of two with high [14C] values had a lower Mr band as well. 
Knowledge of the dpm incorporated per unit heme may be more useful for 
consideration of the role heme plays in the regulation of P-450E expression. 
There is no evidence that xenobiotics induce ALAS in teleosts (e.g., Gooch and 
Matsumura, 83), despite frequent increases in total spectral P-450 content. 
Perhaps heme is not limiting in these cases, or some element of the regulatory 
pathway is nonfunctional in teleosts and heme is in fact a limiting factor. My 
results indicate that the apoprotein moiety of P-450E turns over at a more rapid rate 
than does the heme moiety, in contrast to most of the evidence in mammalian 
systems. Improvements of the experimental protocol, besides further optimization 
of the immunoprecipitation method, include: strict temperature control, fewer 
animals per tank in the recirculating system, less frequent feedings (water fouling), 
and a longer and more intensive sampling regime. Attempts to precipitate the 
radiolabeled material with the antibody-bead complex described in the 
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Immunoprecipitation - Early Attempts section may also prove to be a fruitful 
avenue, especially as the beads can be reused. 
The results presented in the other Chapters of this thesis supplied solid 
background material and answered fundamental questions concerning aspects of 
the regulation of P-450E induction in teleosts, while opening up further avenues of 
investigation. The results presented in Chapter 5 pose more questions than they 
answer. I have established that radiolabeling of P-450E is possible in Fundulus, 
worked out a scheme for isolation of the P-450E from the remaining microsomal 
proteins, and obtained radioactive counts from a preliminary dual label experiment. 
Optimization of the immunoprecipitation procedure, use of healthy animals and 
careful monitoring of their status during and following treatment are areas for 
future improvements, which should lead to a better understanding of protein and 
heme turnover in P-450E. 
During the course of this research, much has been learned about the 
processes of induction of P450IA1 in fish. Chapter 6 summaries the results and 
conclusions gleaned from my studies ofP-450E expression in Fundulus, mentions 
some advances occurring elsewhere in this field, and provides some thoughts on 
future directions of research concerning the questions of regulation of the 
induction of P-450E in teleosts. 
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1 If synthesis is zero order and degradation is first order, then the time it takes a 
protein to reach half of the new induced steady state level is theoretically equal to 
the tl/2· If E = enzyme concentration, ks = rate of synthesis, and k<t = rate of 
degradation, the change in E over time is: dE/dt = ks- k<tE. At induced steady 
state levels of E (dE/dt = 0), ks =~E. Therefore, ~ = ksfE. If half-life is defined 
as t112 = In 2fkd or 0.693/kct, then by rearrangement t112 = (0.693 x E)/k5• 
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CHAPTER6 
SUMMARY AND CONCLUSIONS 
I. Regulation of P-450E Induction in Fundulus heteroclitus 
II. Speculations and Future Directions 
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I. Regulation of P-450E Induction in Fundulus heteroclitus 
Regulation of the expression of the mammalian AHH catalyst, P450IA 1, 
involves an Ah receptor that forms a complex with TCDD, MC, BNF, or other 
specific ligands and interacts with some portion(s) of the sequence 5' of the 
P4501Al protein coding region (Whitlock, 87; Nebert and Gonzalez, 87). This 
interaction leads to transcriptional activation of the gene, resulting in accumulation 
first of P450IA1 mRNA, then of P450IA1 protein. Thus, increases in the 
corrresponding enzyme activities are observed. An Ah receptor was originally 
postulated to exist based on structure-activity relationships of TCDD-analogs and 
AHH activity (Poland and Glover, 73), and the responses in various mouse 
strains. Availability of defined mouse strains and manipulation of these strains 
(matings, backcrosses, etc.) allowed for the definition of the Ah locus on a genetic 
basis (Nebert and Jensen, 79). Using techniques exploiting the tight, specific 
binding of radiolabeled TCDD to the Ah receptor, this receptor has now been 
identified in other mammals, including rabbits, guinea pigs, and humans 
(Gasiewicz and Rucci, 84; Manchester et al., 87). 
When I began my studies of the molecular regulation of induction of 
teleost P-450E, all attempts to find a corresponding Ah receptor moiety in fish had 
been unsuccessful, despite efforts to optimize the assays for tissues containing low 
concentration or labile receptors (Denison et al., 85; Hamilton, personal 
communication). Thus, I decided to attack the question from another angle: if 
transcriptional enhancement is a fundament part of P4501Al induction in mammals 
(Gonzalez et al., 84), is this also the case in fish? This might seem a rather 
obvious hypothesis. However, taking the relatively long times needed to achieve 
maximal AHH and EROD activities in fish and the inability to identify an Ah 
186 
receptor into account, it was postulated (Denison et al., 85) that the mechanism 
was fundamentally different from that known to exist in mammals. 
The wealth of background information on the enzyme itself and the 
availability of antibody probes for identification and measurement of P-450E 
protein and mRNA levels led me to examine the mechanism of regulation of the 
xenobiotic-metabolizing teleost isozyme P-450E. Prior to addressing questions of 
temporal patterns of induction, to approach an understanding of the underlaying 
mechanisms, I further characterized the available anti-scup P-450E antibodies 
(Klotz et al., 83; Park et al., 86a). The MAbs proved to be particularly valuable 
for immunoblot analysis. MAb 1-12-3 was specific for P-450E, not recognizing 
any other P-450 fractions, nor other microsomal proteins separated on large or 
small simple or gradient SDS-PAGE gels. This MAb also recognized a single, 
xenobiotic-inducible protein in all fish species tested. Of special interest was the 
reactivity of the antibody with the Fundulus P-450E orthologue. As expected, 
MAb 1-12-3 recognized a single, BNF-inducible band, which had a Mr near that 
of scup P-450E. MAb 1-12-3 also strongly inhibited EROD activity in hepatic 
microsomes from induced scup and trout. Thus, the antibody is specific not only 
for the denatured protein separated by SDS-PAGE, but also for the protein in its 
catalytically competent state in the microsomal membrane. This antibody was 
utilized in all measurements of P-450E protein levels in control and BNF-treated 
Fundulus. 
The PAb, which recognized only P-450E out of the five scup P-450 
fractions available, also faintly recognized other microsomal proteins. This 
recognition of non-specific (and non-inducible) proteins was of greatest intensity 
in scup, and was reduced in Fundulus. Fortunately, proteins at Mrs near the 
P-450E orthologue were not recognized by the PAb in the immunoblotting 
187 
technique. P Ab inhibited EROD and Aim activity, but did not affect aminopyrine 
N-demethylase activity (which is known to be catalyzed by non-P450IA1 
isozymes in mammals). PAb also partially inhibited ethoxycomarin 0-deethylase 
activity (which is known to be catalyzed by P450IA1 plus other isozymes in 
mammalian microsomes). These results are all consistent with the specificity 
indicated by the immunoblot results: the antibody interferes with the catalytic 
function of the P-450E isozyme, but not with the functioning of other isozymes, in 
the microsomal environment. Precipitation was chosen for separation of the 
P-450E components from remaining cellular components. Because lattice 
formation is crucial for immunoprecipitation, PAb were preferred over MAb for 
such assays. These polyclonal antibodies were invaluable for precipitation of both 
RNA translation products and microsomal P-450E. 
Once the antibodies were characterized and shown to have the necessary 
specificity for P-450E, and reactivity with P-450E in a variety of species, I could 
use them in addressing questions of regulation of P-450E induction. The mode of 
PAH-type induction was investigated by examining hepatic P-450E isozyme 
content, EROD catalytic activity, and P-450E mRNA levels in Fundulus after 
exposure to a single dose (50 mg!kg) of BNF. First, the temporal patterns of 
P-450E protein and EROD activity induction at l6°C were established. In a 20 day 
experiment, EROD activity was significantly elevated in BNF-treated animals 
compared to corn oil-treated controls from Day 4 through Day 20. 
Immunodetectable P-450E showed the same trend, with consistently low control 
values and at least a 19-fold increase in the BNF-treated fish. P-450E protein and 
EROD activity were highly correlated (r2 > 0.9 for all individuals), as expected if 
P-450E is the BNF-inducible EROD catalyst. P-450E protein increased from 
control levels of about 5% of the microsomal P-450 population to up to 75% in 
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BNF-treated animals. (Because purified P-450E is not available for the killifish, 
these numbers are based on the assumption that MAb 1-12-3 has the same affinity 
for Fundulus P-450E as for the standard, scup P-450E, and that protein effects do 
not alter the detectable signal in a purified preparation compared to a microsomal 
sample.) 
High levels of DNase activity had been observed during scup, winter 
flounder, and Fundulus hepatic DNA isolation experiments (E. Metz and P.J. 
Kloepper-Sams, unpublished observations). This activity was not seen for trout 
hepatic tissue or for scup or trout gonadal tissue, indicating that the nucleases were 
not introduced by experimental error or contamination. Thus, to avoid possible 
similar problems with hepatic RNA isolation, I employed a method designed for 
extraction of intact RNA from pancreatic tissue, which has extremely high levels 
of RNase activity (Chirgwin et al., 79). Teleost RNA was isolated with the 
guanidine thiocyanate method, resulting in typical OD 260/280 ratios of 2.0. The 
RNA exhibited 2 bands corresponding to the two major moieties found in total 
RNA, the large and small subunit ribosomal RNA, when electrophoresed on 
formaldehyde/agarose gels. Thus, the preparations appeared to be free of protein 
and phenol contamination and to contain full-size RNA. After preliminary 
experiments to establish favorable RNA concentrations and translation conditions, 
the RNA was used in in vitro translation reactions in the presence of [3H]-leucine. 
Precipitation of Fundulus liver RNA translation products with anti-P-450E PAb 
gave no detectable signal from control fish, while BNF-treated animals showed 
incorporation of [3H]-leucine into a single 56,000 Mr band. 
In a shorter term experiment (48 hr), EROD activity and P-450E levels 
were again coordinately increased in response to BNF treatment. These values 
corresponded well with the values obtained in the 20 day experiment, indicating 
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that these animals were following the same time course of P-450E and EROD 
induction. Immunoprecipitation of translation products from the BNF-treated fish 
showed increased signal for all time points 6 hours or more post-treatment. The 
control P-450E mRNA levels were all below the limits of detection. Thus, a 
second method of P-450E mRNA detection was developed and employed. 
eDNA pfPI450-3' encodes the rainbow trout P450IA1 gene (Heilmann 
et al., 88). Although non-radioactive detection techniques provided ambiguous 
results, the eDNA nick-translated in the presence of [32P]-dC1P yielded discrete, 
unique hybridization bands on Southern blots with scup, trout and Fundulus 
genomic DNA. A Northern blot of RNA from control and BNF-treated Fundulus 
showed increases in a single band in the BNF samples with time when probed 
with the [32P]-labeled trout eDNA. The control was detectable using this probe, 
and by 6 hr the signal was strongly increased over the control, as expected based 
on the translation/immunoprecipitation data. P-450E mRNA increases preceded 
P-450E protein and enzyme activity increases by about 25 hr, supporting the 
hypothesis that transcriptional enhancement is involved in induction of PAR-
inducible P-450s in fish. In another BNF experiment, protein and mRNA levels 
were examined for a longer time period, to ensure that a secondary peak in P-450E 
mRNA, or maintenance of a moderate, sub-maximal level of mRNA, was not 
responsible for the persistence of the P-450E protein as seen in the 20 day 
experiment. Fundulus P-450E mRNA levels declined rapidly, reaching control 
levels by 5 days, while protein and activity levels remained elevated for at least 13 
days. Thus, P-450E induction appears to be not only regulated by transcriptional 
enhancement, but also by other forms of regulatory control. 
Given the differences between mRNA and protein patterns, it was 
interesting to determine whether P-450 protein has an extremely long half-life. 
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Although various studies have examined bulk protein turnover in different fish 
tissues, I found no reports focusing on specific proteins. Microsomal protein, 
P-450E protein, and P-450E heme half-lives (ti/2) were examined in Fundulus 
under conditions of elevated P-450E expression. Decay in incorporated radiolabel 
([3H]-leucine and [14C]-ALA) was followed over time. The immunoprecipitation 
method used for RNA translation products was modified for precipitation of 
P-450E protein from microsomes. A preliminary ([3H]-leucine only) experiment 
indicated that Fundulus rnicrosomes contained no free radiolabeled amino acids at 
2 or 23 hr after injection, and that specific radioactivity was higher at 2 than at 23 
hr. 
In a longer experiment, [14C] counts were not detectable in total 
microsomes, but a peak of [3H] incorporation into microsomal protein was 
observed at 1.5 hr after injection, followed by a rapid decrease and a stabilization 
at 30 hr. A calculation (Parkinson et al., 83a) of the "rapid" and "slow" phases 
indicated that "average" (summed, bulk) microsomal proteins had a "fast" tJ/2 of 
9.3 hr and a "slow" t112 of 190 hr. Both [14C] and [3H] were detectable in PAb-
precipitated P-450E. Leucine incorporation peaked at 1.5 hr, with a second peak 
at 190 hr. Using only the early time points, P-450E protein was calculated to have 
a ti/2 of 32 hr. This was consistent with the 43 hr calculated from the time for 
P-450E to reach half the induced steady state (Berlin and Schimke, 69). 
Incorporation of [14C] into P-450E peaked at 8 hr, indicating a lag between leucine 
and ALA incorporation into the holoenzyme. The subsequent decline in [14C] was 
relatively slow, leading to a calculated heme t112 of 104 hr. Further studies of 
heme and apoprotein turnover will be needed to frrmly establish the roles of these 
players in the regulation of P-450E expression. 
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II. Speculations and Future Directions 
The results presented in this thesis provide some answers to the 
questions of how this complex system of induction might be controlled, but also 
indicate additional avenues of investigation. In addition, the techniques developed 
here can be used to examine a much broader range of environmental and regulatory 
questions (as is already underway with the use ofMAb 1-12-3 in immunoblots for 
examination of P-450E orthologue levels in a variety of species, including birds 
and whales). I would like to indicate briefly some of these fields of investigation, 
and include some areas which were not directly addressed in my laboratory work, 
but will soon be amenable to experimentation as the proper analytical tools become 
available. 
One of the first areas for expansion on our understanding of teleost 
P450IA1 induction is to confirm that transcription rates are enhanced prior to 
increases in P-450E mRNA levels. Isolation of nuclei can be adapted from the 
techniques of Gonzalez et al. (84), and the trout eDNA probe can be used to 
quantitate the RNA produced by nuclear run-off experiments. It might be useful to 
turn to the use of short oligomeric probes, rather than the 1.4 kb eDNA now 
available. Solution hybridization techniques result in much more rapid, and 
sensitive, detection capabilities. Thus, it would be possible to obtain good values 
for all control animals, have more confidence in the fold induction occurring, and 
process multiple samples routinely. Some technical problems must be faced prior 
to the use of this method, however. Use of short "oligos" requires detailed 
knowledge of the nucleotide sequence of the gene in question- several mismatches 
within the necessary 20 to 30 basepairs would probably result in S 1 nuclease 
attack in this region and lead to incorrect results. The trout P450IA 1 gene has 
been sequenced (Heilmann, et al., 88), but it is not known how similar the scup, 
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Fundulus and winter flounder sequences are to the trout sequence. Although the 
sequences of the scup and trout amino-terminal ends are known (Table 3-5), an 
area such as the heme-binding region may be more highly conserved across multi-
species boundaries. Ideally, a suite of oligomeric probes (one per species) or a 
probe which recognizes a sequence identical in all routinely analyzed fish should 
be made. Sequencing of a putative common region in several teleost species could 
be accomplished by employing PCR (polymerase chain reaction) methods. 
One aspect of the induction response, which can be easily manipulated in 
poikilotherms and may provide new insights into the induction process, is 
temperature dependence. Fundulus were chosen as experimental animals partially 
due to their tolerance of a wide range of temperatures. It would be interesting to 
conduct a time course experiment similar to those in Chapter 4, and compare 
P-450E mRNA and protein levels over time at high and low temperatures. 
Stegeman found no apparent AHH induction in Fundulus after 96 hr at 6°C, while 
animals held at 16.5°C were responsive (Stegeman, 79). It is likely that at later 
times, Fundulus at low temperatures would exhibit responsiveness to inducers. 
The turnover of mRN A, protein, and heme may also be affected by temperature. 
Thus, changes in water temperature may allow the investigator to "tease apart" the 
mechanisms that may occur so rapidly in mammals as to appear to be causally 
linked. 
A single report has proved evidence for an Ah receptor-like moiety in 
teleosts (Heilmann et al., 88). Interestingly, these researchers employed a method 
which was unsuccessful in other hands (Denison et al., 85). Others were unable 
to identify a fish Ah receptor, although employing more recent and more sensitive 
techniques (J. Hamilton, personal communication). Preliminary results with scup 
and winter flounder cytosols were also inconclusive (M.E. Hahn, unpublished 
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observations). The imminent availability of anti-Ah receptor antibodies may 
provide the sensitive probes needed to address this question more fully in a 
number of non-mammalian species. It is likely that an Ah receptor, if present in 
fish, will be similar enough to the mammalian receptor to be cross-reactive with 
these antibodies. Preliminary dose-response effects with several PCB congeners 
(Gooch et al., submitted; Appendix I.) indicate that a fish Ah receptor might have 
different ligand-binding properties - that is, it may not show the same relative 
binding affinity for planar and "mixed-type" PCB congeners that mammals do. In 
addition, if the 5' non coding region of the teleost P450IA 1 gene were known, it 
would be easy to identify possible DREs, enhancers and receptor binding sites. 
The possible role of the carcinogen binding protein, which is about as abundant in 
scup as in mouse cytosol (Barton and Marietta, 88), should also be further 
examined. 
It should be clear that a number of questions remain about the 
mechanisms underlying the induction of :MFO activities in teleosts in response to 
foriegn compounds. A variety of findings, from correlations of temporal changes 
in protein and catalytic specific activity to inhibition of a subset of P-450-type 
reactions by antibodies recognizing but a single P-450 isozyme, have established 
that P-450E is in fact the major teleost BNF- (PAH-) inducible EROD and AHH 
catalyst. The prolonged induction response observed is due to the persistence of 
the P-450E protein, which has been newly synthesized following exposure to the 
xenobiotic. P-450E mRNA levels increase prior to increases in protein or activity, 
suggesting that transcriptional enhancement plays a role in induction. 
Transcription rates must be measured before this hypothesis can be confirmed. In 
addition, it is still not firmly established that an Ah receptor-like molecule plays a 
role in teleost P-450E induction. Further characterization of the receptor, its 
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ligand-binding properties, and the putative receptor/ligand binding sites on the 
P450IA1 DNA should shed light on this question. 
P-450E mRNA peaks within one or two days and declines rapidly to 
control levels, while P-450E protein and catalytic activity remain elevated for at 
least 20 days. This suggests that P-450E protein has a relatively long half-life, in 
contrast to the rapid induction and loss of activity (and protein) seen in mammals 
treated with the same inducing chemicals. Results of a dual label turnover study 
are not totally clear. While a portion of the P-450E apoprotein appears to turn over 
fairly rapidly, there may be a more stable sub-population as well. The heme 
moiety appears to have a longer half-life than the rapidly degraded P-450E 
apoprotein, but incorporation of "old" heme into "new" apoprotein, or heme 
switching, was not addressed. These results indicate that the method of 
imrnunoprecipitation of labeled P-450E can be employed to more closely examine 
turnover questions. 
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APPENDIX 
I. Induction of P-450E by PCB Con~eners 
Our laboratory group has been interested for some time in the capacity of 
environmental contaminants to induce teleost P-450E (P450IA1). Most of our 
work, including my investigation of the mechanisms of regulation of P-450E, has 
focused on PAH-type compounds. Polychlorinated biphenyls (PCBs) are another 
dominant class of environmental contaminants. It has been well established that 
PCB mixtures, such as Aroclor 1254, can induce teleost as well as mammalian 
MFOs (Melancon et al., 81; Melancon and Lech, 83; Ankley et al., 86). Much 
less is known about which of the myriad congeners are the active inducing agents. 
To address this question, scup were treated with several individual PCB congeners 
(Figure A1), which were chosen for their dominance in environmental residues 
and their ability· to induce mammalian P-450 isozymes. The following 
characteristics were analyzed in livers of scup sacrificed six days after i.p. 
treatment: P-450E mRNA levels, P-450E protein levels, and EROD activity. 
mRNA was measured by the indirect method of in vitro translation-
immunoprecipitation (Chapter 3), protein was measured by immunoblotting with 
MAb 1-12-3 (Chapter 2), and EROD activity was measured spectrophotometrically 
according to Klotz et al. (84 ). 
Congener 77 (3,4,3',4'-tetrachlorobiphenyl [TCB]), a strong inducer of 
mammalian P-450IA1, was the only PCB congener tested to elicit a significant 
response in scup hepatic tissue. (Higher doses of the other congeners may be 
tested in future studies for response.) Surprisingly, this TCB caused the strongest 
EROD activity increase at the lowest dose used (0.1 mg/kg). I performed 
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Figure Al. PCB Congeners. 
Congeners were tested for their ability to induce scup P-450E mRNA 
levels, P-450E protein levels, and EROD activity levels. 
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in vitro translation/immunoprecipitation assays as described in Chapter 3 to 
determine whether TCB elicited a P-450E mRNA increase at each dose. At Day 6, 
the only time examined, all doses of TCB resulted in a marked increase in P-450E 
mRNA to similar intensities (Figure A2). Although immunodetectable P-450E 
protein content was highest at the low dose, it did not decline to the same degree as 
did EROD activity at higher doses of TCB. 
It is possible that, given the high levels of P-450E mRNA at each TCB 
dose, about the same amount of P-450E protein is synthesized in these animals. 
The decline in immunodetectable P-450E protein at higher doses may be due to 
increased destabilization and degradation of the protein at higher concentration of 
TCB. Preliminary in vitro experiments suggest that the TCB may be acting as a 
competitive inhibitor of the P-450E-catalyzed EROD activity. Such a mechanism 
is not unprecedented: in rats, the P-450d inducers isosafrole and 3,4,5,3',4',5'-
HCB bind to the isozyme and inhibit its normal activities (Voorman and Aust, 88). 
(It is also possible that bound TCB could block the binding of MAb 1-12-3 to the 
antigen and cause an underestimate of the P-450E protein content.) 
The "positive control" BNF dosage elicited P-450E mRNA levels above 
the com oil control levels, but distinctly lower than the TCB-induced RNA levels 
(Figure A2). (Densitometric analysis of RNA from congener 118-treated scup 
resulted in P-450E mRNA levels between the very low control and the faint BNF 
band.) Based on the results obtained with Fundulus -particularly given that the 
temperature of the scup experiment was elevated compared to that of the Fundulus 
experiments (20°C vs. 14-l6°C) - the BNF value probably represents a 
submaximal P-450E mRNA level. BNF-inducible mRNA levels presumably 
peaked prior to six days and then declined rapidly (compare Figure 4-8), while 
TCB-induced levels may have remained elevated much longer. 
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Figure A2. Immunoprecipitated translation products from PCB experiment. Scup 
RNA was isolated, translated in the presence of [3H]-leucine, and immuno-
precipitated with a non-immune antibody followed by PAb 119 (see Chapter 3, 
Materials and Methods, for details). Congener identification and dosage used is 
indicated below each lane on the fluorograph. CON== com oil-treated controls. 
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A B 
Congener CON 105 
DOSE (mg/kg) 1 
Congener CON 
DOSE (mg/ kg) 
J 
118 
1 
C D E 
105 
5 
K 
118 
5 
201 
L 
77 
1 
F 
138 
1 
M 
77 
5 
G H 
138 
5 
N 
77 
10 
0 
~NF 
20 
In the presence of some PCB congeners, both mammalian P-450c 
mRN A and protein levels achieve a maximum after longer intervals than is seen 
with PAH-type inducers such as BNF (compare discussion below with 
Discussion, Chapters 3 and 4). Yeowell et al. (88) followed the induction 
response in rats after treatment with 50 mg!kg congener 169 (3,4,5,3',4',5'-
HCB). P-450c mRNA peaked at Day 3, and protein levels achieved a maximum at 
around 5 days after treatment. By the last time point tested, 7 days, the P-450c 
mRNA levels had declined to about 50% of the maximum. Unfortunately, this 
and similar studies did not document the decline of mRNA levels until they 
returned to control values. Thus, it is difficult to determine whether the 
presistence of the protein is dependent upon maintenance of higher-than-control 
mRNA levels (i.e., P-450c mRNAs may have plateaued at 50% maximal values 
for a few days) or upon some other mechanism .. Parkinson et al. (83a) found that 
P-450c protein was induced to an elevated steady state level for about 17 days by 
Aroclor treatment. In that study, mRNA levels were not measured. If my 
interpretation of the scup results is correct, it is probable that the rat P-450c mRNA 
levels were also elevated for a longer period of time than is seen with fast-acting 
inducers. Another interesting area is a comparison between the slowly and rapidly 
metabolized inducers. Do P-450c mRN A levels remain elevated longer after 
TCDD as opposed to BNF or MC treatment?! Experiments with 2,3,7,8-
tetrachlorodibenzofuran in this laboratory have indicated a longer scup P-450E 
protein induction response to the furan compared to BNF or other PAH-type 
compounds; P-450E mRNA levels have yet to be examined (M.E. Hahn, 
unpublished observations). 
These results provide a caveat for those seeking a "quick fix" to the 
questions of suitable environmental biomonitors. The scup work was part of a 
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collaborative effort with several members of the laboratory, and is described in 
detail in "Effects of ortho and non-ortho substituted polychlorinated biphenyl 
congeners on the hepatic monooxygenase system in scup (Stenotomus chrysops)," 
an article undergoing review in Toxicology and Applied Pharmacology (Gooch et 
al.). 
IT. Scup P-450E rnRNA Induction 
Although the eDNA pfP1450-3' prepared by Heilmann et al. (88) was 
tested for cross-reactivity with genomic DNA from three teleost species and RNA 
from Fundulus (Chapter 4), the research described in Chapters 1 through 5 does 
not further evaluate the properties of this eDNA. Subsequent use of this probe 
will center around the measurement of scup and other teleost P-450E rnRNA 
levels. Thus, I examined scup P-450E mRNA levels in animals at two times 
following treatment with 20 mg!kg BNF. The hepatic microsomal MFO 
parameters (values courtesy of Bruce Woodin, unpublished observations) are 
shown in Figure A3. EROD activity (expressed on a per mg microsomal protein 
or on a per nmol P-450 basis) is above control levels by Day 2 and further elevated 
by Day 3. The same trend is evident for irnmunodetectable P-450E protein. 
Northern blots of total scup RNA were carried out as described in 
Chapter 4. The autoradiogram indicated striking differences between the control 
and the BNF-treated animals (scan results, Figure A3). Control values were low 
but detectable (cl not detectable and not calculated in the results). Day 2 RNA 
showed the strongest signal; Day 3 values were still quite high. The eDNA 
pfP1450-3' thus hybridizes specifically to a single band in scup RNA, a band 
which is induced by BNF treatment. Although the numbers of animals analyzed in 
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this experiment is small, it seems apparent that although EROD activity and 
P-450E protein content have the highest values at Day 3, the P-450E mRNA levels 
peaked at Day 2. Thus, the results of this preliminary experiment are consistent 
with the temporal pattern observed for Fundulus increases: mRNA levels appear 
to reach their maximum prior to increases in P-450E protein or activity levels. The 
low level of scup P-450E mRNA seen 6 days after BNF treatment (Appendix 1.) 
suggests that by this time, scup mRNA levels have declined significantly. Again, 
this is consistent with the results obtained with Fundulus experiments. 
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Figure A3. Scup MFO parameters and P-450E mRNA levels after treatment 
with BNF. 
Scup were treated with 20 mg/kg BNF and sacrificed at the times 
indicated. Catalytic activities and immunodetectable P-450E protein were 
determined as before (see text). P-450E mRNA values were determined by 
hybridization to a [32P]-labeled trout P4501Al eDNA (Heilmann et al., 88). 
mRNA values were transformed to fit onto the scale of the bar graph. 
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1 A recent article reports that 10 or 100 ug/kg TCDD treatment causes prolonged 
elevation of rat P-450c mRNA (total RNA measured in dot blots by hybridization 
with a eDNA recognizing both P-450c and P-450d, indicating that values may 
include induction of both isozymes). Both Allli activity and mRNA levels peaked 
at about Day 2 and remained essentially at the same elevated level for 22 days, or 
for as long as the animals were examined (Dunn et al., 88). 
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